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Abstract 
Streptomycetes produce a plethora of secondary metabolites, including antibiotics, and 
undergo a complex developmental cycle. The GC-rich species, Streptomyces coelicolor is 
used by many laboratories as a model for studying gene regulation, morphological 
development, cellular physiology and microbial signalling. A genome-wide view of many 
factors that control S. coelicolor gene expression at the level of transcription initiation and 
beyond was obtained successfully from a combination of RNA-sequencing approaches. For 
instance, sites of transcription initiation, vegetative promoters, leaderless mRNAs, sites 
involved in the processing and degradation of rRNA, tRNA and mRNA, and small RNAs, 
including those that may be involved in attenuation-like switching mechanisms, were 
successfully detected. Many of the small RNAs identified in this study are novel. Overall, our 
approaches show the ability to identify new layers of transcriptional complexity associated 
with several key regulators of secondary metabolism and morphological development in S. 
coelicolor. Here we were able to show that AtrA activates the transcription of ssgR, the gene 
product of which is in turn required for the transcription of ssgA, the best-studied SALP, 
which has a crucial role in septation and the morphology aerial hyphae. AtrA also binds to 
the promoter region of leuA2, which encodes α-isopropylmalate that directly utilise acetyl-
CoA. Interestingly, crude extract from M1146 strain (Δact, Δred, Δcpk, and Δcda) was found 
to inhibit the DNA-binding activity of AtrA; however, the specificity of the small molecule(s) 
interaction with AtrA should be investigated. Addition of the 3 x FLAG tag™ to the N-
terminus of AtrA does not hinder its ability to substitute functionally for untagged AtrA in S. 
coelicolor and can be used for the mapping of AtrA binding sites by ChIP-sequencing. Taken 
together the above suggest that AtrA has a direct role in morphological development and 
coordinating the utilisation of acetyl-CoA for primary and secondary metabolism. 
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Chapter 1 
1 Introduction 
1.1 Streptomyces 
Streptomycetes are thought to have first evolved about 450 million years ago, 
eventually giving rise to many Streptomyces species, of which 576 have been described 
to date (Embley & Stackebrandt, 1994, Labeda, 2011). Streptomyces are Gram-positive, 
aerobic, soil-dwelling and high GC content (72-73 %) bacteria that belong to the family 
Streptomycetaceae within the Actinobacteria phylum (Waksman & Henrici, 1943, 
Ventura et al., 2007).  Streptomyces coelicolor A3(2) is one of the best-studied species 
of Streptomyces, and undergoes a complex lifecycle (Hopwood, 1999). Like other 
members of its genus, S. coeliocolor grows from a spore, which germinates in the 
presence of suitable nutrients and favourable growth conditions, and grows to form a 
branching vegetative mycelium. When nutrients are limited, the mycelium produces 
aerial hyphae that undergo septation to produce spores (Nodwell et al., 1999, Flardh & 
Buttner, 2009, Bibb, 2005).  This morphological differentiation coincides with the 
production of secondary metabolites (Figure 1.1). The programming of Streptomyces 
morphological differentiation can be broken down into two distict phases, which are 
aerial hyphae formation and spore maturation, and are regulated by bld genes (for 
bald) and whi genes (for white), respectively (Chater, 1993). 
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Figure 1.1: Schematic view of S. coelicolor life cycle. Substrate mycelium grows down 
into the medium by tip extension after spore germination. Depletion of nutrients leads 
to lysis of vegetative mycelium (dot lines), which in turn stimulate erection of aerial 
hyphae.  When extension of these aerial hyphae is complete, the apical cells septate to 
form mature spores. 
1.1.1 Aerial hyphyae formation regulatory networks 
The signals that regulate aerial hyphae formation and the underlying mechanism have 
been studied extensively in S. coelicolor. Most of these signals are encoded by bld 
genes, mutations in which can block the production of the fuzzy colony morphololgy of 
the wild-type (Claessen et al., 2006, Willey et al., 2006, Willey et al., 1993). The 
expression of chp and ram genes play important roles in hyphal erection and are 
dependent on Bld activities. In S. coelicolor, ram encodes and exports a small surface-
active peptide called SapB (Spore associated protein B) (Kodani et al., 2004). Mature 
SapB is a peptide of 21 amino acids encoded by ramS, which is a member of ram 
cluster that includes ramA, ramB, ramC. The ramABC genes encode components of an 
ABC transporter involved in SapB export. The ram cluster is positively regulated by 
another gene member, ramR (Willey et al., 2006, Kodani et al., 2004). The chp genes 
encodes chaplins (coelicolor hydrophobic aerial proteins), which are surface active 
proteins that share a conserved hydrophobic domain called the chaplin domain and a 
Sec secretion signal at their N-terminus (Elliot et al., 2003, Claessen et al., 2003). 
Collectively, SapB and the chaplins reduce surface tension between the aqueous milieu 
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of the vegetative mycelium and the air, thereby allowing  aerial hyphae to emerge 
from the vegetative mass and grow into air (Figure 1.2) (Elliot et al., 2003, Claessen et 
al., 2003). 
 
Figure 1.2: General view of extracellular signals of the bld cascade that govern aerial 
hyphae formation in S. coelicolor. ‘S’ with numbers that directed by arrow indicate the 
sequence of extracellular signals produced by bld genes, which stimulate ram and chp 
production. Short chaplins (ChpD-H, small brown circle with short tail) have single 
chaplin domain, which is a region present in each member of chaplin family, while long 
chaplins (ChpA-C, small brown circle with short tail) have two chaplin domain (Elliot et 
al., 2003). SapB and rodlin are represented as small blue and yellow circles, 
respectively. Rodlins are not required for aerial hyphae formation, but they are 
necessary for organising the chaplains into rodlet layer in the surface of aerial hyphae 
(Claessen et al., 2004). Chaplins and SapBs are exported from the cell by the Sec 
(secretory) system (Flardh & Buttner, 2009) and the ATP-binding cassette transpoter 
encoded by ramAB (Kodani et al., 2004), respectively. 
1.1.2 Sopre maturation regulatory networks 
Sporulation in S. coelicolor is affected by many genes including the whi genes (A, B, D, 
E, G, H and I), ftsZ, sigF, ssgA and SLAP genes (Flardh & Buttner, 2009). Mutants of whi 
can be classified into two groups, early (whiA, B, G, H and I) and late (whiD, E) genes 
depending on the effect of mutation on septation and spore maturation. These genes 
are required for septation and transcription of the late sporulation genes, i.e. ftsZ, sigF, 
whiD and the whiE cluster, which are necessary for spore maturation and pigmentation 
(see Figure 1.3) (Chater, 2006, Flardh et al., 1999). The whiG gene encodes the 
sporulation-specific σWhiG factor that directly activates the transcription of whiH and 
whiI (Ainsa et al., 1999, Ryding et al., 1998). The FixJ subfamily member WhiH 
responds to a change in small organic acids concentration during aerial hyphal growth, 
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while The GntR family member WhiI induces DNA condensation during sporulation 
process. The genes whiI and whiH appear to act in an autoregulatory manner, and 
whiH is negatively controlled by whiI (Ainsa et al., 1999, Ryding et al., 1998).  
On the other hand, whiA and whiB genes are transcribed by RNA polymerase 
associated with the whiG sigma factor (Ainsa et al., 2000, Soliveri et al., 1992). WhiB 
upregulates expression of whiA and acts as an autorepressor, while WhiA represses 
the transcription of whiB and is an autoactivator that positively regulates its own 
transcription (Jakimowicz et al., 2006). WhiA induces the expression of ftsZp2 
promoter, which encodes a tubulin-like protein that assembles into a cytokinetic ring 
(Z ring) to defines the site of cell division for sporulation septation (Mistry et al., 2008, 
Schwedock et al., 1997, Flardh et al., 2000). Another target for WhiA regulation is 
parAB promoter, which encode ParA and ParB that required for chromosome 
segregation and sporulation (Kaiser & Stoddard, 2011). Expression of the whiE cluster 
depends on sigF (Kelemen et al., 1996), which is required for synthesis of the grey 
polyketide spore pigment (Davis & Chater, 1990). The only interaction between bld 
and whi genes occurs via BldD, which represses sigma WhiG and whiB prior to 
sporulation (Jakimowicz et al., 2006, Elliot et al., 2001). 
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Figure 1.3: Schematic summary of the regulatory network of sporulation in S. 
coelicolor. Stealth arrows indicate positive effect, diamond arrows indicate negative 
effect. Information from (McCormick & Flardh, 2012, Kaiser & Stoddard, 2011, Chater 
& Chandra, 2006). 
1.2 Antibiotic production in Streptomyces  
Mycelial bacteria of the genus Streptomyces and their relatives are renowned as the 
premier source of the majority of antibiotics used clinically, in addition to many other 
therapeutics such as antihelmintics and anticancer agents (Baltz, 2008, Caffrey et al., 
2008, Graziani, 2009, Olano et al., 2009, Shiomi & Omura, 2004). Furthermore, such 
substances are only a proportion of the vast array of secondary metabolites (SMs) 
produced by this group (Challis, 2008, Davies, 2011). Most, if not all, Streptomyces are 
capable of producing numerous SMs (Corre & Challis, 2009, Gross, 2009, Nett et al., 
2009) and the timing of the production of SMs and the quantities generated are 
exquisitely sensitive to growth and environmental conditions (van Wezel & McDowall, 
2011). SMs are typically, although not invariably, produced when the period of most 
rapid growth gives way to slower growth and eventually the production of aerial 
hyphae and spores.  
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SM production has been associated with the depletion of sources of nitrogen, carbon 
or phosphate, and with the accumulation of small signalling molecules such as the 
stringent factor (p)ppGpp (Bibb, 2005, Chatterji & Ojha, 2001) and a family of γ-
butyrolactone microbial hormones (Hsiao et al., 2009, Horinouchi & Beppu, 2007, 
Takano, 2006). Where studied, it appears largely to reflect changes in the level of 
transcription of activators that are found with the corresponding biosynthetic genes as 
part of a cluster (Bibb, 2005, van Wezel & McDowall, 2011). It has also been proposed 
that certain cluster-situated regulators (CSRs) are controlled at the post-transcriptional 
level by the availability of the BldA leucyl-tRNA, which recognizes the rare UUA codon 
found in the genes of these regulators and some genes required for morphological 
development (Chater & Chandra, 2008, Chater, 2006, Chater, 2001). Examples of genes 
containing the TTA codon in S. coelicolor include actII-ORF4, redZ, adpA (bldH) and 
actA (Fernandez-Moreno et al., 1991, White & Bibb, 1997, Nguyen et al., 2003). 
As a means of establishing the regulatory pathways that control antibiotic production 
by the Streptomyces genus, the model species S. coelicolor and its close relative S. 
lividans have been screened numerous times to identify mutants (> 50) that regulate 
the production of antibiotics (Bibb, 2005, van Wezel & McDowall, 2011). Indeed the 
importance of S. coelicolor as a model species stems largely from two of its main SMs 
being pigmented; actinorhodin (ACT) is blue, while undecylprodigiosin (RED) is red. 
This pigmentation makes the detection of mutants that affect secondary metabolism 
relatively easy. Despite these endeavours, only one regulatory pathway has been 
described for S. coelicolor that extends without gaps from a signalling molecule all the 
way through to the transcriptional activation of biosynthetic genes. Most of the 
currently identified regulators of secondary metabolism can be viewed as isolated 
pieces of a complex jigsaw, with few links to each other and the signals they transduce. 
In addition to ACT and RED, S. coelicolor produces undecylprodigiosin, calcium 
dependent antibiotics, cryptic polyketide and methylenomycins. 
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1.2.1 Undecylprodigiosin (RED) 
Undecylprodigiosin, also known as Red, is a member of prodiginine family, which 
comprises red-pigmented tripyrrole antibiotics possessing anti-cancer, 
immunosuppressant and antimicrobial properties (Feitelson & Hopwood, 1983, White 
& Bibb, 1997, Williamson et al., 2006). This highly nonpolar tripyrrole compound is 
chemically similar to prodigiosin produced by Serratia marcescens, and has ability to 
inhibit the proliferation of human T and B lymphocytes without damaging the cells 
(Williamson et al., 2006, Songia et al., 1997). The orphan response regulator RedZ 
activates transcription of redD, the final regulator of the RED biosynthetic genes 
cluster (White & Bibb, 1997, van Wezel & McDowall, 2011). The control of redZ shares 
some features with that of the actII-ORF4 gene, with the promoter in both cases 
subject to repression by AbsA2 and DasR (Uguru et al., 2005), which suggests that the 
redZ promoter may respond to the level of GlcNAc and regulates production of 
antibiotic (Rigali et al., 2008). The binding of RedZ to the redD promoter is inhibited by 
undecylprodigiosin in vitro, suggesting the existence of a feedback loop for modulating 
Red biosynthesis (Wang et al., 2009). 
1.2.2 Calcium Dependent Antibiotics (CDAs) 
CDA is an acidic lipopeptide belonging to a family of anionic undecapeptides that 
includes daptomycin produced by Streptomyces roseosporus, and friulimicins produced 
by Actinoplanes fruliensis (Debono et al., 1988, Vertesy et al., 2000). CDAs are effective 
in the presence of calcium ions against a wide range of Gram-positive bacteria.  They 
disrupt cell membrane function with effects similar to those of the cationic 
antimicrobial peptides, such as daptomycin (Kempter et al., 1997, Lakey et al., 1983, 
Jung et al., 2004). The cda gene cluster (82 kb) contains forty genes, of which twenty 
involved in the biosynthesis of seven CDAs with different functional group and the 
same peptide sequence (Hojati et al., 2002). The CDA cluster is regulated by three 
genes, which are absA1, absA2 and cadaR. Tailoring enzymes asnO, hasp and trpO 
modify each variant after been released from cdaPS3 and cyclised (Hojati et al., 2002). 
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1.2.3 Cryptic Polyketide (CPK) 
Both yellow-cryptic polyketide (yCPK) and polyketide-derived antibiotic (CPK) are final 
products of cpk cluster (Liu et al., 2013). The extracellular molecules, γ-butyrolactone, 
SCB1 and SCBs have been shown to regulate the cpk cluster (Takano et al., 2005a). The 
cpkO gene, a pathway-specific transcriptional activator essential for CPK biosynthesis, 
is regulated by ScbR, which also binds to operator sites in the bidirectional scbA/scbR 
promoter to activate SCB biosynthetic gene scbA (Takano et al., 2005a, Wietzorrek & 
Bibb, 1997). SCBs binds to ScbR and prevent ScbR from interaction with scbA/scbR 
promoter (Gottelt et al., 2010). As a result of ScbA and ScbR production, a heterodimer 
of the two proteins form, which bind to a different site upstream of scbA to activate its 
transcription. Subsequently, the produced SCBs bind to all free ScbR and activate cpkO 
transcription (Gottelt et al., 2010). It is worth mentioning that cpkO is directly 
repressed by phosphate response regulator (RR) PhoP and AfsQ1 (Wang et al., 2013, 
Allenby et al., 2012). 
1.2.4 Methylenomycins (Mm) 
The linear plasmid SCP1 in S. coelicolor A3(2) harbours the methylenomycin gene 
cluster (mmy cluster), which includes 21 genes that involve in regulation (mmfR, L, H, 
P-mmyR and mmyB), self resistance/export (mmr) and biosynthesis of methylenomycin 
(Kirby & Hopwood, 1977, Bentley et al., 2004, O'Rourke et al., 2009). Methylenomycin 
A is a cyclopentanone antibiotic that has an activity against Gram-positive bacteria and 
some Gram-negative strains (Haneishi et al., 1974). Methylenomycin C (desepoxy-4,5-
didehydromethylenomycin A) has been shown to be the Mm precursor, while  
methylenomycin B demonstrated to result from the spontaneous decarboxylation of 
Mm C under acidic conditions (Challis & Chater, 2001, Corre & Challis, 2005). 
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1.2.5 Actinorhodin biosynthesis overview in S. coelicolor 
ACT is an aromatic polyketide antibiotic that is red at acidic pH (below 8.5) and blue at 
basic pH (above 8.5) (Wright & Hopwood, 1976). It is found intracellularly, but a 
lactone form called γ-actinorhodin is excreted (Bystrykh et al., 1996). The biosynthesis 
of ACT is well characterised, but not fully understood (Figure 1.4) (Carreras & Khosla, 
1998, Craney et al., 2013). It starts with the condensation of one acetyl-coenzyme A 
unit and seven malonyl-CoA extender units (Fernandez-Moreno et al., 1992) by the 
minimal polyketide synthase (PKS) (Carreras & Khosla, 1998, Craney et al., 2013), 
which is composed of a ketosynthase (KS) with two subunits (α and β) and an acyl 
carrier protein (ACP) (Matharu et al., 1998). The genes corresponding to the minimal 
PKS are located within the actI region of the cluster (Craney et al., 2013). The 
octaketide is reduced at the C-9 position by a ketoreducase (KR) encoded by a single 
gene within the actIII region. This reduction, which converts a keto to a hydroxyl 
group, primer the octaketide for the first of three ring cyclisations, which is catalysed 
by an aromatase (ARO) that produces a hydroxyl group at C-11 as well as removing the 
keto group at C-7 (McDaniel et al., 1994, Javidpour et al., 2013). 
The second cyclisation is catalysed by a cyclase (CYC) that removes the keto at C-5. The 
ARO and CYC enzymes are encoded by single genes within the actVII and actIV regions, 
respectively. The resulting bicyclic intermediate now released from the ACP is then 
reduced at C-3 by a dehydrogenase, the third ring is produced and the hemiketal 
dehydrated to form (S)-DNPA (Fernandez-Moreno et al., 1994). At one point it was 
thought that the third ring closure is catalysed by the product of actVI-ORF3, but a 
more recent study implicates the produce of actVI-ORF1 (RED1) (Taguchi et al., 2000). 
The product of actVI-ORF1 has also been implicated in the C-3 reduction and the 
dehydration step (Taguchi et al., 2000). Clearly much of the enzymology of the steps 
immediately prior to (S)-DNPA remains to be resolved. The product of actVI-ORF2 with 
the assistance of the actVI-ORF4 product, both of which resemble reductases, are 
thought following ring closure to reduce the double bond between C-14 and C-15 of 
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(S)-DNPA to produce DDHK (5-deoxy-dihydrokalafungin) (Fernandez-Moreno et al., 
1994, Taguchi et al., 2000). 
DDHK is oxidised at C-6 to form dihydrokalafungin (DHK ) by the product of actVA-
ORF5, a flavin-dependent monooxygenase (FMO), which forms a two subunit system 
with the product of actVB, a flavin: NADH oxidoreductase (Taguchi et al., 2011, 
Okamoto et al., 2009). It should be noted that earlier studies had tentatively assigned 
other gene products to this role. The tricyclic intermediate is dimerised at C-10 in the 
next step by the product of actVA-ORF4 and then further oxidised at C-8 by the two 
subunit; ActVA-ORF5/ActVB system or alternatively oxidised and then dimerised 
(Okamoto et al., 2009, Taguchi et al., 2013, Taguchi et al., 2012). The product of either 
of these final routes is ACT (Figure 1.4). Actinorhodin is then exported by the products 
of actII-ORF2/3 (now called actAB) operon, which is regulated by the product of actII-
ORF1 (actR) (Tahlan et al., 2007). Both ACT and its 3-ring intermediates, e.g. (S)-DNPA, 
relieve repression by ActR (Xu et al., 2012). The cluster-situated activator of the 
transcription of act biosynthesis is the product of actII-ORF4 (Rudd & Hopwood, 1979, 
Hallam et al., 1988, Fujii et al., 1996, Gramajo et al., 1993). Several genes within the 
act cluster remain to be assigned clear functions. These included actVA-ORF1, actVA-
ORF2 and actVA-ORF3. ActVA-ORF1 resembles ActII-ORF2, which is involved in ACT 
export (Bystrykh et al., 1996). However, disruption of actII-ORF2 did not affect the 
ability to export ACT (Fernandez-Moreno et al., 1991), which suggests that ActVA-ORF1 
engages in ACT export either with actII-ORF2 assistance or as a separate channel 
(Caballero et al., 1991). 
As outlined above, the gene products of the act cluster produce one molecule of ACT 
from fourteen molecules of malonyl-CoA and two molecules of acetyl-CoA. The supply 
of these carboxylic acid precursors through the catabolism of carbon substrates and 
their utilisation by competing pathways has an impact on the yield of ACT (Ryu et al., 
2006). Undecylprodigiosin, the other pigmented antibiotic produced by S. coelicolor, 
needs six molecules of malonyl-CoA to produce a 2-undecylpyrrole intermediate (Mo 
et al., 2008). All members of the polyketide family of antibiotics, which includes 
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tetracyclines, anthracyclines, angucyclines, macrolides, polyenes, ansamycins, 
polyenes, tetranoates and isochromanequinones, are synthesised from small 
carboxylic acids in a manner which has much in common with the biosynthesis of fatty 
acids (Robinson, 1991, Zotchev, 2012). The similarities between polyketide and fatty 
acid biosynthesis, in particular the modular nature of the synthases that produce the 
carbon backbone has been the subject of several excellent reviews and will not be 
described herein (Staunton & Weissman, 2001, Donadio et al., 2007, Hertweck et al., 
2007, Kwan & Schulz, 2011). Small carboxylic acids are also required for the production 
of peptide β-lactams antibiotics. However, small carboxylic acids are not required for 
the production of all antibiotics; aminoglycosides being an example. 
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Figure 1.4: Actinorhodin biosynthesis overview. (A) 21283 bp ACT cluster is colour 
coded. actII-ORF4 activator gene is in purple and actR repressor in red. actI genes are 
in pink. Tailoring genes are coloured depending on their role in forming ACT (light, 
medium and dark blue). Putative resistance genes are in brown. Uncharacterised genes 
are in green. (B) ACT biosynthetic pathway, which adapted from (Taguchi et al., 2013). 
KSα, beta-ketoacyl synthase alpha subunit; KSβ, beta-ketoacyl synthase beta subunit; 
ACP, acyl carrier protein; KS, ketosynthase; KR, ketoreductase; ARO, aromatase; CYC, 
cyclase. 
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The route from glucose, as an example, through substrate catabolism to the 
production of acetyl- and malonyl-CoA is shown in Figure 1.5. The route goes via the 
Embden-Meyerhof, Entner-Doudoroff, and pentose phosphate pathways and is subject 
to regulation by key enzymes in these individual pathways. Moreover, it has been 
shown that manipulation of central carbohydrate metabolism can increase the 
production of ACT in S. coelicolor. For example, overproduction of acetyl-CoA 
carboxylase (ACCase) increased the efficiency of the conversion of glucose to ACT (Ryu 
et al., 2006). Culture conditions, in particular media formulations and available oxygen 
can alter flux through the pathways of central metabolism and consequently the level 
of precursors available for secondary metabolism (Olano et al., 2008).  
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Figure 1.5: The sequence of enzymatic reactions in the glucose metabolism for Act 
production in S. coelicolor. The abbreviations used are as follows: G6P, glucose-6-
phosphate; F6P, fructose-6-phosphate; F1,6DP, fructose-1,6-diphosphate; GAP, 
glyceraldehyde-3-phosphate; 1,3 BPG, 1,3-diphosphoglycerate; 3PG, 3-
phosphoglycerate; 2PG, 2-phosphoglycerate; PEP, phosphoenolpyruvate; 6PGL, 6-
phosphoglucolactone; 6PG, 6-phosphogluconate; Ru5P, ribulose-5-phosphate; Ri5P, 
ribose-5-phosphate; Xu5P, xylulose-5-phosphate; SHu7P, sedoheptulose-7-phosphate; 
E4P, erythrose-4-phosphate; HK, hexokinase; Pfk, phosphofructokinase; Adl, aldolase; 
Tpi, triose phosphate isomerase; GpdH, glyceraldehyde-3-phosphate dehydrogenase; 
Pgk, phosphoglycerate kinase; Pgm*, phosphoglycerate mutase; Eno, enolase; Pyk, 
Pyruvate kinase; Pdh, pyruvate dehydrogenase; ACCase, acetyl-CoA carboxylase; Zwf, 
glucose-6-phosphate dehydrogenase; Pgm, phosphoglucomutase; Pgl, 
phosphoglucolactonase; PgdH, phosphogluconate dehydrogenase; Ppi, 
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phosphopentose isomerase; Tkl, transketolase; Tal, transaldolase. Taken from (Ryu et 
al., 2006). 
1.3 ActII-ORF4, its regulon and regulation 
The nomenclature of regions within the act cluster stems from the classification of 
mutants blocked in ACT biosynthesis on the basis of co-synthesis experiments. 
Mutants in the same class were unable to produce ACT using intermediates produced 
by other mutants of the class, while mutants of different classes could produce ACT 
using intermediates produced by mutants of another class with the exception of class 
II, which were unable to produce ACT using intermediates that accumulated in any of 
the other classes (Rudd & Hopwood, 1979). It was presumed, correctly it transpires, 
that these mutants were deficient in a positive-regulatory factor. This notion gained 
further credence with the finding that a fragment of the act cluster when inserted into 
a multi-copy-number plasmid was not only able to restore, but increased ACT 
production by Class II mutants (Hopwood, 1986). Mutational analysis of the region of 
the act cluster that complements Class II mutants, guided by prior sequencing, 
identified actII-ORF4 as the gene encoding the positive regulator of ACT biosynthesis 
(Fernandez-Moreno et al., 1991). An analysis of transcript levels revealed the mRNA of 
actII-ORF4 increased as growth slowed, as did the mRNA of actIII and actVI-ORF1, but 
their increase was delayed relative to actII-ORF4 (Gramajo et al., 1993). The actII-ORF4 
gene contains the rare UUA codons recognised by BldA leucyl-tRNA (Fernandez-
Moreno et al., 1991). 
The product of actII-ORF4 belongs to a family of Streptomyces antibiotic regulatory 
proteins (SARPs), members of which are homologous to each other and share 
similarities with members of a larger family based on OmpR (Wietzorrek & Bibb, 1997), 
which is a well-characterised transcription factor that is part of a two-component 
system (TCS) that regulates the levels of the outer membrane porin F (OmpF) 
(Rampersaud et al., 1994, Batchelor et al., 2005). Many mutations that affect the 
production of ACT have been shown to affect the level of actII-ORF4 mRNA (Aceti & 
Champness, 1998). The simplest interpretation of these results is that the effects of 
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these mutations on ACT production are a consequence of direct or indirect effects on 
the transcription of actII-ORF4. Biochemical characterisation of ActII-ORF4 revealed 
that it binds to the intergenic regions of actVI-ORFA/ORF1 and actIII/actI, more 
specifically to two or three direct repeats that overlap the -35 regions of the 
corresponding promoters (Arias et al., 1999). These repeats and their location are 
characteristic of the DNA-binding sites of members of the OmpR family (Wietzorrek & 
Bibb, 1997). Subsequent bioinformatic analysis (McDowall, unpubl. data) of a type 
described below revealed similar direct repeats upstream of actVA-ORF3 and accA2 
(SCO4921). The latter of which encodes one of two subunits of an acyl-CoA carboxylase 
(converts acetyl- to malonyl-CoA) (Rodriguez et al., 2001), that suggest an intriguing 
link to primary metabolism. 
The finding that mRNA levels of actII-ORF4 are growth dependent and seem to 
correspond with the production of ACT raised the possibility that the promoter of actII-
ORF4 was regulated. A biochemical screen of a S. coelicolor extract identified an 
activity that could bind the promoter region of actII-ORF4 in vitro (Uguru et al., 2005). 
Through purification of the activity it was identified as being conferred by AtrA, a 
member of TetR family of transcriptional regulators (TFRs) (Uguru et al., 2005). TFRs 
are one-component systems that dominate signal transduction in bacteria, archaea 
and streptomycetes (Cuthbertson & Nodwell, 2013, Ahn et al., 2012, Ramos et al., 
2005). In S. coelicolor 153 TFRs have been found, which makes 15.8% of the regulatory 
proteins in this bacterium (Cuthbertson & Nodwell, 2013). Homologues of AtrA are 
found in all streptomycetes (Ahn et al., 2012). Of these, S. griseus, which binds to the 
strR promoter and moderate streptomycin production (Hirano et al., 2008), 
Streptomyces roseosporus, which binds to dptE promoter to positively regulate 
daptomycin biosynthetic cluster (Mao et al., 2015), Streptomyces avermitilis, which 
negatively regulate avermectin biosynthesis (Chen et al., 2008), and S. globisporus, 
which binds to sgcR1 and activates lidamycin biosynthesis. It is worth highlighting that 
the latter binding activity can be inhibited by heptaene, a biosynthetic intermediate of 
lidamycin in S. globisporus and actinorhodin from S. coelicolor (Li et al., 2015). 
Disruption of the corresponding atrA gene (SCO4118), which is not associated with any 
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SM gene cluster (Uguru et al., 2005), reduced the production of ACT, but had no 
detectable effect on the production of RED, indicating that atrA has specificity with 
regard to the biosynthetic genes it influences (Uguru et al., 2005). Within the 
streptomycetes, atrA (SCO4118) is associated with a divergent gene (SCO4119) 
encoding NADH dehydrogenase (Ahn et al., 2012), a member of the oxidoreductases. 
The role of this enzyme in maintaining the redox balance is maybe what links it to ACT. 
ACT is an oxidant, it is redox active, that when production or added exogenously 
induces the SoxR regulon, which in S. coelicolor encodes enzymes that provide 
protection against redox-sensitive molecules (Shin et al., 2011). 
There are two binding sites of AtrA in the actII-ORF4 promoter region, centred at −162 
and +86 bp relative to the transcriptional start site (Gramajo et al., 1993). This places 
them within the coding regions of actII-ORF3 and actII-ORF4, respectively. Binding to 
the -162 site has been confirmed in vivo, although the identity of the transcription 
factor was not confirmed (McArthur & Bibb, 2008). Since the identification of AtrA as a 
regulator of ACT production, several other transcription factors have been proposed to 
regulate the promoter of actII-ORF4. In most case, it was been shown that mutation of 
the corresponding gene affects the production of ACT and binding to the promoter of 
actII-ORF4 was tested directly in vitro. A limitation of such studies is that the relative 
specificity and affinity of interactions, i.e. likely functional relevance, is difficult to 
gauge. Evidence for binding in vivo such as that obtained using chromatin 
immunoprecipitation (ChIP) -based approaches (Rico et al., 2014, McKenzie & Nodwell, 
2007) is lacking in most cases, and in all cases the effects of disrupting the binding sites 
of transcription factors on promoter activity has not been determined to our 
knowledge. 
The first transcription factor to join AtrA as a regulator of actII-ORF4 was AbsA2, the 
response regulator of the AbsA two-component system, which negatively controls 
antibiotic production in S. coelicolor (McKenzie & Nodwell, 2007, Aceti & Champness, 
1998, Anderson et al., 2001). In addition to showing that AbsA2 binds in vitro to the 
promoter region of actII-ORF4 (plus the promoter regions of cdaR and redZ, which 
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encode CSRs of the calcium-dependent antibiotic and RED, respectively), evidence for 
binding in vivo was provided by showing the promoter region of actII-ORF4 could be 
amplified in an extract precipitated using anti-AbsA2 antibodies (McKenzie & Nodwell, 
2007). However, an extract from an absA strain was not included as a negative 
control. The signal to which the AbsA locus responds and consequently the wider 
physiological of AbsA-mediates regulation is not known. 
AtrA was next joined by DasR, a member of the GntR family that controls the uptake 
and metabolism of N-acetylglucosamine (GlcNAc) and the degradation of chitin to N-
acetylglucosamine (Rigali et al., 2008, Rigali et al., 2006). The DasR regulon is induced 
by glucosamine-6-phosphate (GlcN-6-P) (Rigali et al., 2006), an internal intermediate of 
GlcNAc, allowing mycelia to make maximum use of GlcNAc when it is available. 
Analysis of the promoters of genes within the DasR regulon identified a conserved 
sequence called the DasR responsive element (dre), which was subsequently found in 
the promoter region of actII-ORF4. Binding of DasR to the promoter region of actII-
ORF4 was shown in vitro and subsequently confirmed in vivo by ChIP in combination 
with sequencing (Rigali et al., 2008, Swiatek-Polatynska et al., 2015). The dre in the 
promoter region of actII-ORF4 overlaps the -35 box of the promoter and as is thought 
to mediate repression of actII-ORF4 in the absence of induction by GlcN-6-P. It is 
thought that de-repression occurs under conditions of famine via GlcNAc derived from 
the degradation of peptidoglycan as part of wider recycling of the vegetative material 
to fuel the production of aerial hyphae and the production of spores (Rigali et al., 
2008, Manteca et al., 2006). 
The analysis of proteins in crude extracts of S. coelicolor that could be “captured” in 
vitro using immobilised fragments of promoter regions identified AdpA and the 
products of SCO5405 and SCO1480 as candidate regulators of actII-ORF4 after 
confirming binding using electrophoretic mobility shift assays and purified components 
(Park et al., 2009). AdpA was first described in S. griseus as part of a cascade that 
facilitates morphological development and antibiotic production in response to the 
accumulation of a microbial hormone called A factor (2-isocapryloyl-3-R-
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hydroxymethyl-γ-butyrolactone) (Khokhlov et al., 1973, Horinouchi, 2002, Horinouchi, 
2007). AdpA was named A factor-dependent protein as its production requires 
induction by the binding of A factor to ArpA (A-factor receptor protein A), which would 
otherwise continue to repress transcription from the adpA promoter (Onaka & 
Horinouchi, 1997, Ohnishi et al., 2005). AdpA in S. griseus has been shown to directly 
control the expression of hundreds of genes, acting as a repressor or activator of 
transcription (Onaka et al., 1995, Ohnishi et al., 2004, Higo et al., 2012). Antibiotic and 
morphological development in S. coelicolor, like S. griseus, is dependent on adpA (also 
called bldH), but unlike S. griseus, is not under the control of an A factor-like γ-
butyrolactone (Takano et al., 2003, Nguyen et al., 2003, Chater & Horinouchi, 2003). 
The binding of DNA by S. coelicolor AdpA has been studied and the consensus binding 
site found to be identical to that of S. griseus AdpA (Yamazaki et al., 2004, Lee et al., 
2013). Unfortunately, the signal(s) that is relayed by AdpA in S. coelicolor is not known. 
The products of SCO5405 (absC) and SCO1480 encode a member of the MarR family 
and a novel nucleoid-associated protein specific to Actinobacteria, respectively. The 
signal relayed by SCO5405 (absC) and the role of SCO1480 beyond being associated 
with chromosomal DNA are not known. ROK7B7 (SCO6008) was also captured, but 
binding was not confirmed, at least clearly, by EMSA. ROK7B7 is a member of the ROK 
family and regulates the utilisation of xylose, carbon catabolite repression, and 
secondary metabolism in S. coelicolor (Swiatek et al., 2013, Park et al., 2009). 
In a separate study, DraR, the response regulator of another TCS (SCO3062/3063), was 
shown to bind the promoter region of actII-ORF4 in vitro and the site of binding was 
mapped by footprinting. Deletion of this TCS causes a reduction in production of ACT 
and an increase in the production of RED and the yellow-pigmented type I polyketide 
(yCPK) on minimal medium with glutamate. Under the same growth conditions, the 
production of ACT, RED and CDA was shown to require the AfsQ TCS (Yu et al., 2012, 
Shu et al., 2009). Moreover, the response regulator (AfsQ1) was shown to bind 
promoter regions of actII-ORF4, redZ and cdaR in vitro and the sites of binding mapped 
by footprinting (Wang et al., 2013). RedZ and CdaR are CSRs of RED and CDA 
production, respectively. The RED cluster contains another CSR called RedD 
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(Malpartida et al., 1990). The response regulator of the AbrC TCS has also been shown 
to bind to the promoter region of actII-ORF4. The AbrC system is atypical in that it has 
two histidine kinases. Deletion of the gene encoding the RR (abrC3; SCO4596) reduces 
ACT and RED production and delays morphological development. The binding of AbrC3 
to the promoter region of actII-ORF4 was shown in this case by ChIP-chip in vivo as 
well as EMSA in vitro (Rico et al., 2014). Again the signal transduced the AbrC system is 
unknown.  
Crp, the cyclic AMP receptor protein, which is perhaps best known for mediating 
carbon catabolite repression of the lac operon in E. coli (Gorke & Stulke, 2008) and 
controls diverse cellular processes in many bacteria (Korner et al., 2003), is a key 
regulator of secondary metabolism as well as spore germination and colony 
development in S. coelicolor (Piette et al., 2005, Gao et al., 2012). Carbon catabolite 
repression is an important control system in carbon breakdown, allows bacteria to 
metabolic and uptake preferred (rapidly metabolisable) substrate in the presence of 
different carbon sources (Deutscher, 2008). Using ChIP-chip and transcriptome assays, 
it has been shown that Crp binds within the promoter region of actII-ORF4 (plus those 
of other CSRs) and appears to activates transcription (Gao et al., 2012). In addition to 
direct regulation, the expression of actII-ORF4 is also completely dependent on relA, 
which is required for the switching on of the stringent response (Sun et al., 2001, Kang 
et al., 1998). The stringent response enables bacteria to survive sustained periods of 
nutrient deprivation by enhancing the transcription of numerous genes required to 
survive stress, while lessening transcription of genes, such as those encoding the stable 
RNAs, whose products are required in significantly reduced amounts during periods of 
slowed growth. S. coelicolor relA deletion mutants are unable to produce detectable 
amounts of ACT and RED and normal levels of the mRNA of actII-ORF4 and redD 
suggesting a direct role of the stringent response in activating transcription from the 
promoters of these genes. The relative positions of the sites of binding for the 
transcription factors described above are shown in (Figure 1.6).  
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Figure 1.6: Binding of global regulatory proteins to the actII-ORF4 promoter. The 
pathway-specific activator ActII-4 integrates many of the global regulators. 
Transcriptional activation in the network is illustrated by line ending with an arrow, 
whereas transcriptional repression indicated by spherical end. The binding sites for all 
regulators are experimental proved. The central line (olive green) represents the 
chromosomal position of magnified region (olive green box) including noncoding 
intergenic region between actII-ORF3 and actII-ORF4. AtrA binds at position (- 200/ - 
186) and (+ 45/ + 68) from actII-ORF4 start codon (Uguru et al., 2005), DasR binds to 
the region between -35 and - 10 at position (- 60/ - 44) (Rigali et al., 2008), DraR binds 
at (- 151/ - 131) (Yu et al., 2012), AfsQ1 bind at (- 93/ - 78) (Wang et al., 2013), AbrC3 
bind at (+ 72/ + 81) (Rico et al., 2014) and Crp bind at (+ 25/ +38) and Crp (+ 235/ + 
248) (Gao et al., 2012). 
1.4 The regulon of atrA - unpublished work leading to this project 
DNA Footprinting of S. coelicolor AtrA identified two binding sites within the actII-ORF4 
promoter and one within the S. griseus strR promoter (Uguru et al., 2005). To obtain 
better knowledge of the range of sequences that could be recognised by AtrA, double-
stranded DNA ligands (called aptamers) were selected (Bunka, Yepes and Cobley, 
unpubl. results) using the SELEX procedure (Tuerk & Gold, 1990, Gold, 1995). 
Sequencing of 20 clones revealed 7 unique sequences of which 5 were similar to those 
that had been footprinted previously in the promoter region of actII-ORF4 (Figure 1.7).  
22 
 
 
 
 
Figure 1.7: Recognition of AtrA binding sequence using aptamers. Panel A shows the 
5 sequence alignment of AtrA-bound aptamers. The reverse complement (RC) of 
aptamer LU5 and Site 2 for the actII-ORF4 promoter (Uguru et al., 2005) are shown to 
maximise sequences matches when aligned with the other sequences. Lower case 
indicates sequences found in constant (primer) regions of the SELEX template. Panel B 
represents a sequence WebLogo derived from AtrA aptamers. Panel C shows the 
original consensus sequence (Uguru et al., 2005) that coincides with the sequence logo 
in panel B.  
Alignment of the sequences identified a 25 nt, palindromic motif between positions 9 
and 33 inclusively. A palindromic sequence is expected for a member of the TetR 
family, which uses a dimeric, head-to-head unit to bind DNA (Meier et al., 1988, 
Cuthbertson & Nodwell, 2013, Hillen & Berens, 1994). The sequences between 
positions 9 and 33 motif were then used to build a position weight matrix, which in 
turn was used to scan the S. coelicolor genome for similar sequences. This was done 
using PREDetector (see Table S1) (Hiard et al., 2007). 
PCR was then used to amplify segments containing candidate binding sites for AtrA, 
and binding was assayed in vitro using EMSAs (Boomsma, unpubl. results). Sequences 
that were found to be bound by AtrA using the electrophoretic mobility shift assay 
were added to the alignment and the in silico prediction of binding sites repeated. It 
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should be noted that the most recent predictions were generated using a core 19 nt 
motif (positions 12 to 30 in the original alignment). Sequences beyond this core were 
found to be not highly conserved in genomic sequences that bind AtrA in vitro. 
Several genes associated with acetyl-CoA metabolism are predicted to be bound 
directly by AtrA in vivo. These are SCO5424 (ackA), SCO5529 (leuA2), SCO6027 and 
SCO6026 (encoding acetyl-CoA acetyltransferase and the α-subunit of the fatty acid 
oxidation complex, respectively). In addition, it should be remembered that SCO4921 
(aacA2) is thought to be a potential target for actII-ORF4, i.e. subject to indirect 
regulation by atrA. The locations of the predicted binding sites and the positions of 
each of the corresponding genes in acetyl-CoA metabolism are shown in Figure 4.14. A 
role for AtrA in the regulation of acetyl-CoA metabolism is potentially very exciting, as 
acetyl-CoA provides the precursors for the production of many types of antibiotic and 
other therapeutic agents (see above). Thus, AtrA may have a pivotal role in 
coordinating primary and secondary metabolism. 
1.5 General and Specific aims 
The broad objective of this proposal is to better understand the role of AtrA in the 
growth, physiology and morphological development of S. coelicolor, with a view to 
uncovering hitherto undescribed links between primary and secondary metabolism 
that might allow the manipulation of streptomycetes to awaken the production of 
cryptic SMs and aid the discovery of new potential antibiotics, which are much needed 
given the alarming increase in resistance amongst bacterial pathogens (Beceiro et al., 
2013, Beever et al., 2015). 
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Specific aims of the project were to: 
1. Develop a pipeline for the generation of maps of transcription units that detail 
the positions of transcription start sites; thereby providing a platform to 
interpret the functional significance of the binding of regulators of transcription 
such as AtrA to specific chromosomal locations. 
2. Assay the binding of AtrA to the promoters of a selection of genes identified by 
scanning the genome sequence of S. coelicolor using the position weighted 
matrix for sites of AtrA binding and the effects of disrupting atrA on the 
transcription of potential targets of AtrA regulation in S. coelicolor.  
3. Investigate the possibility that the DNA-binding activity of AtrA, like many other 
members of the TetR family, is regulated by a small molecule(s). 
4. Tag AtrA with the 3 X FLAG™ tag and confirm that this recombinant protein is 
still functional and suitable for the mapping of sites of AtrA binding by ChIP-
sequencing. 
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Chapter 2 
2 Material and Methods 
2.1 Bacterial strains and culture conditions 
All bacterial strains used are listed in Table 2.1. S. coelicolor strains were cultivated at 
30°C with shaking (220 rpm) in 250 mL Erlenmeyer flasks fitted with a spring baffle to 
aid dispersed growth of the mycelia (Kieser et al., 2000) and containing 50 mL of 
media. Escherichia coli strains were cultivated at 37°C with shaking (220 rpm) in either 
50 mL Falcon tube containing 10 mL media for the purpose of cloning or in 2 L flask 
containing 500 mL media for protein production. 
Strains Description Source 
Streptomyces Strains 
M145 SCP1-, SCP2-. Contains a mutation of the sre-I gene. (Kieser et al., 2000) 
M145  
(pAU3-45) 
M145 containing plasmid pAU3-45  This thesis 
M145  
(pAU-atrA3x) 
M145 containing plasmid pAU-atrA3x, which encodes S. 
coelicolor AtrA with 3 x FLAG tag™ at the C-terminus. 
This thesis 
M145 
(pAU-atrA) 
M145 containing plasmid pAU-atrA, which encodes S. 
coelicolor AtrA 
This thesis 
M145 
(pAU-3xatrA) 
M145 containing plasmid pAU-3xatrA, which encodes S. 
coelicolor AtrA with 3 x FLAG tag™ at N-terminus. 
This thesis 
M145 
(pSET152)  
M145 containing plasmid pSET152  This thesis 
M145 
(pSET-atrA3x) 
M145 containing plasmid pSET-atrA3x, which encodes S. 
coelicolor AtrA fused with 3 x FLAG tag™ at C-terminus. 
This thesis 
M145 
(pKC1139) 
M145 containing plasmid pKC1139 This thesis 
M145 
(pKCEatrA-gl-
3xFlag) 
M145 containing plasmid pKCEatrA-gl-3xFlag which encodes 
S. globisporus AtrA with 3 x FLAG tag™ at C-terminus. 
This thesis 
L645 M145 containing a disrupted atrA gene. (Uguru et al., 2005) 
L645  
(pAU3-45) 
L645 containing plasmid pAU3-45 This thesis 
L645 
(pAU-atrA3x) 
L645 containing plasmid pAU-atrA3x, which encodes S. 
coelicolor AtrA with 3 x FLAG tag™ at C-terminus. 
This thesis 
L645 
(pAU-atrA) 
L645 containing plasmid pAU-atrA, which encodes S. 
coelicolor AtrA 
This thesis 
L645 
(pAU-3xatrA) 
L645 containing plasmid pAU-3xatrA, which encodes S. 
coelicolor AtrA with 3 x FLAG tag™ at N-terminus. 
This thesis 
LA145  
(L646) 
M145 containing plasmid pL646, which constitutively 
expresses S. coelicolor atrA 
(Towle, 2007) 
M511 M145 containing a disrupted actII-ORF4 gene (ΔactII-ORF4) 
(Floriano & Bibb, 
1996) 
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M1146 
M145 derivative in which four well described metabolite gene 
clusters have been deleted (Δact, Δred, Δcpk, Δcda) 
Dr Ryan Seipke, 
(Gomez-Escribano & 
Bibb, 2011) 
E. coli Strains 
DH5α 
F ‾ Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17 
(rK‾, mK+) phoA supE44 λ‾ thi-1 gyrA96 relA1  
Laboratory stock 
ET12567 
(pUZ8002) 
dam13::Tn9(chlR) dcm-6 hsdM hsdR recF143 zjj-201::Tn10 
galK2 galT22 ara14 lacY1 xyl-5 leuB6 thi-1 tonA31 rpsL136 
hisG4 tsx-78 mtlI glnV44, pUZ8002 (kanR) 
Dr Ryan Seipke, 
Laboratory stock 
XL1-Blue 
(MRF’) 
Δ(mcrA)183 Δ(mcrCB-hsdSMR-mrr)173 endA1 supE44 thi-1 
recA1 gyrA96 relA1 lac [F´ proAB lacIqZΔM15 Tn10 (tetR)] 
Dr Ryan Seipke, 
Laboratory stock 
BL21-Gold  
(DE3) 
E. coli B F‾ ompT hsdS(rB‾ mB‾) dcm+ tetR gal λ(DE3) endA Hte Stratagene Corp. 
 
Table 2.1: Description and sources of bacterial strains.  
2.2 Media and chemicals 
Unless otherwise stated, all media, chemicals, solutions were purchased from Fisher 
Scientific UK Ltd, Sigma-Aldrich Ltd, MP BiomedicalsTM, Alfa Aesar®, OxoidTM, or Lab 
MTM. Media and solutions were prepared as instructed by the vendor and sterilized by 
autoclaving at 121°C for 20 min. Some components were sterilized by filtration 
through a 0.22 µm Millex®GP syringe filter unit, as indicated. 
2.2.1 R5 (Kieser et al., 2000) 
The following were added to 1 L of dH2O and then autoclaved: 103 g sucrose, 0.25 g 
K2SO4, 10.12 g MgCl2.6H2O, 10 g glucose, 0.1 g casamino acids, 2 mL trace elements (1 L 
made of 4 mg ZNCl2, 200 mg FeCl3.6H2O, 10 mg CuCl2.4H2O, 10 mg MnCl2.4H2O, 10 mg 
Na2B4O7.10H2O and 10 mg (NH4)6Mo7O24.4H2O), 5 g yeast extract, 5.73 g TES buffer, and 
20 g agar (Fisher Scientific). After autoclaving, the following reagents, which had been 
autoclaved separately, were added: 10 mL 0.5% KH2PO4, 4 mL 5 M CaCl2.2H2O, 15 mL 
20% L-proline, and 7 mL 1N NaOH.  
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2.2.2 Minimal medium (MM) (Hopwood, 1967)  
The following were added to 1 L of dH2O, the pH adjusted to between 7.0 and 7.2 and 
then autoclaved: 1 mg (NH4)2SO4, 0.5 g K2PO4, 0.2 g MgSO4.7H2O, 0.01 g FeSO4.7H2). 
Then 10 mL of 50% mannitol, which had been sterilized by filtration through a 0.22 µm 
filter unit, was added as a carbon source.  
2.2.3 Mannitol soya flour medium (MSF) (Hobbs et al., 1989) 
The following were added to 1 L of tap water: 20 g from each of agar, mannitol and 
soya flour and autoclaved twice, with gentle shaking after each cycle. 
2.2.4 Yeast extract-malt extract medium (YEME) (Kieser et al., 2000) 
The following were added to 1 L of dH2O and then autoclaved: 3 g yeast extract, 5 g 
peptone, 3 g malt extract, and 340 g sucrose (34%). After autoclaving 2 mL of 2.5 M 
MgCl2.6H2O was added. 
2.2.5 2X YT medium (Kieser et al., 2000) 
The following were added to 1 L of dH2O and then autoclaved: 16 g tryptone, 10 g 
yeast extract, and 5 g NaCl. 
2.2.6 Tryptone Soya Agar (TSA) 
The following were added to 1 L of dH2O and then autoclaved: 17 g pancreatic digest 
of casein, 3 g pancreatic digest of soyabean meal, 5 g sodium chloride, 2.5 g Di-basic 
potassium phosphate, 2.5 g glucose, and 20 g agar. 
2.3 Antibiotics 
All antibiotics were sterilized by filtration and used at the following final 
concentrations: ampicillin (AMP), 50 µg/mL; apramycin (AM), 50 μg/mL; thiostrepton 
(TS), 50 μg/mL; chloramphenicol (CHL), 25 μg/mL; kanamycin (KAN), 25 μg/mL; and 
nalidixic acid (Piette et al., 2005), 25 μg/mL. 
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2.4 Preparation of S. coelicolor spore stocks 
Spore stocks of S. coelicolor were prepared by scrapping spores from the surface of a 
well isolated colony on an agar plate using a sterile loop and streaking onto R5 agar to 
produce well-isolated colonies. After incubation for an appropriate time, the spores 
from a single colony were harvested using a sterile loop and resuspended in 5 mL of 
sterilized dH2O. Multiple aliquots (~300 µL) of the suspension were spread over 
mannitol soya flour medium (MSF) plates with a sterile glass spreader and incubated 
until the surface of confluent growth displayed a grey colouration. The spores were 
harvested by adding 10 mL of sterilized distilled water to each plate and scraping the 
medium surface with sterile cotton swap. The combined suspensions were filtered 
through a plug of sterilized cotton (~5 cm3) inserted into the barrel of 20 mL syringe. 
The filtered spores were centrifuged at 4700 x g for 10 min and the pellet was re-
suspended in sterile 25% glycerol. The spore suspension was divided into aliquots and 
stored at -20°C. 
2.5 Nucleic acid methods 
2.5.1 Extraction of chromosomal DNA from S. coelicolor and E. coli for use in PCR 
An overnight culture of 50 mL was poured into 50 mL Falcon tube containing a 1/8th 
volume (6.25 mL) of stop solution (95% [v/v] ethanol; 5% [v/v] phenol). The culture 
was centrifuged at 5000 x g (Sigma, 11133-rotor) for 10 min and the cell pellet washed 
with 10 mL sterilized dH2O and re-harvested. The pellet was suspended in 10 mL of 1 
M TE buffer (pH 8) containing lysozyme (20 mg/mL). The suspension was incubated for 
60 min at 37°C. SDS and NaCl were added to final concentrations of 0.5% [w/v] and 
150 mM, respectively. The tube was vortexed briefly and added to a boiling-water bath 
for 1 min and then cooled down by placing in ice. An equal volume of buffer-saturated 
phenol (pH 8) was added and the tube vortexed. The cell lysate was split between 
multiple 2 mL Eppendorf tubes and the cell debris removed by centrifugation at 13,000 
x g (Eppendorf centrifuge 5415 R) for 10 min at room temperature. The upper layer 
from each tube was transferred to a new tube and extraction further using an equal 
volume of phenol (pH 8): chloroform: isoamyl alcohol (25:24:1) as described for the 
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phenol extraction. The extraction was then repeated using chloroform: isoamyl alcohol 
(49:1). The resulting aqueous phase was transferred to new tubes and a 2.5 volume of 
absolute ethanol was added to each. NaCl was added to a final concentration of 150 
mM and the mixture incubated at -20°C for 30 min. The precipitate was harvested by 
centrifugation at 13,000 x g for 30 min at 4°C. Finally, the pellet was washed with 70% 
[v/v] ethanol, re-suspended in nuclease-free water (Sigma) and stored at -20°C. 
2.5.2 Streptomyces RNA extraction from broth culture 
RNA was isolated from S. coelicolor grown in YEME, as described previously (Lin et al., 
2013), with minor modification. At the required stage of growth, a 1/8th volume of stop 
solution was added to inhibit cell metabolism (Kime et al., 2008) and the cells were 
harvested by centrifugation at 4700 x g for 10 min (Sigma, 11180-rotor). When 
necessary, cell pellets were stored frozen at -80°C. In order to lyse the cells, 5.0 OD600 
units of mycelia were re-suspended in 375 µL sterilized dH2O and transferred to Lysing 
Matrix B tube (MP Biomedicals) containing 375 µL of modified Kirby mix (1% [w/v] SDS, 
6% [w/v] sodium-4-aminosalicylate, and 6% [v/v] phenol buffered with 50 mM Tris-HCl 
[pH 8.3]; (Kieser et al., 2000). Lysis was achieved using a benchtop homogenizer 
(FastPrep®-24 MP Biomedicals, India). Mycelial samples were subjected to three cycles 
of 50 s bursts at 6.5 M/s with 1 min incubation in ice between each cycle. The resulting 
lysates were extracted with an equal volume of phenol saturated with 100 mM citrate 
buffer (pH 4.3), which involved mixing by inverting the tube several times. The phases 
were separated by centrifugation at 13,000 x g for 10 min at room temperature. The 
aqueous phase was then extracted with an equal volume of phenol (pH 4.3): 
chloroform: isoamyl alcohol (25:24:1), and once with an equal volume of chloroform: 
isoamyl alcohol (49:1). Total nucleic acid was then precipitated by adding 2.5 volumes 
of absolute ethanol and NaCl to 150 mM. The samples were incubated for 30 min at -
20°C then centrifuged at 13,000 x g for 30 min at 4°C. The pellet was washed with 70% 
[v/v] ethanol, dissolved in nuclease-free water (Sigma) and stored at -80°C. 
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2.5.3 DNase I Treatment 
In order to obtain RNA samples free of DNA, 100 µg of nucleic acid was incubated with 
2 U of DNase RQ1 (Promega) and 100 U of RNaseOUTTM (Invitrogen) in 50 µL of 1 x RQ1 
DNase buffer at 37°C for 60 min. The reaction mix was extracted with phenol: 
chloroform: isoamyl alcohol as described above and DNA in the aqueous phase 
precipitated by the addition of 2.5 volumes of absolute ethanol and NaCl to a final 
concentration of 150 mM. The mixture was incubated at -20oC for 30 min, and then 
the DNA was harvested by centrifugation at 13,000 x g for 30 min at 4°C. The pellet 
was washed with 70% [v/v] ethanol, air dried and re-suspended in nuclease-free water 
(Sigma). To check the integrity of RNA, 500 ng of a sample was run in a 1.2% [w/v] 
agarose gel for 40 min at 10 V cm-1. The gel was imaged using a GeneGenius UV 
transilluminator (Syngene). 
2.5.4 Quantify the Nucleic Acid Concentration 
The concentration of nucleic acid was determined by NanoDropTM 1000 
spectrophotometer (Thermo Fisher Scientific). 
2.6 Preparation of mycelial patches 
2.6.1 Solid media overlaid with cellophane membrane 
Cellophane discs (A. A. Packaging Ltd.) were soaked in dH2O and sterilized by 
autoclaving after placed between blotting paper. Two pairs of sterile forceps were 
used to lay the membranes on surface of solid media plates and exclude any bubbles. 
The plates were dried in a laminar flow (Faster TWO 30) for a few minutes. 
2.6.2 Streptomyces RNA isolation from plate 
Appropriate numbers of spores were spotted onto TSA or minimal media plates 
overlaid with cellophane and allowed to dry. Plates were incubated at 30°C for the 
required amount of time. Mycelium patches were scraped off the surface of the 
cellophane using a sterile blunt-end spatula and placed in 200 µL sterilized nuclease-
free water (Sigma) containing 1/8th volume of stop solution and harvested by 
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centrifugation at 13,000 x g for 1 min. The pellets were transferred to Lysing Matrix B 
tube (MP Biomedicals) containing modified Kirby mix (Kieser et al., 2000) and the 
patches smashed using sterilized glass rod. The suspensions were sonicated using a 
benchtop homogenizer (FastPrep®-24 MP Biomedicals, India), and then extracted with 
phenol (pH 4.3), phenol: chloroform: isoamyl alcohol, and chloroform: isoamyl alcohol 
as described previously in Section 2.5.2. 
2.7 RNA sequencing methods 
2.7.1 RNA extraction 
S. coelicolor was grown in YEME broth and RNA isolated as described previously for 
Propionibacterium acnes (Lin et al., 2013). Briefly, cell pellets were resuspended in 
Kirby mix (Kieser et al., 2000). Cells were lysed by three cycles of homogenizing for 1 
min (set at 6.5 M/s) followed by cooling in an ice-water bath for 1 min. RNA was 
extracted using an equal volume of acidic phenol: chloroform: isoamyl alcohol (50: 50: 
1), and then chloroform: isoamyl alcohol (49: 1). The RNA was precipitated, treated 
with DNase I, quantified, and integrity was determined as mentioned in Sections 2.5.2, 
2.5.3 and 2.5.4. Samples were then enriched for mRNA using MICROBExpressTM-
Bacteria beads, as described by the manufacturer (Ambion). 
2.7.2 Differential RNA sequencing 
Differential RNA-seq data was generated by Vertis Biotechnologie AG (Germany) as a 
service that included the construction of cDNA libraries before and after treatment 
with TAP, and the alignment of RNA-sequence reads to the corresponding genome 
positions (Lin et al., 2013), which were retrieved from the NCBI database (Pruitt et al., 
2007). For each genome position, the number of times it was the first nucleotide in 
sequence reads, i.e. associated with a 5′ end in vivo, was counted. This was done 
separately for each of the two libraries and the counts compared. It should be noted 
that, as described previously (Lin et al., 2013), the 5′-sequencing adaptor was ligated to 
transcripts prior to fragmentation, thereby allowing the 5′ ends of both long and short 
transcripts to be detected.  
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2.7.3 Global RNA sequencing 
Global RNA-seq was performed at the Wellcome Trust Sanger Centre (Cambridge, UK) 
by Lira Mamanova using a published methodology (Mamanova et al., 2010) and the 
sequences processed as described previously (Lin et al., 2013). After aligning the gRNA-
seq reads to the genome, the number of times each genome position was present in a 
read irrespective of its position was counted. For both types of RNA-seq, the reference 
genomes for S. coelicolor A3(2) strain M145 was AL645882. The RNA-seq data has been 
deposited in the GEO archive (Barrett et al., 2013) under accession number 
GSM1126846. The same RNA from S. coelicolor was also analysed using custom 
105,000 x 60 mer whole genome arrays manufactured by Agilent Technologies (Lewis 
et al., 2010) in collaboration with Prof. Colin Smith and members of his group 
(University of Surrey). The preparation of cDNA, labelling, and hybridization was 
performed as described previously (Bucca et al., 2009, Bucca et al., 1997). Two 
technical repeats of co-hybridising the RNA with labelled genomic DNA were 
performed. A single Log2 RNA/gDNA value for each probe that passed the Agilent 
probe-quality criteria on at least one array was generated by averaging the global 
median normalized microarray signals. Corresponding Log2 “probe” signals from the 
RNA-seq data were generated by averaging the signals of each base within the 60-bp 
sequence that a probe targets. RNA-seq coverage vectors for the forward and reverse 
strands were used to generate the data for forward-gene-targeting and reverse-gene-
targeting probes respectively. 
2.8 Northern blotting  
RNA for northern blotting was isolated as described in Section 2.5.2. For each sample, 
an aliquot of 5-10 µg was mixed with an equal volume of 2 x RNA-loading dye (New 
England BioLabs), denatured by incubation at 90°C for 90s, chilled on ice, and analysed 
along with other samples by denaturing electrophoreses using a 6% [w/v] 
polyacrylamide sequencing-type gel (acrylamide: bis-acrylamide was 29: 1) containing 
1 x TBE (Severn Biotech Ltd) and 7 M urea. Fractionated RNA was electro-transferred 
to a Hybond-N+ membrane (Amersham) using 20 x saline-sodium citrate (SSC) buffer at 
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11 V for 1 h, and subsequently fixed to the membrane by UV-crosslinking. The nylon 
membrane was cut into separate strips for each group of lanes. 
Specific S. coelicolor transcripts were probed using riboprobes generated by in vitro 
transcription. The primers used to construct the templates for the riboprobes are 
listed in Table S2. Reactions of 20 µL contained 100 nM template (produce by PCR), 
100 U T7 RNA polymerase (Invitrogen), 8 pmoles α-32P UTP (3000 Ci mmol-1 10 mCi mL-
1, 250 µCi; Perkin-Elmer), 5 µM UTP, 0.5 mM rATP, rGTP and rCTP, 1 U yeast inorganic 
pyrophosphatase (Sigma), 80 U RNaseOUT™ in 1 x T7 RNA polymerase buffer (40 mM 
Tris-HCl [pH 8.0], 8 mM MgCl2, 2 mM spermidine-(HCl)3, 25 mM NaCl, and 5 mM DTT0. 
Reactions were incubated at 37°C for 3 h. Unincorporated nucleotides were removed 
by adding nuclease free water (Sigma) to 50 µL and passing reaction products through 
G-25 spin columns, as per the manufacturer’s instructions (GE healthcare). 
Hybridizations were carried out overnight in the PerfectHyb™ Plus Hybridization buffer 
(Sigma-Aldrich) at 68°C by incubating each membrane strip separately with a specific 
riboprobe. After hybridization, 2 x 20 min washes in high stringency buffer (0.5 x SSC, 
0.1% [w/v] SDS) at 68°C was performed. The hybridized blots were then exposed to a 
phosphoimager plate (Fuji) and read with a FLA 5000 scanner (Fuji). 
2.9 PCR Methods 
The volume of PCR was 50 µL. GoTaq polymerase (Promega) was used for amplifying 
small DNA products (80-700 bp), while FailSafe Premix J and FailSafeTM PCR Enzyme 
Mix (Epicentre Technologies, Cambio, Ltd) were used for gene amplification longer 
than 700 bp from S. coelicolor. 
2.9.1 Standard PCR Method 
The following conditions were used for standard PCR: the initial denaturation was 95°C 
for 5 min, followed by 40 cycles of denaturation at 95°C for 30 s, annealing at 
temperature indicated in Table S2 for 30 s and extension time at 72°C for 1 min/kbp, 
and a final extension at 72°C for 5 min. 
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2.9.2 Purification of PCR amplified DNA fragments 
PCR products were analysed by gel electrophoresis. The concentration of agarose was 
dependent on the sizes of the expected products. A high percentage of agarose was 
use to analysed small fragments of DNA, and vice versa. 1X TAE buffer was used to 
analysis digested plasmids as the image resolution slightly better than 1X TBE which 
used to analysis PCR products (<2 kb). Concentration of agarose gels and running 
buffer are stated in the corresponding figure legends. Products of the expected size 
were cut out from the gel using a clean blade. The DNA was then extracted from the 
gel slice and purified using the QIAquick® gel extraction kit, as per the manufacturer’s 
instructions. DNA was eluted from spin columns using 100 µL of nuclease-free water 
(Sigma), and then quantified using NanoDropTM 1000 spectrophotometer. To prevent 
bleaching, fluorescent PCR products were stored in foil covered tubes at -20°C. 
2.9.3 Reverse Transcriptase Quantitative polymerase chain reaction (RT-qPCR) 
A 429 bp DNA fragment from rpsL gene was amplified by PCR using primers 
SCO4735p1 and SCO4735p2. The PCR product was purified and quantified as 
mentioned in Section 2.9.2. To test the reliability of qPCR, 4-fold serial dilution series 
from rpsL DNA fragment ranging from 2 ng/ µL to 1.907 X 10-6 ng were prepared to 
construct standard curve. Each dilution was analysed by PCR using a SensiMix™ SYBR 
No-ROX kit, as instructed by the vendor (Bioline) in combination with 0.5 µM of 
primers and 3.5 mM MgCl2. Reactions were assembled in 0.1 mL strip tubes (Corbett) 
and analysed using a Corbett Rotor-Gene 6000 system. The PCR conditions were 10 
min at 95oC, followed by 40 cycles of 30 s at 95°C, 20 s at 55°C and 30 s at 72°C. The CT 
value in each dilution were measured and plotted against the logarithm of their 
concentration. 
Quantitative PCR analysis was carried out following reverse transcription that used 
SuperScript® II, as instructed by the vendor (Invitrogen), in combination with 500 ng of 
DNase I-treated total RNA as template and 50 ng of random hexamers (Applied 
Biosystems) as primer in 20 µL reactions. Mock reactions minus the reverse 
transcriptase were also conducted to control for residual chromosomal DNA 
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contamination (Uguru et al., 2005). At the end of each of the reactions, 80 µL of yeast 
tRNA (Ambion) was added to a final concentration of 8 ng/µL, and 2 µL aliquots 
analysed by PCR as mentioned above. The PCR conditions were 10 min at 95oC, 
followed by 40 cycles of 10 s at 95°C, 15 s at 60°C or 55°C and 15 s at 72°C. The 
products were analysed by determining melting curves and the sizes of the amplicons. 
The latter was done as a second step by gel electrophoresis. A threshold common to 
the exponential phases of all the reactions in a single run was selected manually and 
the corresponding number of cycles for each reaction recorded. These CT values were 
then expressed as the difference relative to rpsL (SCO4735), which was used as the 
internal control. In turn, the ΔCT values were used to calculate the difference in 
abundance using the equation 2ΔCT. qPCR for each gene was run in duplicate and no 
ampliﬁcation was detect for negative control (NTC) up to cycle 35. 
2.10 Oligohistidine tagged protein 
Fragments for cloning were generally generated by PCR (see Section 2.9.1). NdeIatrA-
F primer, which adds CAT to the start codon of atrA generating an NdeI cloning site 
and an atrABamHI-R primer, which adds a BamHI cloning site after the stop codon of 
the recombinant gene were used to amplify atrA3x from pAU-atrA3x construct. The 
resulted DNA fragments and vectors were subjected to double digest with NdeI and 
BamHI. The digested vector purified using a QIAquick® PCR purification kit while the 
insert was purified and quantified as described in Sections 2.9.2. The molar ratio of 
vector: insert of 1: 4 was used to prepare 20 µL ligation reactions in 1 x T4 ligase 
buffer (Invitrogen) containing 1 U T4 DNA ligase (Invitrogen). The reaction was 
incubated at 16°C for 15 h, and then inactivated by heating at 65°C for 10 min. 
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Plasmid Size Description Source 
pUC19 2686bp E. coli cloning vector, ampicillin resistance. Laboratory stock 
pSET152 5715bp 
Streptomyces cloning vector containing the ɸC31 
attachment site, confers apramycin resistance. 
Dr Bin Hong, (Bierman 
et al., 1992) 
pSET-atrA3x 7041bp 
pSET152-derivatived plasmid containing 891 bp 
coding region of S. coelicolor atrA fused with 3 x 
FLAG tag™ at C-terminus under its own promoter. 
This thesis 
pKC1139 6500bp 
E. coli/Streptomyces shuttle vector, apramycin 
resistance. 
Dr Bin Hong,(Bierman 
et al., 1992) 
pKCEatrA-gl-
3xFlag 
7800bp 
pKC1139 derivative plasmid containing 792 bp 
coding region of S. globisporus atrA fused with 3 x 
FLAG tag™ under control of ermE*p. 
Dr Bin Hong 
pET16b 5711bp 
A T7 lac promoter expression vector, encodes 
polyhistidine at N-terminus of recombinant 
proteins, ampicillin resistance.  
Laboratory stock 
pRA001 6600bp 
pET16b-derivatived plasmid containing 901 bp 
DNA fragment including coding region of S. 
coelicolor atrA. 
Laboratory stock, Jon 
Stead 
pET-atrA3x 6666bp 
pET16b-derivatived plasmid containing 891 bp 
coding region of S. coelicolor atrA fused with 3 x 
FLAG tag™ at C-terminus. 
This thesis 
pET16b-
atrA-gl 
6498bp 
pET16b-derivatived plasmid containing 792 bp 
coding region of S. globisporus atrA. 
Dr Bin Hong 
pET16b-ActR 6483bp 
pET16b-derivatived plasmid containing 780 bp 
coding region of S. coelicolor actR (SCO5082). 
Dr Bin Hong 
pET16b-TetR 6330bp 
pET16b-derivatived plasmid containing 627 bp 
coding region of tetR from E. coli XL1-Blue MRF’. 
Dr Bin Hong 
pAU3-45 6525bp 
pSET152-derivatived with tsr gene from pAU5 
cloned into the NheI site, apramycin and 
thiostrepton resistance.  
Stock of Dr Ryan 
Seipke, (Bignell et al., 
2005) 
pAU-atrA3x 7851bp 
pAU3-45-derivatived plasmid containing 891 bp 
coding region of S. coelicolor atrA fused with 3 x 
FLAG tag™ at C-terminus under its own promoter. 
This thesis 
pAU-atrA 7733bp 
pAU3-45-derivatived plasmid containing 894 bp 
coding region of S. coelicolor atrA under its own 
promoter. 
This thesis 
pAU-3xatrA 7893bp 
pAU3-45-derivatived plasmid containing 891 bp 
coding region of S. coelicolor atrA fused with 3 x 
FLAG tag™ at N-terminus under its own promoter. 
This thesis 
 
Table 2.2: List of plasmids and their sources. 
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2.11 Preparing E. coli competent Cells 
E. coli competent cells were prepared as described previously (Inoue et al., 1990). 10 
mL of LB broth medium containing antibiotic to select for retention of plasmids as 
appropriate was inoculated with cells from single bacterial colony. The culture was 
incubated overnight at 37°C with shaking (220 rpm). This starter culture was diluted 
1:100 in required volume with LB broth and incubated at 37°C. When the OD600 
reached 0.55, the culture was placed on ice for 15 min. The cells were harvested using 
50 mL Falcon tube by centrifugation at 4700 x g for 10 min at 4°C and resuspended in 
1/3 volume of ice-cold Inoue transformation buffer (55 mM MnCl2.4H2O, 15 mM 
CaCl2.2H2O, 250 mM KCl, 10 mM PIPES pH 6.7). The cells were harvested again at 4700 
x g for 10 min at 4°C. The pellet was re-suspended in Inoue transformation buffer at 
1/12.5 of the original volume of cells. DMSO was added to 0.6% [v/v], swirled and left 
on ice for 10 min. Aliquots of 150 µL of the suspension were dispensed into chilled, 
sterile Eppendorf tubes. The competent cells were snap-frozen by placing the tubes on 
dry ice. The tubes were stored at -80°C until time of use. 
2.12 Heat shock transformation of cloned gene 
An aliquot (one µL) of ligated reaction or 50 ng of a plasmid construct was added to 50 
µL of competent cells, mixed gently, and kept on ice for 30 min. The cells were “heat 
shocked” for 45 s at 42°C, and then placed back on ice for 2 min. An aliquot (475 µL) of 
LB broth was added to the cells and incubated at 37°C for 1 h at 225 rpm. Aliquots of 
50 µL, 100 µL, 250 µL, were spread onto LB agar plates containing appropriate 
antibiotic and incubated at 37°C overnight. Alongside two reactions were set up as 
above using pUC19 as positive control and water as negative control. Single colonies 
from transformants (routinely 10) were used to inoculate 10 mL aliquots of LB broth 
and incubated overnight. Plasmid DNA was isolated from overnight culture using 
Wizard® Plus SV Minipreps DNA according to manufacturer’s instructions (Promega). 
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2.13 Enzymatic and sequencing confirmation 
One µg of the isolated plasmid DNA was subjected to double digest with appropriate 
restriction enzyme, and then run on a 1% [w/v] agarose gel. The restriction enzymes 
are stated in the corresponding figure legends. Inserts of constructed plasmid were 
sequenced by Beckman Coulter Genomics using universal primers (T7P and T7TERM) 
for pET16b-based plasmids; Bec-F and Bec-R primers for pAU3-5 and pSET152 based 
plasmids; and gl-atrA-F and gl-atrA-R for pKC1139-based plasmids (see Table S2). 
2.14 Protein Methods 
2.14.1 Overproduction and purification of oligohistidine-tagged protein 
Recombinant S. coelicolor AtrA, AtrA-3xFlag tagged at C-terminus, ActR, Streptomyces 
globisporus AtrA and Escherichia coli TetR were overproduced and purified from 
cultures of E. coli BL21 (DE3) cells containing pRA001, pET-atrA3x, pET16b-ActR, 
pET16b-atrA-gl, pET16b-TetR, respectively. Typically, a 10 mL overnight culture was 
diluted 1:100 in 400 mL of LB broth containing 50 µg/mL of ampicillin. Then the culture 
was incubated at 37°C with shaking (225 rpm). Expression of the chromosomally-
encoded T7 RNA polymerase gene was induced by adding IPTG (Isopropyl β-D-1-
thiogalactopyranoside) to a final concentration of 1 mM, when the cultures reached an 
OD600 of 0.6. Incubation was continued for a further 3 h to allow over-expression of the 
recombinant gene encoded in the pET16b-based construct. After 3 h, cells were 
harvested by centrifugation at 4000 x g for 30 min at 4°C (Sorvall RC-5B, SLA-3000 
rotor). The pellet was washed with 20 mL of ice-cooled lysis buffer (20 mM Tris-HCl [pH 
7.6], 0.5 M NaCl, 50 mM Imidazole) and centrifuged at 4000 x g for 30 min at 4°C. Cell 
pellet was re-suspended in 30 mL ice-cold lysis buffer (20 mM Tris-HCl pH 7.6; 0.5 M 
NaCl; 50 mM Imidazole) with appropriate amount of cOmplete Mini EDTA-free 
protease inhibitor cocktail tablet (1 tablet/ 10 mL) (Roche Diagnostics). Pre-cooled cell 
disruptor with a one head setting at 15000 psi was used to lyse the cells. Lysate was 
cleared by ultra-centrifugation at 28000 x g at 4°C for 35 min (Optima™ L-80 XP 
Beckman Coulter ultracentrifuge), and then passed through a 0.45 µm filter (Sartorius 
stedim) before loading onto column. 
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In order to purify the protein, 1 mL HisTrap HP column (GE Healthcare Life Sciences) 
was washed with 5 mL dH2O charged using 0.1 M NiCl2 and washed with 5 mL dH2O 
again. The sample lysate applied to the column at flow rate of 0.7 mL/min using a 
peristaltic pump (Econo Pump model EP-1 Bio Rad). Purification was performed using 
an AKTA Explorer FPLC system. The protein was eluted from column using gradient of 
elution buffer (0 to 100%) (20 mM Tris-HCl [pH 7.6], 0.5 M NaCl, 1 M Imidazole) and 
collected 1.5 mL fractions at flow rate of 1 mL/ min. Peak fraction were pooled into 
dialysis tube (Spectra/Por® Membrane Dialysis Spectrum, 3500 MWCO) and dialysed 
twice for 3 h at 4°C against 500 mL dialysis buffer (50 mM Tris-HCl [pH 7.6] 300 mM 
NaCl, 1 mM DTT, 1 mM EDTA, 40% [v/v] glycerol). Sample was removed from dialysis 
tube and then aliquots of 50 µL were stored at -80°C until required. 
2.14.2 Analysis of purified oligohistidine-tagged protein  
SDS-polyacrylamide gel electrophoresis (PAGE) was performed using 15% [w/v] 
polyacrylamide resolving gel with 5% [w/v] stacking gel. The 15% resolving gel 
contained 15% [w/v] (29:1) acrylamide: bis-acrylamide solution; 380 mM Tris-HCl (pH 
8.8), 0.1% [w/v] SDS; 0.1% [w/v] APS; 0.1% [v/v] TEMED. The 5% stacking gel contained 
5% [w/v] (29:1) acrylamide: bis-acrylamide solution; 126 mM Tris-HCl pH (6.8), 0.1% 
[w/v] SDS; 0.1% [w/v] APS; 0.1% [v/v] TEMED. After adding an equal volume of 2 x 
sample buffer (Laemmli, Sigma-Aldrich), samples were incubated at 99°C for 5 min and 
then centrifuged briefly (13,000 x g), before being loaded using a 200 µL fine pipette 
tip. Samples were run alongside PageRuler Unstained Protein Ladder (Fermentas). Gel 
electrophoresis was performed in 1 x Tris-Glycine buffer (25 mM Tris-HCl [pH8.3], 190 
mM glycine; 0.1% [w/v] SDS) for 2 h at a constant 12 W. The gel was removed from 
between the glass plates and stained in 20-50 mL of Coomassie Blue solution (1 tablet 
of PhastGEl® Blue R was dissolved in 200 mL dH2O after 200 mL methanol and 40 mL 
glacial acetic acid were added) for 3 h with shaking. Excess stain was removed by 
rinsing the gel in tap water and the gel incubated in destain solution (50% [v/v] 
methanol, 10% [v/v] glacial acetic acid) for a further 2 to 12 h, destain solution was 
40 
 
 
 
replaced every 2 h. Protein bands were visualized by illuminating from underneath 
with white light using GeneGenius UV transilluminator (Syngene) and photographed. 
2.14.3 Protein Quantification 
Protein concentration was determined by running serial dilution of protein samples on 
SDS-PAGE alongside dilution of prepared Bovine serum albumin (BSA) (Sigma) 
standards and comparing the intensity after staining with Coomassie blue. The protein 
concentrations were quantified using AIDA software (v4.22.034, Raytest GambH). 
2.15 Electrophoresis Mobility Shift Assays (EMSA) 
Promoter regions for EMSA were amplified and purified as described in Sections 2.9.1 
and 2.9.2. To visualise the promoter regions, the 5’ end of each of the reverse primers 
(see Table S2) was labelled with 6-FAMTM (fluorescein amidite) during its synthesis 
(MWG Eurofins). Each 20 µL of a reaction contained 5 nM of probe, 2 µg of Salmon 
Sperm DNA (Invitrogen) and a 10-fold dilution series of protein in the range 1.2 nM to 
5 µM. The reaction buffer was 1 x TGEK buffer (10 mM Tris-HCl [pH 8], 10% [v/v] 
glycerol, 0.1 mM EDTA, 50 mM KCl). Control reactions had all the compounds except 
protein. The binding reactions were allowed to proceed at room temperature for 20 
min. Then analysed by running in a 4% [w/v] 37.5:1) acrylamide: bis-acrylamide gel in 1 
x TGED buffer (50 mM Tris-HCl [pH 8.5], 0.4 M glycine, 2 mM EDTA). Electrophoresis 
was performed in Bio-Rad Protein II XI tank at 120 V for 40 min in 1 x TGED buffer with 
a water-cooled central core. The protein-DNA complex were visualized by using 
Fujifilm FLA-5000 imaging analyser system, an excitation laser wavelength of 473 nm 
was used. 
2.16 Reintroducing atrA into S. coelicolor 
2.16.1 Plasmids constructed as part of this study 
Plasmid pSET-atrA3x is a pSET152 derivative which contains the coding region of S. 
coelicolor atrA fused with 3 x FLAG tag™ at C-terminus. Plasmid pAU-atrA3x is a pAU3-
45 derivative which contains atrA coding region fused with 3 x FLAG tag™ at C-
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terminus. Plasmid pAU-atrA is a pAU3-45 derivative which contains the coding region 
of atrA. Plasmid pAU-3xatrA is a pAU3-45 derivative which contains atrA gene fused 
with 3 x FLAG tag™ at N-terminus. The coding sequence of the 3 x FLAG tag™ was 
codon optimised for streptomycetes 
(ATGGACTACAAGGACCACGACGGCGACTACAAGGACCACGACATCGACTACAAGGACGACG
ACGACAAGTGA). pSET-atrA3x, pAU-atrA3x, pAU-atrA, and pAU-3xatrA were 
constructed by cloning 1356-bp, 1356-bp, 1270-bp, and 1392-bp DNA fragment into 
the BamHI and EcoRI sites, respectively (see Figure 5.1, panel A). 
A 1456bp DNA fragment, including the coding region of atrA (891) fused with 3 x FLAG 
tag™ (72 bp) at C-terminus in addition to 332 bp upstream of the gene and 49 bp 
downstream of the gene flanking with 56 bp of pUC18 at each side, was synthesized at 
Life Technologies. A 1270-bp DNA fragment including atrA gene was amplified using 
atrAF2 and atrAEcoRI-R2 primers. The forward primer annealed upstream of the 
BamHI restriction site in pAU-atrA3x plasmid, which was used as a template. While the 
reverse primer annealed to the end of atrA gene adding a stop codon and an EcoRI site 
to the DNA fragment (Table S2). A 1392-bp DNA fragment including the 894-bp atrA 
coding region fused with 3 x FLAG tag™ at N-terminus was obtained as a gift from 
Professor Colin Smith (University of Surrey). Each recombinant has two cloning sites 
BamHI site at the N-terminus and EcoRI site at the C-terminus. The cloned atrA was 
under it is own promoter in all constructs. After gel electrophoresis the fragments 
were purified from excised gel using a QIAquick® gel extraction kit. All DNA fragments 
and pAU3-45 plasmid proceeded to double digested with BamHI and EcoRI using 
conditions recommend by the vendor of these enzymes (New England Biolabs). 
Ligation, transformation, enzymatic and sequencing confirmation were done as 
described previously under Section 2.13. 
2.16.2 Conjugation 
Conjugation was performed using an established method (Gust et al., 2003). 
Competent cells of E. coli ET12567 (pUZ8002) were grown in LB at 37°C. Kanamycin 
and chloramphenicol were added to maintain selection for pUZ8002 and the dam 
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mutation, respectively. The plasmid of interest was introduced into the strain by 
transformation as described in Section 2.12. Transformants were selected by spreading 
the cells on the LB agar plates containing apramycin (50 μg/mL). A single transformed 
colony was used to inoculate 10 mL of LB broth containing apramycin, 
chloramphenicol, and kanamycin, and then incubated overnight. An aliquot (100 μL) of 
overnight culture was inoculated into 10 mL LB broth containing appropriate 
antibiotics and incubated for 8 h to an OD600 of 0.4. The cells were washed twice with 
LB broth to remove antibiotics, and re-suspended in 1 mL of LB broth. 1 x 106 S. 
coelicolor spores in 0.5 mL 2 x YT broth were “heat shocked” at 50°C for 10 min and 
place in an ice-water batch.   
A mixture of 0.5 mL E. coli cells and 0.5 mL of S. coelicolor spores was pelleted and re-
suspended in 50 μL residual liquid. A serial dilution of the mixture was made in sterile 
dH2O from 10-1 to 10-4. 100 μL from each dilution was plated out and spread over SFM 
plate containing 10 mM MgCl2, and incubated at 30°C for 18 h. Transconjugants were 
selected by overlaying the plates with 1 ml sterilized dH2O containing 1.25 mg 
apramycin (for M145 strains) or 1.25 mg thiostrepton (for L645 strains) as selective 
marker in addition to 0.5 mg of nalidixic acid to kill E. coli cells. Spore stocks were 
prepared from each single transconjugants colony (see Section 2.4). The control was 
also performed as above, but without donor bacteria. 
2.16.3 Analysis of actinorhodin (ACT) production 
Ten mL cultures (YEME) of the strains to be analysed were set up in 50 mL Falcon tubes 
with appropriate selection. All tubes were incubated for 5 d at 30°C with shaking (220 
rpm). Mycelia were collected and weighted. 200 µg of mycelium in 20 µL of 25% [v/v] 
glycerol were spotted onto R5 plates. The well sporulated strains were analysed by 
spotted appropriate numbers of spores onto R5 plates. All plates were incubated for 
48 h before being photographed at this point and every 24 h for the next 120 h.  
 
 
43 
 
 
 
2.17 ACT extraction and EMSA assay 
2.17.1 Preparation of crude extract 
5 X 105 spores of S. coelicolor L646 (Towle, 2007), which overproduces ATC, were 
spread on TSA plates and incubated at 30°C for 6 d to obtain an even lawn. The agar 
was collected, submerged in 2.5 x volumes of water and incubated at room 
temperature for 1 h with shaking (200 rpm). The liquid, which containing ACT was 
collected, acetic acid added to lower the pH until the ACT changed colour from blue to 
red. The supernatant was then extracted with an equal volume of ethyl acetate (Fisher 
Scientific Ltd). The ethyl acetate extract was concentrated using a rotary evaporator 
(Rotavapor, RE Buchi), and then dried using a parallel evaporator (EZ-2 personal 
evaporator, Genevac). The dried crude extract was dissolved into methanol at high 
concentration. Crude activity was checked as described in Section 2.15 with exception 
of using fixed concentration of AtrA-c (150 nM) and 5 nM of actII-ORF region 2 probe 
as substrate. To provide controls, crude extract was similarly prepared from M511 
(Floriano & Bibb, 1996), which is ΔactII-ORF4, and M1146 (Gomez-Escribano & Bibb, 
2011), which is Δact, Δred, Δcpk, and Δcda. 
2.17.2 Thin layer chromatography (TLC) purification of actinorhodin (ACT) 
Aliquots of crude extract dissolved in methanol were spotted on a pencil line drown 
about a 1 cm from the bottom of TLC silica gel plate (Merck Millipore) using a capillary 
glass tube. The plate was moved into a TLC tank and immersed in toluene: glacial 
acetic acid (4:1 [v/v]) just under the line where the crude extract loaded. After the 
solvent front reaches around 1/3 of the plate, the plate was removed and the solvent 
front was marked with a pencil line. After the plate was dried the upper red band with 
Rf 0.5 was cut out and eluted with ethyl acetate. The EtOAc extract was dried and 
weighted. The resulting material was dissolved in methanol and subjected to Liquid 
chromatography – Mass Spectrometry (LC-MS). 1 mL (1 mg) of extracted material was 
injected onto Phenomenex Luna C18(2) column (50 x 2 mm) and connected to an 
Agilent 1200 series HPLC with diode array detector and Bruker HCT Ultra Ion Trap Mass 
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Spec. Distance travelled by pigment was divided by distance travelled by solvent front 
to calculate Rf value. ACT activity was checked as same as crude extract (Section 2.17.1)  
2.17.3 Preparative High performance liquid chromatography (HPLC)  
Crude extract from L646 was fractionated by injecting 3 x 500 µL (5 mg) onto a Waters 
XBridge Prep C18 5 µm OBD column (19 x 100 mm). This column was connected to an 
Agilent 1260 series HPLC with Diode array detector and an Agilent 6100 series single 
quad mass spec. The column was washed with 95% MeOH. Components that bound to 
the column were eluted by a gradient of MeOH (5 to 95%) in 0.1% [v/v] formic acid 
(300 mL, 20 mL / min). At the end, the gradient was held at 95% [v/v] MeOH for 7 min. 
ACT eluted as a peak at 90% [v/v] MeOH. All peaks and the flow through were 
concentrated, dried, weighed and then dissolved in 100% [v/v] MeOH to a 
concentration of 9.5 mg/mL.  
2.17.4 Analysis of ACT 
Various concentrations of each fraction were used to test their activities (see Section 
2.17.1). Fraction concentration and reaction conditions are stated in the corresponding 
figure legends. ActR (SCO5082), which is transcription regulator of actA (SCO5083) and 
TetR, which is transcription regulator of tetA were used as controls. Promoter region 
for actA and tetA were amplified and purified as described in Section 2.9.1 and 2.9.2. 
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Chapter 3 
3 The production and initial interpretation of a nucleotide-
resolution transcription map for Streptomyces coelicolor 
showing the positions of sites of transcription initiation and 
RNA processing and degradation. 
3.1 Introduction 
As outlined in the General Introduction, numerous genes and growth conditions that 
influence secondary metabolite production and morphological development have 
been identified for S. coelicolor and for some the underlying changes in gene 
expression have been determined using microarrays and to a lesser extent proteomic 
approaches (for reviews, see (van Wezel & McDowall, 2011, Liu et al., 2013). Despite 
this considerable effort, there is no coherent understanding of the pathways that 
control the flow of genetic information at the level of the whole cell. A limiting factor is 
the scarcity of experimental information on the organisation and regulation of the 
transcriptional units that encode proteins and RNA components of the translation and 
regulatory machinery. Elements such as promoters, transcription start sites and 
untranslated regions have not been identified experimentally on a genome-wide scale. 
Other key aspects of gene expression for which virtually no information was available 
for S. coelicolor, and indeed any other bacterial species, were the sites of RNA cleavage 
that facilitate rapid mRNA turnover (Carpousis et al., 2009), a key process that ensures 
translation follows programs of transcription, and generate the RNA components of 
the translation machinery (Deutscher, 2009, Hartmann et al., 2009). Currently, 
genome-wide knowledge of operons and cis-regulatory elements is largely inferred 
from a promoter-centred analysis of modules of co-expressed genes that were 
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identified from a large compendium of transcriptome data (Castro-Melchor et al., 
2010). 
The specific objective of this chapter was to develop a pipeline for the generation of 
maps of transcription units that detailed the positions of transcription start sites. A 
major driver for developing this pipeline was to provide a platform for interpreting the 
functional significance of the binding of regulators of transcription to specific sites. As 
indicated earlier, of particular interest to this project is the function of AtrA, a TetR 
family member that is highly conserved in Streptomyces spp. and regulates the 
production of actinorhodin in S. coelicolor (Uguru et al., 2005). It was also appreciated 
that the generation of detailed transcription maps for S. coelicolor would provide new 
insight beyond the transcription initiation and its regulation. The pipeline described 
here combined two RNA sequencing approaches, one that identifies and 
“differentiates” sites of transcription initiation and endonucleolytic cleavage (dRNA-
seq) and another that provides a “global” view of transcript abundance and the 
boundaries of transcription (gRNA-seq) (Lin et al., 2013). The transcriptome of 
Escherichia coli was mapped in parallel by David Romero-Alves, another member of 
the laboratory. The inclusion of E. coli validated the approach, as many features 
identified previously using traditional gene-specific methods, such as northern blotting 
and primer extension, were identified by RNA sequencing. As detailed elsewhere 
(Romero et al., 2014), it also provided new insights into the regulation of gene 
expression in E. coli and revealed the limitations of previous global analyses, for 
example, in the mapping of transcription start sites (Cho et al., 2009).  
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3.2  Results 
3.2.1 Overview of RNA-seq approaches 
Sites of transcription initiation and RNA cleavage were mapped for S. coelicolor M145 
grown in YEME broth until the mycelia became visibly pigmented. This point was 
chosen as it is known to coincide with exit from exponential growth and the onset of 
secondary metabolism (Bibb, 2005, van Wezel & McDowall, 2011). A detailed growth 
curve was not produced as the primary objective was to develop a methodological 
pipeline and not describe a specific phase of growth. M145 was chosen for this study 
as it has been, and continues to be, used extensively worldwide for biochemical and 
genetic studies (Chater et al., 2002, Baba et al., 2006). Total RNA was isolated from the 
single point in growth and enriched for mRNA by depleting 16S and 23S rRNA. To 
differentiate 5′-triphosphorylated ends generated by transcription from 5′-
monophosphorylated ends produced by RNA processing or degradation, an aliquot of 
the enriched mRNA was incubated with tobacco acid pyrophosphatase (Loria et al., 
2008, Loria et al., 2007, Breter & Rhoads, 1979), which leaves a monophosphate on 5′ 
ends that were originally triphosphorylated. A second aliquot was incubated under the 
same conditions, but without TAP. 5’ end fragments were then cloned and sequenced 
via a strategy that required the ligation of an adapter to 5′-monophosphorylated ends 
(Lin et al., 2013). A significant increase in the number of sequencing reads at a specific 
position following TAP treatment provided an identifier of a transcription start site 
(TSS). It should be noted that after the addition of the 5′ adaptor the RNA was 
fragmented to allow good coverage of the 5′ ends of large transcripts and 
intermediates. A third aliquot of each RNA sample was analysed using FRT-seq, an 
amplification-free form of strand-specific global RNA-seq (Lin et al., 2013, Mamanova 
et al., 2010). This allowed the transcripts to be mapped along their entire length. 
Importantly, the RNA-seq approaches used here should not be affected unduly by high 
GC content (Lin et al., 2013, Mamanova et al., 2010), a feature of streptomycete 
genomes. In brief, the gRNA-seq approach avoided the use of PCR, which introduces 
bias with GC-rich templates (McDowell et al., 1998), while the dRNA-seq approach did 
not use Terminator™ 5′ monophosphate-dependent exonuclease (TEX), which does 
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not degrade Streptomyces RNA efficiently, presumably because of the high prevalence 
of stable secondary structures. In the original and most widely used dRNA-seq 
approach to date, TSSs are identified by their resistance to treatment with TEX 
(Sharma et al., 2010). 
3.2.2 Identification of transcription start sites 
To classify the 5′ ends identified by dRNA-seq, reads obtained before and after TAP 
treatment were analysed using M-A (ratio-intensity) scatterplots. For S. coelicolor 
(Figure 3.1 A) and E. coli (Figure 3.1 B), two populations of values were found, as 
described previously for Propionibacterium acnes (Lin et al., 2013). The largest 
population corresponds to sites of processing and degradation and centres on a value 
of M close to 0, while the smaller population associated with higher M values 
corresponds to TSSs. The TSSs for S. coelicolor were on average associated with higher 
M values and lower A values (Figure 3.1 A), which may reflect a lower proportion of 
the 5′ ends of primary transcripts being monophosphorylated in vivo. E. coli has an 
RNA pyrophosphohydrolase (Celesnik et al., 2007, Deana et al., 2008). The situation for 
S. coelicolor is not yet known. For both organisms, nucleotide positions with M values 
above what was judged to be the upper boundary of the central cone of the 
population corresponding to processing and degradation sites (red line, Figure 3.1 A 
and B) were designated positions of possible TSSs. The positioning of the upper 
boundary was based on knowledge of the shape of cones produced by plotting two 
biological replicates of samples (before TAP treatment) against each other (data not 
shown). Positions within 8 nt of each other were assigned to the same TSS, as it is 
known that many promoters initiate transcription from a cluster of nucleotide 
positions (Salgado et al., 2006). These sites were then mapped against leading edges of 
transcription, which were determined independently via manual inspection of the 
global RNA-seq data, as described previously (Lin et al., 2013). 
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Figure 3.1: M-A scatterplots of values from the differential RNA-seq analysis. Panels 
A and B represent data for S. coelicolor M145 and comparator E. coli BW25113 
(Romero et al., 2014). The M values correspond to Log2 (plus/minus) and A values to 
(Log2 plus + Log2 minus)/2, where minus and plus refer to the number of reads before 
and after treatment with TAP. The numbers correspond to individual genome 
positions, not genes. For further details, see Section 2.7.3. In each panel the red line 
represents the upper boundary of the population of values corresponding to sites of 
processing and degradation (see main text). The upper boundaries were placed 
manually to enclose the majority of the lower population, while taking into 
consideration the spread of M values scattered around 0. The boundaries were then 
described by the polynomial equations. These were M = 0.054A2 – 0.96A + 4.68 and 
M= – 0.003A3 + 0.13A2 – 1.57A + 7.08 for S. coelicolor M145 and E. coli BW25113, 
respecively. 
For S. coelicolor, 1147 sites associated with leading edges of transcription as well as 
being enriched following TAP treatment (Class I) were identified. E. coli BW25113 data 
were included to allow comparison. The number of class I sites was higher for S. 
coelicolor than E. coli and probably reflects the larger gene content (7.8 vs 4.3k genes). 
TSSs were identified for all types of functional RNA: mono- and poly-cistronic mRNAs, 
ribosomal RNAs, transfer RNAs and ubiquitous small RNAs (for examples, see below). 
As described previously for P. acnes (Lin et al., 2013) , 217 S. coelicolor sites were 
identified that were enriched following TAP treatment, but not associated with leading 
edges of transcription (Class II), and 451 sites were associated with leading edges, but 
not enriched (Class III). In comparison, 311 TSSs form class II and 1554 TSSs from class 
III have been identified in E. coli (Romero et al., 2014). Although, Class I sites were 
assigned with the most confidence, being based on two criteria, all three classes 
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contained TSSs that have been identified previously by others and recorded in 
RegTransBase (Cipriano et al., 2013). Examples of different classes of TSS are shown in 
Figure 3.2. This information has been included in the annotation of these sites (Table 
S2). The probable origin of the different classes of TSSs, which has been described 
previously (Lin et al., 2013), is outlined in the Discussion section. 
 
Figure 3.2: Examples of different classes of TSSs. Panels A, B and C correspond to 
previously identified TSS of litS (Takano et al., 2005b), bldC (Hunt et al., 2005) and hrdD 
(Paget et al., 2001), respectively. The panels are modified screenshots from the UCSC 
Microbial Genome Browser (Schneider et al., 2006, Chan et al., 2012). The tracks 
depict from top to bottom show the genome positions, gene locations, position of 
RegTransBase TSSs, position of TSSs classes, differential RNA-seq reads (in the 
presence and absence of TAP treatment) and gRNA-seq reads. The numbers at the left 
of the RNA-seq tracks indicate the scale of the sequencing reads. dRNA-seq and gRNA-
seq data for the forward strand are coloured black and have positive values, while the 
reverse strand is coloured red and has negative values. The positions of TSSs identified 
by the analysis of M-A scatterplots (Figure 3.1), and the number of times each position 
on the corresponding strand was sequenced following fragmentation of the 
transcriptome (gRNA-seq). TSSs are marked by short vertical lines that are labelled to 
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indicate the forward (FWD) and reverse (RVS) strand of DNA. The class are colour 
coded. Class I is in black, class II in blue and class III in red. 
3.2.3 Leaderless mRNAs  
By mapping TSSs onto the annotated genomes, 264 mRNAs that cannot be translated 
via the canonical Shine-Dalgarno (SD) interaction (Shine & Dalgarno, 1974, Shine & 
Dalgarno, 1975) because they either lack or have a short 5′ leader (>10 nt) were 
identified (Table S3). These mRNA species are classified here as being leaderless. A 
prevalence of leaderless mRNAs (lmRNAs) in S. coelicolor has been reported previously 
(Vockenhuber et al., 2011). The global RNA-seq data for some of the many S. coelicolor 
lmRNAs are shown in Figure 3.3. This includes data for a homologue of WhiH, which 
also has an lmRNA (Ryding et al., 1998). WhiH and other members of the GntR family 
have roles in controlling morphological development and secondary metabolism 
(Hoskisson et al., 2006, Persson et al., 2013, Hillerich & Westpheling, 2006). The 
possibility that the function of WhiH and other regulators is dependent on the 
leaderless status of the mRNA has not been investigated. It should be noted that here 
and elsewhere in this report the range of the global RNA-seq reads was restricted in 
genome-browser views to make it easier to determine the boundaries of transcription 
units. This can result in a block-like appearance. For the reverse strand, the RNA-seq 
data was given negative values and plotted in red instead of black. TSSs are 
represented by vertical lines and labelled according to strand, class and genome 
position. 
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Figure 3.3: Examples of leaderless mRNAs. (A), (B), (C), and (D) correspond to 
SCO3818, SCO4008, SCO5152 and an unnamed paralogue (SCO1678) of whiH. The 
panels are modified screenshots from the UCSC Microbial Genome Browser (Schneider 
et al., 2006, Chan et al., 2012). In each panel the tracks depict from top to bottom, the 
genome position, location of annotated genes, positions of TSSs and gRNA-seq data. 
Labelling is as in Figure 3.2. 
3.2.4 Processing and maturation of the stable RNAs 
Recently, it has been shown that E. coli lmRNAs, or at least those generated by 5′ 
processing under conditions of stress, are translated by specialised ribosomes from 
which the last 43 nt of the 3′ end of 16S rRNA have been removed endonucleolytically 
by MazF, the toxic component of a toxin-antitoxin (TA) system (Vesper et al., 2011). 
This region of 16S rRNA contains the anti-SD sequence and the binding site of S1 
(Lauber et al., 2012, Shine & Dalgarno, 1974), a protein that augments the SD 
interaction (Sorensen et al., 1998). Interestingly, while cleavage at the -43 site 
(numbered relative to the 3′ end of mature 16S rRNA) was identified for E. coli by the 
parallel analysis (Romero et al., 2014). Processing within the equivalent region in S. 
coelicolor 16S rRNA was not detected; however, this was not unexpected as it has 
been shown for streptomycetes that specialised ribosomes capable of translating 
lmRNA can be produced by modification of the 16S rRNA in the presence of 
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kasugamycin (ksg), which disrupting h2, h26, and h27 loops. Subsequently, stable 
ribosomal particles (61S) lacking six proteins of the small subunit (S1, S2, S6, S12, S18, 
and S21) will form that selectively translate lmRNAs (Kaberdina et al., 2009, Poot et al., 
1996). 
Despite the central role of ribosomes in translation, little is known about the 
processing and degradation of its RNA in S. coelicolor. However, the study of E. coli and 
B. subtilis has revealed that mature ribosomal RNAs are produced via a series of 
nucleolytic steps involving several ribonucleases and that rRNA can be degraded in 
response to aberrant assembly of the ribosome or cellular stress (Deutscher, 2009). 
The parallel RNA-seq analysis detected most of the known endonucleolytic processing 
sites for E. coli (Romero et al., 2014). It was initially considered that many of the 
processing sites might not be detected given the transitory nature of the 
corresponding intermediates and the fact that the mRNA had been enriched. Analysis 
of the S. coelicolor data revealed evidence of process at the 5′ ends of mature 16S, 23S 
and 5S rRNA, and at positions +3 and +52 relative to the mature 3′ end of 16S rRNA 
(Figure 3.4, panel A). The +52 site is within a segment complementary to another at 
the 5′ end of 16S rRNA. Thus, this site may correspond to cleavage by RNase III (AbsB, 
SCO5569), which is specific for double-stranded regions and has been shown to 
process rRNA in many bacteria (Nicholson, 2003) including S. coelicolor (Price et al., 
1999). However, the product of the staggered cut within the complementary region at 
the 5′ end of 16S rRNA was not detected. This differs from E. coli and might reflect the 
closer coordination of subsequent 5′ processing steps, which could include 5′ to 3′ 
exonucleolytic processing by RNase J (SCO5745), an ribonuclease with dual 
endonucleolytic and 5′ to 3′ exonucleolytic activity (Mathy et al., 2007, Bralley et al., 
2014) that is absent in E. coli, but present in B. subtilis. One of the functions of RNase J 
in B. subtilis is to generate the 5′ end of 16S mature rRNA (Britton et al., 2007). 
No obvious processing sites were detected at the 3′ end of mature 23S or 5S rRNA 
suggesting that, as described for E. coli (Gutgsell & Jain, 2012), the 3′ ends of these 
RNAs in S. coelicolor are generated primarily by 3′ exonucleolytic activity. A large 
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number of cleavage sites internal to the functional regions of the mature rRNAs of S. 
coelicolor were also detected. Cleavage at these internal sites is likely to be involved in 
the recycling of rRNA transcripts. The ribonucleases responsible for cleavage at these 
internal sites as well as those involved in processing the 5′ and 3′ ends can now be 
determined by analysing knockout mutants using fragment-specific approaches, such 
as those used to analyse B. subtilis rRNA processing (Redko & Condon, 2010). 
However, the incorporation of dRNA-seq into such studies is recommended as it will 
provide a genome-wide view on the roles of S. coelicolor ribonucleases beyond rRNA 
processing. 
Like rRNAs, tRNAs are produced with 5′ and 3′ segments that have to be removed in 
order for the molecule to become functional. 53 of the 65 tRNAs in S. coelicolor 
encode the 3′ CCA motif to which amino acids are attached, the others must have this 
motif added post-transcriptionally. Studies of tRNA processing in E. coli have led to a 
model in which the mature 5′ end is generated by the ubiquitous endonuclease RNase 
P, and the mature 3′ end via endonucleolytic cleavage a few nucleotides downstream 
followed by 3′ exonucleolytic trimming to the CCA motif. The maturation of the 3′ end 
can be mediated by tRNase Z (RNase BN), which has dual endo/3′ to 5′ exonucleolytic 
activity (Dutta et al., 2012, Dutta & Deutscher, 2010), or by the combined action of 
RNase E and 3′ to 5′ exonucleases, mainly RNases PH and T (Hartmann et al., 2009). In 
contrast to this model for E. coli, most of the 12 CCA-encoding tRNAs in S. coelicolor 
were found to be cut within the CCA motif between the Cs. This includes the bldA (Leu) 
tRNA (Figure 3.4, panel B), which is required for morphological development and 
accompanying secondary metabolism (Lawlor et al., 1987). The positions of cleavages 
within the CCA motif have been recorded (Table S4). It is possible that the S. coelicolor 
homologue of tRNA nucleotidyltransferase (SCO3896), which presumably adds CCA to 
tRNAs that are not transcribed with this motif (Cudny & Deutscher, 1986), may also be 
capable of recognising partial CCA ends and adding only the residues that are missing. 
There is evidence that at least some tRNA nucleotidyltransferases, including the E. coli 
enzyme (Reuven et al., 1997), have the capability of repairing CCA (Betat et al., 2010). 
Such an activity in S. coelicolor would mean that cleavages within 3′ CCA triplets would 
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not result in terminal inactivation of the tRNA. For several of the S. coelicolor tRNAs 
encoded without the CCA motif, processing within a few nucleotides downstream of 
the 3′ end was identified (Table S4). S. coelicolor has homologues of both RNase E 
(SCO2599) and tRNase Z (SCO2547), which could cut on the 3′ side of tRNAs. These 
cleavages presumably allow 3′ to 5′ exonucleolytic trimming of the tail prior to addition 
of the CCA by tRNA nucleotidyltransferase.  
 
Figure 3.4: Maturation of stable RNAs. (A) Annotated view of the rrnA operon of S. 
coelicolor. The tracks from top to bottom show the genome position, differential RNA-
seq reads in the absence of TAP treatment and the location of genes within the 
operon. The track containing the differential RNA-seq reads has been labelled to 
shown the position of cleavage sites referred to in the text and TSSs. As Figure 3.3, the 
labelling of the latter also indicates the strand and nucleotide position. (B) Processing 
within the CCA at 3′ end of S. coelicolor bldA (Leu) tRNA. An arrow indicates the 
position of cleavage within the CCA motif. 
3.2.5 The degradation and processing of mRNA 
With regard to mRNA, the parallel analysis of E. coli detect many endonucleolytic sites 
known to be involved in both the degradation and processing of mRNA (Romero et al., 
2014), thereby further validating the RNA-seq strategy. Numerous processing sites 
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were detected within S. coelicolor mRNA. This included sites upstream of the coding 
segment of pnp (Figure 3.5), which are cut by RNase III to initiate a mechanism that 
autoregulates the cellular level of PNPase activity (Gatewood et al., 2011). Thus, 
although S. coelicolor, unlike E. coli, contains RNase J (SCO5745), a endoribonuclease 
with dual 5′ to 3′ exonuclease activity (Condon, 2010), the precise 5′ ends of the 
downstream products of endonucleolytic events can be detected. Moreover, the 
density of 5′ ends (number per transcribed kbp) is not significantly higher in S. 
coelicolor than in E. coli (data not shown) suggesting that 5′ to 3′ exonucleolytic decay 
does not dominate bulk mRNA degradation in the former, even though it contains a 
ribonuclease with 5′ to 3′ exonucleolytic activity. 
 
Figure 3.5: Cleavage sites within the mRNA of the S. coelicolor pnp (SCO5737) gene. 
The tracks from top to bottom show the genome positions, the positions of TSSs, 
forward strand differential RNA-seq reads (in the absence of TAP treatment), gene 
locations and gRNA-seq reads. TSSs and cleavage sites referred to specifically in the 
text are labelled. The RNase III site on the downstream side was detected using a lower 
range of reads. TSSs are labelled according to the strand, class and nucleotide position. 
3.2.6 Identification of potential sRNAs 
The mapping of the transcription data against the annotated genomes of S. coelicolor 
revealed a number of short transcripts of high abundance within intergenic region and 
did not extend into annotated gene, which from hereon will be referred to as  small 
RNA (sRNA). A sRNA is a non protein-coding RNA molecule with a size range from fifty 
to five hundred nucleotides (Liang et al., 2011). A proportion of these transcripts 
mapped to palindromic sequences, which are the signatures of intrinsic transcriptional 
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terminators (Peters et al., 2011) and possibly only correspond to metastable decay 
intermediates. Short transcripts corresponding to 3′UTRs not included here in the list 
of potential regulatory RNAs. However, it should be noted that a number of reports 
indicate that some stable secondary structures in 3′ UTRs do correspond to functional 
sRNAs, in at least E. coli (Gossringer & Hartmann, 2012). The remaining group of 83 
small RNAs was found to contain all of the ubiquitous bacterial sRNAs (Figure 3.6): 6S 
RNA, tmRNA, and the RNA components of RNase P and the Signal Recognition Particle 
(Storz et al., 2011). Moreover, subsequent analysis revealed that 51 of the 83 sRNAs 
had been identified by prior RNA-seq studies focussed on the small RNA component of 
S. coelicolor (Vockenhuber et al., 2011, Moody et al., 2013) or predicted by bio-
computational approaches (Swiercz et al., 2008, Panek et al., 2008). This left 32 sRNAs 
that were previously undetected. Interestingly, 12 transcripts annotated previously as 
sRNAs (Vockenhuber et al., 2011) were found to extend into protein-coding sequences 
(for examples, see Figure 3.7). The differences in annotation may simply reflect an 
increase in the sensitivity of detection and transcript coverage provided by the gRNA-
seq approach adopted here. The comparison with the prior RNA-seq study of S. 
coelicolor has been summarised (Table S5). 
 
Figure 3.6: Ubiquitous sRNAs. Panels A to D show data for 6S RNA, the RNA 
components of RNase P and the signal recognition particle (SRP), and tmRNA, 
respectively. The tracks from top to bottom show the genome positions, gene 
locations, TSSs and gRNA-seq reads. The S. coelicolor homologue of 6S RNA that is 
shown is the one known to interact with the housekeeping sigma factor (Panek et al., 
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2011). The other was poorly expressed in our sample. As in Figure 3.3, the gRNA-seq 
data for the forward strand is coloured black and has positive values, while the reverse 
strand is coloured red and has negative values. 
To verify the ability of our approach to detect small RNAs for S. coelicolor, nine were 
selected randomly (indicated in Table S6) from a list of sRNAs that at the time had not 
been identified experimentally. These were then analysed using Northern blotting 
under stringent conditions that detect tmRNA and the RNA component of SRP, both of 
which are relatively abundant species. For three, scr2100 (Touzain et al., 2008), 
scr2822(d+) and scr3871 (Xu et al., 2012), signals were detected readily (Figure 3. 6, 
panels A and B). The sRNAs are labelled according to the nearest annotated gene, 
while the symbols in parenthesis indicate whether the RNA is downstream (d) or 
upstream (u) and transcribed from the same (+) or opposite strand (-). Moreover, the 
estimated sizes of the largest of the bands in each case corresponde well with the 
segment of highest abundance. For scr2822(d+) and scr3871 (Xu et al., 2012), these 
segments did not coincide with the predicted transcription start sites indicating a role 
for processing in their maturation. The presence of scr2100 (Touzain et al., , 2008) and 
scr2822d(+) were confirmed by Moody et al. (2013). The list of 32 small RNAs that are 
listed here for S. coelicolor as being potentially novel include examples of riboswitches 
that appear to be actively reducing the levels of downstream transcripts and potential 
cis-encoded antisense RNAs (Figure 6, panel C). 
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Figure 3.7: Northern blot analysis of S. coelicolor sRNAs. Labelling of sRNAs in 
parentheses indicates whether the sRNA is upstream (u) or downstream (d) of the 
nearest protein-coding gene and whether on the same (+) or opposite (-) strand. Panel 
A shows annotated views of sRNAs downstream of SCO2100 on the opposite strand, 
downstream of SCO2822 on the opposite strand and upstream of SCO3871 on the 
opposite strand. The tracks from top to bottom show the genome positions, gene 
locations, TSSs and gRNA-seq reads. Panel B shows northern blot analysis of sRNAs 
depicted in (A). The tmRNA and RNA component of the signal recognition particle were 
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probed to provide controls. The expected sizes of the most abundant species of these 
controls as judged from gRNA-seq data were ~400 and 80 nt, respectively. Panel C 
shows examples of active ribo-switching (attenuation) and a possible cis-encoded 
antisense RNA. The yybP element is reported to be pH responsive (Nechooshtan et al., 
2009) and is found in a large number of bacteria (Barrick et al., 2004) including E. coli 
(Argaman et al., 2001), SCO2347 encodes an integral membrane protein. The gcvT 
element binds the amino acid glycine (Mandal et al., 2004), SCO1378 encodes glycine 
dehydrogenase. The RFN element (or FMN riboswitch) binds flavin mononucleotide 
(Serganov et al., 2009), SCO1443 encodes riboflavin synthase. SCO0627, the target of 
the putative cis-encoded asRNA, encodes a putative ATP-utilising protein. 
3.2.7 Transcription regulation and organisation 
The previous RNA-seq analysis of S. coelicolor (Vockenhuber et al., 2011) identified 193 
TSSs for mRNA, 98 were associated in our analysis with readily detectable transcription 
downstream, and of these 79 were identified as Class I sites (see Table S2). The finding 
that not all TSSs identified previously by RNA-seq (Vockenhuber et al., 2011) or indeed 
conventional mapping approaches, such as S1 mapping and primer extension 
(recorded in RegTransBase) (Cipriano et al., 2013), were identified here is not 
surprising given the physiological and regulatory complexity of streptomycetes (van 
Wezel & McDowall, 2011, Chater, 2001, Strohl, 1992) and the analysis here of only one 
time point. There are also technical reasons that are discussed below. Nevertheless, 
the identification of 1147 Class I TSSs within the overall transcriptional landscape for S. 
coelicolor provides a much-improved platform for studying gene expression. For 
example, several obvious transcription units that started within the 5′ portion of 
regions annotated as being coding sequences were identified (Table S7) suggesting 
that the corresponding genes are actually shorter than previously thought. In support 
of this, it was found using the BlastP track of the UCSC browser, which displays the 
results from running BLASTP for all predicted proteins in the genome against those 
from other prokaryotic species, that many homologues were predicted to be shorter, 
with regard to their N-terminal ends, than their S. coelicolor counterpart (data not 
shown). Thus, as others have indicated, RNA-seq data can aid the accurate prediction 
of the 5′ ends of protein-coding regions (Sallet et al., 2013). 
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In addition, our global RNA-seq data revealed many examples of operon structures 
that differ significantly from ‘Arkin Lab’ predictions (Price et al., 2005). Fortunately, 
automated processes are being developed that allow transcriptional units identified by 
RNA-seq to be mapped onto genome sequences (Sallet et al., 2013). Clearly accurate 
annotation is required for gene expression and regulation to be modelled closely at the 
level of the whole cell (Karr et al., 2012). In the context of gene expression, transcript 
levels in our S. coelicolor RNA were also analysed by Colin Smith and co-workers 
(Surrey) using high-density oligonucleotide-based microarrays and compared the level 
of hybridisation (as a log2 ratio of signal obtained for the RNA sample to signal 
obtained for chromosomal DNA) against the number of global RNA-seq reads obtained 
over the regions covered by the oligonucleotide probes. This revealed reasonable 
congruence (Figure 3.8) with a Pearson correlation coefficient of 0.63, supporting the 
view that the global RNA-seq approach adopted here, which does not require PCR, is 
suited to the study of bacteria with GC-rich genomes (Lin et al., 2013). The disparity 
that exists appears to be due at least in part to some regions that were not sequenced 
with high frequency producing significant hybridisation signals. The latter may have 
resulted from a limited amount of cross-hybridisation. Although the probes were 
experimentally validated and selected on the basis of sensitivity and selectivity (Bucca 
et al., 2009) and the microarrays have been used successfully (Lewis et al., 2010, 
Allenby et al., 2012, Swiatek et al., 2013, Rico et al., 2014), it is not possible to 
completely eliminate the effects of cross-hybridisation (Wernersson et al., 2007, Mulle 
et al., 2010). 
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Figure 3.8: Comparison of global RNA-seq and microarray data for S. coelicolor. The 
mean RNA-seq reads for each base within the 60-bp region targeted by a microarray 
probe is directly compared with the microarray signal for the same probe target. 
Trendline calculated by the linear model fit within R (lm function) when given the 
formula RNA-seq_data ~ Array_data. 
Consistent with the S. coelicolor RNA being isolated during exit from exponential 
growth, viewing of the transcriptome map revealed that the production of several 
secondary metabolites was primed. Readily detected was transcription of actII-ORF4, 
redZ and redD, and cdaR, the cluster-situated regulators of actinorhodin (Act), 
undecylprodigiosin (Red) and the calcium-dependent antibiotic (CDA), respectively 
(Gramajo et al., 1993, Guthrie et al., 1998, Narva & Feitelson, 1990, Hojati et al., 2002), 
and bldA, the leucyl tRNA for the rare TTA codon (Lawlor et al., 1987), which is 
required for the effective translation of actII-ORF4 and redD, two of the 
aforementioned regulators. The level of transcription of bldA was similar to other 
tRNAs such as Val (CAC), Leu (TAG) and Arg (CCG) (data not shown). Transcription of 
the biosynthetic genes for Act, Red and CDA was barely detectable suggesting 
secondary metabolite production may have been awaiting the triggering of the 
stringent response (Strauch et al., 1991). Interestingly, however, in the case of actII-
ORF4 a long asRNA (>500 nt) that conceivably has a regulatory role was detected 
(Figure. 9, panel A). Moreover, a long asRNA was also detected for scbA (Figure. 9, 
panel B), which encodes the synthase of -butyrolactones (Kato et al., 2007, Hsiao et 
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al., 2007), small signalling molecules that regulate secondary metabolism and 
morphological differentiation (Willey & Gaskell, 2011). A transcript antisense to scbA 
was also reported by Moody et al. (2013). Further unexpected features were identified 
for other key regulators. For example, previously unknown transcripts in the intergenic 
region between afsR2 (Vogtli et al., 1994) and afsR (Horinouchi et al., 1990), both of 
which are regulators of secondary metabolism was detected. This transcript could have 
a discrete function or be the result of active riboswitching upstream of afsR2 (Figure 9, 
panel C). Additional transcriptional complexity was also detected for a number of 
transcription factor genes including whiB, a redox-sensitive transcription factor 
required for sporulation (Davis & Chater, 1992); in addition to the two promoters 
previously identified for whiB (Soliveri et al., 1992), a strong promoter farther 
upstream was identified (Figure. 9, panel D). 
 
Figure 3.9: Examples of transcriptional complexity associated with key regulators of 
S. coelicolor metabolism and development. Panels A, B, C and D show annotated 
views of actII-ORF4, whiB, afsR2, and scbA, respectively. Labelling is as in Figure 3.3.  
Finally, knowing the nucleotide position of a control step narrows and simplifies the 
search for cis-regulatory elements (Lin et al., 2013). By way of illustration, sequences 
immediately upstream of TSSs associated with genes of the translational machinery 
were searched using MEME (Figure S1) (Bailey et al., 2009). This reveal conserved 
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hexanucleotide regions similar to the consensus sequences reported previously for the 
‘vegetative’ promoters of streptomycetes (Strohl, 1992) and E. coli (Harley & Reynolds, 
1987, Lisser & Margalit, 1993). Moreover, as has been reported recently for P. acnes 
(Lin et al., 2013), another actinomycete, the ‘-35′ box in S. coelicolor appears to be on 
average 2 to 3 bp further upstream from the TSS than its E. coli counterpart (Figure 
3.10). This means that a shared TTG motif, located in the 5′ half of the E. coli box and in 
the 3′ half of the S. coelicolor box, is on average in the same position relative to TSSs in 
both organisms. This may explain at least in part why many Streptomyces promoters 
function effectively in E. coli (Strohl, 1992). Alignment of the S. coelicolor promoters 
did not reveal the GC-rich discriminator region (Travers, 1980), which is located 
immediately downstream of the ‘-10’ box of promoters of E. coli genes encoding rRNA 
and r-proteins and is now known to facilitate regulation by the RNA polymerase-
binding factors DksA and (p)ppGpp (Haugen et al., 2006) as part of the bacterial 
stringent response (Aldridge et al., 2013).  
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Figure 3.10: Conserved sequences in promoters associated with genes encoding the 
translational machinery. Panels A and B are Weblogo representations of the 
promoters of S. coelicolor and E. coli, respectively. The length of the space upstream of 
the -10 box was adjusted manually to maximise alignment of the −35 box as described 
previously (Lin et al., 2013). The combined height of nucleotide symbols shows the 
level of sequence conservation at a particular position, while the height of individual 
symbols within a stack of nucleotides indicates the relative frequency at that position. 
The blank positions in the Weblogo show sites lacking nucleotide sequence 
conservation. The nucleotide positions are numbered relative to the average position 
of TSSs to the point at which gaps were introduced to maximise the alignment. The 
numbering of position over the region of the -35 box is based on the average length of 
the spacer region. 
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3.3  Discussion 
By combining global and differential RNA-seq methodologies that should not be unduly 
affected by high GC content (Lin et al., 2013), a genome-wide view of many factors 
that control S. coelicolor gene expression at the level of transcription initiation and 
beyond was obtained successfully. For example, lmRNAs (Figure 3.3), key steps in the 
processing and degradation of rRNA, tRNA and mRNA (Figure 3 & 4), and small RNAs, 
including those that may be involved in attenuation-like switching mechanisms (Figure 
3.7), were detected. Many of the small RNAs identified in this study are novel (Table 
S6). Moreover, it is likely that more exists because the limited number of growth 
conditions studied to date (Vockenhuber et al., 2011, Moody et al., 2013) are unlikely 
to have captured the full physiological depth of S. coelicolor (Bentley et al., 2002). Our 
approach also identified over one thousand TSSs (Table S2) and transcription units, 
encompassing all classes of RNA. The global RNA-seq data can now be mapped onto 
the genome sequence (Sallet et al., 2013) to provide experiment-based annotation 
that should aid whole-cell modelling of, for example, regulatory modules (Castro-
Melchor et al., 2010). The examination of individual regulators that are central to the 
control of secondary metabolism and morphological development has already 
revealed new layers of transcriptional complexity (for examples, see Figure 3.9). 
Moreover, as was illustrated using promoters associated with the translational 
machinery (Figure 3.10), knowing the nucleotide positions of key events in gene 
control can aid the identification of cis-regulatory sequences. This type of analysis can 
now be extended to other steps in the control of gene expression such as RNA 
processing and degradation and transcriptional termination. The RNA-seq data 
analysed here has been deposited in the GEO archive (Barrett et al., 2013). The parallel 
analysis of E. coli in addition to validating the approach provided new insights into its 
gene regulation (for further details, see Romero et al., 2014), despite it being one of 
the best-studied model organisms (Neidhardt, 1996). 
Although lmRNAs are prevalent in S. coelicolor, processing of 16S rRNA at the 
equivalent of the -43 site in E. coli, which generates specialised ribosomes capable of 
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‘leaderless’ translation was not detected (Figure 3.4). As mentioned earlier, this was 
not unexpected, as it has been shown for streptomycetes that specialised ribosomes 
capable of translating lmRNA can be produced by modification of the 16S rRNA 
(Kaberdina et al., 2009). It would be interesting to determine whether S. coelicolor 
produces a molecule analogous to kasugamycin, a ribosome-interacting 
aminoglycoside originally isolated from S. kasugaensis that promotes 16S rRNA 
modification and thereby the translation of lmRNA (Kaberdina et al., 2009, Schluenzen 
et al., 2006, Schuwirth et al., 2006), and what role, if any, links the functions encoded 
by lmRNAs in Streptomyces spp. The substantial difference in the prevalence of 
lmRNAs between S. coelicolor and E. coli may also reflect the fact that the r-protein S1, 
which strongly promotes SD interactions in E. coli (Sorensen et al., 1998), is truncated 
at its C-terminus in S. coelicolor (SCO1998). Regardless of the underlying molecular 
biology, the results of this study add to the growing body of evidence that bacteria 
differ substantially in the extent to which they use lmRNAs (Nakagawa et al., 2010). 
While this study adds to growing evidence for sRNAs in S. coelicolor, simply because a 
region is transcribed does not mean it has a function (Graur et al., 2013). Evidence for 
background (or pervasive) transcription on a genome scale has been obtained for 
several bacterial species (e.g. (Lin et al., 2013)) including E. coli (Raghavan et al., 2012). 
Therefore, an assessment of the impact on cell physiology of the plethora of small 
RNAs being discovered will require careful genetic analysis. Background transcription 
could explain at least a proportion of the TSSs in Class II, which are associated with TAP 
enrichment, but not an obvious step increase in transcription. However, verification of 
background transcription initiation will require a number of biological replicates and 
statistical analysis, as applied recently to P. acnes (Lin et al., 2013). TSSs associated 
with alternative promoters nested downstream of ones that produce a substantial 
increase in transcription would also have been assigned here to Class II. 
The ability to detect sites involved in the initiation or mediation of rapid mRNA 
degradation using the differential RNA-seq approach described here (Figure 3.5) offers 
a much-improved platform to further understanding of this key aspect of gene 
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regulation. By extending the analysis to strains defective in key ribonucleases and their 
regulators, it should be possible to determine the impact of individual factors on a 
genome-wide scale, and to identify model transcripts, whose subsequent 
characterisation should reveal the underlying molecular and structural biology. 
Moreover, by adapting our differential RNA-seq approach to include the ligation of a 3′ 
adaptor prior to fragmentation of the RNA and the subsequent addition of a 5′ 
adaptor, it should be possible to investigate degradation by 3′-5′ exonucleases. While 
the results of this and related studies show that treatment with TAP is able to 
differentiate nascent 5′ ends, treatment with TEX, the 5′ to 3′ exonuclease specific for 
5′-monophosphorylated transcripts, may offer increased discrimination of TSSs that 
cannot be identified by TAP enrichment in vitro should efficient de-
pyrophosphorylation occur for some transcripts in S. coelicolor as in E. coli and B. 
subtilis (Sharma et al., 2010, Irnov et al., 2010, Thomason et al., 2015). TEX treatment 
would remove the majority of the de-pyrophosphorylated species thereby allowing 
those with nascent 5′ triphosphorylated ends to be detected. Another improvement 
would be to remove the PCR step from the differential RNA-seq approach. As 
illustrated by the global RNA-seq approach, amplification is not required during the 
preparation of cDNA libraries (Mamanova et al., 2010). The removal of PCR would 
remove amplification bias. 
Combining Class I and III, 1598 TSSs were obtained for S. coelicolor. This number is 
slightly lower than the number of proteins that have been detected for single 
conditions by proteomic approaches (Manteca et al., 2006, Rodriguez-Garcia et al., 
2007); however, it should be remembered that many transcription units in both 
contain multiple genes. In addition, the numbers of transcripts detected will likely 
increase as more conditions are analysed. The inclusion of differential RNA-seq, 
regardless of its form, is crucial for accurate TSS assignment. Sites of processing, 
including many which are well characterised and documented (e.g. RNase P 
maturation of the 5′ end of tRNA), have been identified erroneously as transcriptional 
start sites by a previous RNA-seq analysis of E. coli (Cho et al., 2009). Finally, the 
addition of a phosphorylation step to our differential RNA-seq approach would allow 
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the identification of the cleavage sites of RNases that produce downstream products 
with 5′-hydroxyl group. This is likely to be particularly relevant to studies of suboptimal 
growth conditions under which such RNases, e.g. E. coli MazF (Vesper et al., 2011), are 
highly activated. The addition of a phosphorylation step would also allow the 
identification of positions with transcriptional start sites that are primed by nanoRNAs 
(Nickels & Dove, 2011, Goldman et al., 2011), which a recent study indicates tend to 
have a 5′-hydroxyl group (Vvedenskaya et al., 2012). The latter study also suggests that 
while nanoRNAs can alter gene expression, this class of sRNA are not absolutely 
required for transcription from individual promoters. Thus, the omission of a 
phosphorylation step in this study should not have prevented TSSs being identified.  
Data access 
The RNA-seq data has been deposited in the GEO archive (Barrett et al., 2013) under 
accession number GSM1126846. 
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Chapter 4 
4 Potential targets of AtrA, the binding activity of 
recombinant orthologues and regulation by small molecules 
4.1 Introduction 
As already described (see Section 1.3), AtrA is a TetR-family transcriptional regulator 
that was initially discovered in the guise of an activity that binds to the promoter 
region of actII-ORF4 in vitro and is require for maximum production of actinorhodin 
production in Streptomyces coelicolor (Uguru et al., 2005). Sites bound by AtrA in vitro 
are also known to be occupied under at least some conditions in vivo (McArthur & 
Bibb, 2008). Recently, evidence has emerged through promoter engineering that 
higher levels of actinorhodin production can be achieved by inducing expression of 
actII-ORF4 early in growth (Sohoni et al., 2014). Thus, the role of AtrA may be primarily 
to control temporal rather than bulk expression. The details of AtrA-mediated 
regulation remain unclear, but it has emerged that a number of other transcription 
factors also bind the actII-ORF4 promoter (see Section 1.3). These transcription factors 
included DasR, which controls the transport and metabolism of the monosaccharide N-
acetylglucosamine (GlcNAc) (Rigali et al., 2006, Colson et al., 2007), coordinating with 
wider cellular activities including secondary metabolism (Swiatek-Polatynska et al., 
2015). Indeed, DasR binds directly the promoters of the cluster-situated regulators of 
actinorhodin biosynthesis and other secondary metabolites (Swiatek-Polatynska et al., 
2015). The nagE2 gene, which encodes the high-affinity transporter of GlcNAc, is 
regulated by AtrA as well as DasR (Nothaft et al., 2010). Thus, AtrA may influence the 
regulation of actinorhodin production by GlcNAc at both the start and end of the 
biosynthesis pathway. 
Using the position weighted matrix for sites bound by AtrA in vitro, the sequence of 
the genome of S. coelicolor has been scanned by us and our collaborators for sites 
71 
 
 
 
resembling the consensus binding site for AtrA (see Section 1.4). This revealed, for 
example, a possible AtrA-binding site in the promoter region of ssgR (van Wezel, pers. 
comm.), the transcriptional activator of ssgA (Traag et al., 2004), which encodes a key 
member of a family of actinomycete-specific proteins that regulate cell division and 
spore maturation (Traag & van Wezel, 2007). Moreover, analysis of the ssgR promoter 
region using a DNA-affinity capture assay (DACA) (Park et al., 2009) by the laboratory 
of Prof. Byung-Gee Kim (Seoul National University, Korea) identified AtrA as a potential 
binding partner. The RNA-seq analysis described in the previous chapter revealed that 
ssgA (and all other ssg genes in the same operon) were poorly expressed during 
submerged growth in liquid culture. This is consistent with the finding that S. 
coelicolor, unlike S. griseus, only sporulates on solid media (Daza et al., 1989, Manteca 
et al., 2010). The expression of atrA also appeared to be poor and is consistent with 
the possibility that AtrA activates expression of ssgR. 
The function of atrA is also being studied beyond S. coelicolor. Very recently, AtrA was 
found using a DACA-type approach to bind to the promoter that directs transcription 
of the entire cluster for daptomycin (Mao et al., 2015), a cyclic lipopeptide antibiotic 
produced by Streptomyces roseosporus (Miao et al., 2005). Disruption of atrA-sr 
produced a bald phenotype and completely blocked daptomycin production. In the 
same study, atrA-sr expression was shown to be positively regulated by AdpA, an 
orthologue of the A-factor receptor (Ohnishi et al., 1999). Thus, in S. roseosporus AtrA 
is a mediator of the A-factor signalling pathway. Moreover, it was also shown that 
AtrA-sr binds to its own promoter and autoregulates its own expression. Interestingly, 
comparison of the binding sites identified in S. roseosporus revealed little similarity 
with those identified in S. coelicolor. 
In S. griseus, AtrA is not a major mediator of the A-factor regulatory cascade, but can 
have an influence under some conditions (Hirano et al., 2008). AtrA-sg binds to the 
promoter of strR, the final activator of streptomycin production, between the binding 
sites of AdpA (Hong et al., 2007, Hirano et al., 2008). Disruption of AtrA in S. avermitilis 
led to an increase in the production of avermectin by S. avermitilis, by a mechanism 
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that directly involves the cluster-situated regulator, AveR (Chen et al., 2008). 
Transcriptomics revealed that the disruption of AtrA-sa (also called AveI) affected the 
expression of the biosynthetic clusters for oligomycin and filipin as well as genes 
encoding enzymes, such as crotonyl-CoA reductase and methylmalonyl-CoA 
decarboxylase, involved in the supply of precursors for avermectin and other natural 
products (Mao et al., 2015). Disruption also altered the expression of several genes 
involved in protein synthesis and fatty acid metabolism suggesting that AtrA may 
function as a global regulator of flux of carbon from primary to secondary metabolism 
in S. avermitilis. Consistent with such a role, scanning of the S. coelicolor genome for 
potential sites of AtrA binding using the position weighted matrix (see Section 1.4) 
identified potential targets in the promoters regions of genes encoding acetate kinase, 
α-isopropylmalate/homocitrate synthase family transferase and acetyl-CoA 
acetyltransferase/thiolase. 
One aspect of AtrA-mediated regulation that had not been reported in the literature 
prior to the initiation of the work described in this chapter was the possibility that the 
binding activity of AtrA, like many other members of the TetR family (Cuthbertson & 
Nodwell, 2013), is regulated by the binding of a small molecule. However, while Bin 
Hong and colleagues (Peking Union Medical College, China), were investigating the 
regulation of lidamycin production by S. globisporus, they not only discovered that 
AtrA-gl binds directly to promoter of cluster-situated regulator of lidamycin 
production, but that the DNA-binding activity of AtrA-gl could be inhibited by the 
binding of a biosynthetic intermediate of lidamycin. In addition, they also reported 
that the activity of AtrA-gl could be inhibited, at least in vitro, by actinorhodin, a 
secondary metabolite not produced by S. globisporus. This chapter describes the 
purification of AtrA-gl and its characterisation in direct comparison with S. coelicolor 
AtrA, which from hereon will be referred to as AtrA-c. In addition, it describes the 
assay used to validate putative AtrA-binding sites (see Section 1.4) and the effects of 
disrupting atrA on the transcription of potential targets of AtrA regulation in S. 
coelicolor. 
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4.2 RESULTS 
4.2.1 Purification and characterisation of AtrA from S. coelicolor and S. globisporus 
4.2.1.1 Constructed Plasmids 
All constructs used for the expression of recombinant genes in E. coli were based on 
pET16b (Figure 1, panel A). The genes were inserted between the NdeI and BamHI sites 
such that their products were tagged with decahistidine (or 10xHis) at the N-terminus 
to facilitate purification by immobilised metal affinity purification as detailed 
previously (Uguru et al., 2005). In addition to AtrA from S. coelicolor and S. globisporus, 
S. coelicolor ActR, which encodes the regulator of the efflux pump for actinorhodin 
(Tahlan et al., 2007) and E. coli TetR, which is the archetypal member of the TetR 
family and controls the expression of the TetA tetracycline resistance determinant, an 
efflux pump (Meier et al., 1988) were included as controls (see below, for details). 
Digestion of the corresponding “expression” plasmids (Table 2.3) with NdeI and BamHI 
produced fragments of the expected size (Figure 1, panel B). The integrity of each 
cloned gene was verified by DNA sequencing (data not shown).  
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Figure 4.1: Plasmids used to produce AtrA and other members of the TetR family in E. 
coli. Panel A is a schematic illustration of each of the four genes cloned into pET16b. 
The lengths of the corresponding NdeI-BamHI fragments are indicated in parentheses. 
Key features of the pET16b plasmid are also indicated, such as the segment that 
encodes decahistidine (10xHis), the T7 promoter (T7P) that drives transcription of 
cloned genes, the T7 terminator (T7ter), which terminates transcription by 
bacteriophage T7 RNA polymerase, the lac operator (lacO), which represses 
transcription from T7P in the absence of induction, the AmpR, which confers resistance 
to ampicillin, carbenicillin, and related antibiotics, and factor Xa-protease site 
(Croxatto et al., 2002), which is useful in cleaving 10xHis tags from engineered His-
tagged fusion proteins. The atrA-c, atrA-gl, tetR and actR (SCO5082) genes are 
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coloured gold, green, orange, and purple, respectively. Panel B shows the agarose gel 
electrophoresis (1 %) analysis of the products of digestion with NdeI and BamHI. Lanes 
1 to 4 correspond to plasmids encoding AtrA-c (pRA001), AtrA-gl (pET16b-atrA-gl), ActR 
(pET16b-ActR), and TetR (pET16b-TetR), respectively. The expected sizes of the 
corresponding insert fragments are 901, 799, 784 and 631 bp, respectively. Lane M 
corresponds to Quick Load 1 kb DNA ladder (New England Biolabs). Numbers on the 
left of this panel indicate the sizes of the marker fragments. 
4.2.1.2 Over-production and purification of AtrA-c, AtrA-gl, ActR and TetR 
AtrA-c, AtrA-gl, ActR and TetR were each purified by IMAC as described previously 
(Uguru et al., 2005) with only minor modification (see Section 2.14.1). SDS-PAGE 
analysis of the purification of proteins are shown in Figure 4.2. A polypeptide of the 
size expected for AtrA-c (29.93 kDa) was clearly induced (cp. lanes 1 and 2), remained 
in the soluble fraction following lysis of the cells and ultracentrifugation (lane 3), 
bound to the column with high efficiency (lane 4), eluted as a single major species 
(lane 5), and remained soluble during dialysis and concentration (lane 6). Preparations 
of AtrA-gl (27.5 kDa), ActR (28.3 kDa) and TetR (23.3 kDa) of comparable purity were 
also obtained (see Figure 4.2). The purity of AtrA-gl was comparable to that of AtrA-c 
(Figure 4.2, panel B, lane 7). 
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Figure 4.2: Purification of AtrA-c, AtrA-gl, ActR and TetR from E. coli by IMAC. Left 
inset from each panel shows the HPLC profile for the elution step of the purification. 
The absorbance measure at 260 nm (blue) and 280 nm (red) are plotted against elution 
volume (mL). The green line shows the gradient of imidazole from 145 mM to 1 M (0 to 
100%, respectively). The flow rate was 1 mL/min. Fractions corresponding to the single 
peak were pooled together prior to dialysis and concentration. Right inset from each 
panel shows SDS-PAGE analysis of fractions from different steps in the purification. 
Lanes 1 to 6 are as described in the main body of the text. Lanes labelled M contain 
PageRuler Unstained Protein Ladder (Fermentas). Numbering on the left of this panel 
indicates the sizes of the markers (kDa). Lane 7 in panel B contained 3.2 µg of purified 
S. coelicolor AtrA.  
4.2.1.3 EMSA analysis 
To investigate the possibility that AtrA modulates primary metabolism we generated 
promoter probes for genes encoding enzymes associate with acetyl-CoA metabolism, 
acetate kinase, α-isopropylmalate/homocitrate synthase family transferase and acetyl-
CoA acetyltransferase/thiolase (SCO5424, ackA; SCO5529, leuA2; and SCO6027, 
respectively), as suggested by scanning of the S. coelicolor using the PWM for AtrA (see 
Section 1.4), probes corresponding to these regions were amplified by PCR. Positive 
controls were provided by amplifying two regions corresponding to the promoter of 
actII-ORF4. The first encompassed the two binding sites for AtrA, while the second only 
encompassed “Site 2”, which of the two sites forms the highest affinity interaction 
(Uguru et al., 2005). Negative controls were provided by amplifying regions 
corresponding to the promoters of actI-ORF1 and actIII, which are divergent, and vdh. 
Both regions do not have sequences with significant matches to the PWM for AtrA. The 
latter, which encodes valine dehydrogenase, was used previously as a negative control 
for AtrA binding (Uguru et al., 2005). The promoter region between atrA (SCO4118) 
and the gene encoding NADH dehydrogenase (SCO4119) was also included, as contrary 
to a report by others, previous attempts by the McDowall laboratory to identify AtrA 
binding to this region had failed (McDowall, pers. comm.). The opportunity was also 
taken to confirm binding to the promoter region upstream of ssgR. Each probe was 
incubated separately with increasing amounts of purified AtrA-c from 0 to 5 µM (lanes 
1 to 15, Figure 4.3). 
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AtrA bound within the promoter region of actII-ORF4 forming distinct complexes 
(Figure 4.3, panel A). More than 50% of the probe (labelled P) was shifted to higher 
position (labelled I) with an AtrA concentration of 156 nM (lane 10). As the 
concentration of the probe was considerably less, 5 nM, the concentration of AtrA at 
which 50% of the probe was shifted (78 to 156 nM, lanes 9 to 10) provided an estimate 
of the apparent equilibrium dissociation constant of this interaction (Kd´). With the 
addition of higher concentrations of AtrA, the probe shifted to a higher position 
(labelled II) consistent with the presence of a second binding site (Uguru et al., 2005). 
The majority of the probe was present in a second complex in the presence of 156 nM 
AtrA (lane 10). Above 156 nM the migration of the probe was increasingly retarded 
(lanes 11 to 16), a finding that may represent additional binding that less sequence 
specific. AtrA bound to a region of the promoter of actII-ORF4 containing only Site 2 
forming a single complex (labelled I; Figure 4.3, panel B). The majority of this probe 
was bound by 156 nM (lane 10). Interestingly, at higher AtrA concentrations the 
migration of this complex (corresponding to Site 2) was not increasingly retarded. This 
suggests that the proposed sites of less sequence-specific binding flank Site 1 and not 
Site 2. Overall, the results described above were consistent with previous findings both 
qualitatively and quantitatively (Uguru et al., 2005). 
AtrA binding to the promoter region between actI-ORF1 and actIII (panel C) and vdh 
(panel D) occurred at only the highest AtrA concentrations of 2.5 and 5 µM (lanes 14 
and 15, respectively). Given the absence of any significant matches to the PWM for 
AtrA, these interactions are thought to be non-specific. Incubation of AtrA with the 
probe for SCO5424 (panel E) failed to detect any binding except at the highest protein 
concentrations (lanes 14 to 15). However, a single complex was readily detected for 
SCO5529 (panel F) with approximately 50% of the probe being shifted by 78 nM AtrA 
(lane 9). A complex was also detected for SCO6027 (panel G), but at a concentration 
(1.25 µM, lane 13) just below that at which AtrA binds to the negative controls actI and 
vdh (panels C and D, respectively). Consistent with the observed affinities, the 
sequence in the promoter of SCO5529 (leuA2) is a better match to the PWM of AtrA 
than that of SCO6027, which is a better match than that of SCO5424. Thus, although it 
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is clear that genome scanning with the AtrA PWM may produce false positives (e.g. 
SCO5424), it has identified sites that may regulate the expression of SCO5529 (leuA2) 
and SCO6027, which encode enzymes that directly utilise and produce acetyl-CoA, 
respectively. Binding to the ssgRA promoter region was also detected (panel H), as 
found by others (Prof. Byung-Gee Kim, pers comm.). However, the affinity of the 
interaction was clearly weaker than some others, e.g. actII-ORF4 and SCO5529. Binding 
was not detected to the promoter region of ssgB (panel I), which was included as an 
additional negative control, and the promoter region between atrA (SCO4118) and the 
divergent gene upstream (SCO4119) (panel J). The latter is consistent with previous 
findings of the McDowall lab, but contradicts a report by others (Ahn et al., 2012).  
 
Figure 4.3: S. coelicolor AtrA electrophoretic mobility shift assay. Each lane in panels 
A to J contain 5 nM of specific fluorescein-labelled probe and 2 µg of Salmon sperm 
DNA (Invitrogen). Lanes 1 to 16 in each panel contain 0 nM, 0.6 nM, 1.2 nM, 2.4 nM, 
4.8 nM, 9.75 nM, 19.5 nM, 39 nM, 78 nM, 156 nM, 312.5 nM, 625 nM, 1.25 µM, 2.5 
µM, 5 µM and 0 nM of AtrA-c protein, respectively. The reactions were run in a 4% 
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(37.5:1) acrylamide: bis-acrylamide gel in 1 x TGED buffer for 40 min at 120 V. The gel 
was imaged using Fujifilm FLA-5000 imaging analyser system. The numbers in 
parenthesis indicate the size of probe. 
To assess the binding activity of S. globisporus AtrA, increasing concentrations were 
incubated with probes for the promoter regions of actII-ORF4, actII-ORF4 region 2, 
SCO4119 and SCO5529 (Figure 4.4). The results quantitatively and qualitatively were 
indistinguishable from those obtained for S. coelicolor AtrA. The results confirmed that 
AtrA binds to the promoter of SCO5529, but not SCO4119 with an affinity similar to 
that for its interaction with the promoter region of actII-ORF4. 
 
Figure 4.4: S. globisporus AtrA electrophoretic mobility shift assay. Each lane in 
panels A to D contain 5 nM of specific fluorescein-labeled probe and 2 µg of Salmon 
sperm DNA (Invitrogen). Lanes 1 to 16 in each panel contain 0 nM, 0.6 nM, 1.2 nM, 2.4 
nM, 4.8 nM, 9.75 nM, 19.5 nM, 39 nM, 78 nM, 156 nM, 312.5 nM, 625 nM, 1.25 µM, 
2.5 µM, 5 µM and 0 nM of AtrA-gl protein, respectively. The numbers in parenthesis 
indicate the size of probe. Electrophoresis conditions are identical to that described in 
Figure 4.3. 
4.2.2 Measuring transcript abundance in M145 and L645 strains by RT-qPCR 
4.2.2.1 Morphology and RNA purification 
Having confirmed in vitro binding of AtrA-c to several promoter regions in the previous 
section, the next objective was to investigate whether disruption of the atrA gene 
affected the transcription of genes putatively regulated by AtrA. RNA for RT-qPCR 
analysis was isolated from M145 and L645, the congenic atrA mutant, grown on the 
surface of cellophane-overlaid agar plates containing minimal media, with 0.5% [w/v] 
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mannitol as the sole carbon source (MM). The mycelia were grown as lawns covering 
the entire surface of the cellophane (diameter of 90 mm) or as distinct patches 
(diameter of ~16 mm). In each case, the inoculum was 1 x 105 CFU of spores/ mycelia 
fragments. M145 reproducibly generated detectable amounts of actinorhodin when 
grown as lawns for 4 days and as patches for 9 days (Figure 4.5, panel A). The longer 
time required for the production of actinorhodin when M145 was grown as patches 
probably reflected the slower utilisation of nutrients in the plate as a result of limiting 
the area of inoculation. After being grown as a lawn for 4 days or patches for 9 days, 
production of actinorhodin by L645 was not observed, despite undergoing normal 
morphological differentiation (Figure 4.5, panel A). Previously, the time at which 
actinorhodin production by M145 was first detected offered good discrimination of the 
effects of atrA on transcription of actII-ORF4 (Towle, 2007). Representative samples of 
total RNA preparations before and after treatment with DNase I are shown in Figure 
4.5, panels B and C. Distinct bands were evident for 23, 16 and 5S rRNA indicating that 
degradation of the samples had not occurred during isolation or purification. 
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Figure 4.5: Phenotype and RNA analysis of M145 and L645 strains. Panel A shows 
bacterial growth on cellophane-overlaid MM plates. The mycelial patches and lawns 
were exposed to ammonia fumes before being photographed. RNA was isolated from 
additional patches and lawns grown in parallel, not exposed to ammonia. Panels B and 
C show RNA samples before and after treatment with DNase I, respectively. Lanes 1 
and 2 contain 1 µg of RNA from each of M145 and L645, respectively, grown on MM 
plates for 96 h. Lane M contains 0.5 µg of GeneRuler 100 bp DNA plus ladder (Thermo 
Scientific). Numbers on the left of the two panels indicate the sizes of the marker 
bands (bp). The samples were analysed using 1.2% agarose gels (1X TBE). 
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4.2.2.2 RT-qPCR 
After preliminary investigations, rpsL, which encodes ribosomal protein S9, was 
adopted as an internal control because it is constitutively expressed and the 
abundance of its mRNA is in the middle of the range for transcripts of interest (Romero 
et al., 2014). The analysis focused initially on the effects of atrA disruption on a 
selection of ssg genes and used RNA isolated from mycelia grown as lawns for 4 days. 
The integrity of the resulting PCR amplicons were subjected to gel electrophoresis and 
melt curve analysis to confirm that they were the expected size and the absence of 
primer dimers, respectively. Representative examples of these analyses for end-
products of RT-qPCR are shown in Figure 4.6. In each case, a single species of the 
expected size was detected. 
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Figure 4.6: Melting curve and polyacrylamide gel electrophoresis analysis of 
amplified qPCR products. Panels A to F represent melting curve analysis of the end 
product of qPCR exploiting gene-specific primers against rpsL (as internal control), actI-
ORF1, actII-ORF4, ssgR, SCO5529 and SCO6027, respectively. Raw data were analysed 
using rotor-gene 6000 series software. Four µL of each qPCR end product was run on 
8% polyacrylamide gel (29:1) for 1:30 hr at 12 W (inset). Lanes 1 and 2 contain DNA 
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from M145 and L645, respectively. Lane M contains 0.5 µg of GeneRuler 100 bp DNA 
plus ladder (Thermo Scientific) and the sizes of representative bands are shown on the 
left hand side of inset. The size of each product is shown beneath the gel. Gel 
electrophoresis revealed one visible band with expected sizes in all PCR products, 
monitoring a single sharp melting peak. 
A threshold common to the exponential phases of all the reactions in a single run was 
selected manually and the corresponding number of cycles for each reaction recorded. 
These CT values were then expressed as the difference relative to rpsL (SCO4735), 
which encodes 30S ribosomal subunit protein S9. In turn, the ΔCT values were used to 
calculate the difference in abundance using the equation 2ΔCT. The initial analysis 
focussed on two independent samples of mycelia grown as lawns for 4 days. To allow 
statistical analysis, a third sample was added, but of mycelia grown as patches for 9 
days. The average fold decreases in the abundance of the transcripts of actII-ORF4 and 
actI-ORF1 in L645 were 20.1 ( 1.9) and 7.5 ( 2.9), respectively. Moreover, the results 
for the individual samples were similar (data not shown), i.e. the reported differences 
were not dominated by the results from one or two of the samples. These results are 
in line with our previous data showing that transcription of the act biosynthetic gene 
cluster requires AtrA (Uguru et al., 2005) and provide a control for the effects of AtrA. 
Disruption of atrA did not influence transcription of ssgD, which is consistent with it 
neither being directly or indirectly regulated by AtrA. In contrast, the abundance of 
ssgR transcript (a direct target of AtrA) and that of ssgA, which is activated by SsgR, 
decreased on average 2.9 ( 0.5) and 2.8 ( 0.7) fold, respectively. These RT-qPCR 
results provided in vivo evidence consistent with the direct transcriptional activation of 
ssgR by AtrA. The considerably higher abundance in M145 of the ssgD transcript 
relative to those of ssgA and ssgR (Figure 4.7) was associated with higher transcription 
as determined by independent promoter probing results (van Wezel, pers. comm.). 
SsgD is the only SALP (SsgA-like protein) that plays a role during vegetative growth 
(Noens et al., 2005). 
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Figure 4.7: Expression levels of transcripts in M145 and L645. Dependency of 
transcript levels on atrA in vivo. Histogram showing the average levels of transcripts in 
M145 and L645 (the congenic ΔatrA partner of M145) expressed as a percentage of 
the average abundance of the rpsL transcript (SCO4735). The values are the average of 
three independent measurements. Bars indicated the standard error. The Y axis has a 
log scale, which represents expression level. 
To analyse the effects of atrA disruption on genes encoding enzymes associate with 
acetyl-CoA metabolism, in particular those encoding α-isopropylmalate/homocitrate 
synthase family transferase (SCO5529) and acetyl-CoA acetyltransferase (thiolase) 
(SCO6027), samples from mycelia grown as lawns for 2, 3 and 4 days were analysed 
(Table 4.1). A time series was analysed to determine the normal expression profile, 
such that the significance of any differences between wild-type and atrA mutant could 
be better observed and evaluated. A large difference against a background of 
constitutive expression is more likely to be of significant than a small difference against 
a background of changing expression. Between day 2 and 4 the expression of both 
actII-ORF4 and actI-ORF1 increased by over 250 fold in M145 (wild-type). This is 
consistent with the previous finding that actII-ORF4 normally peaks at the time 
actinorhodin is first detected (Uguru et al., 2005). At day 4, the fold decreases in the 
abundance of the transcripts of actII-ORF4 and actI-ORF1 in L645 (cf. M145) were 4.5 
and 6.3, respectively. The equivalent values obtained in the preceding analysis were 
20.1 ( 1.9) and 7.5 ( 2.9), respectively. These quantitative differences may reflect 
relatively small differences in the growth profile of one or both of the strains between 
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the analyses, given the large increases in the expression of actII-ORF4 and actI-ORF1 
that accompany growth.  
Interestingly, while the expression of actI-ORF1 was reduced in the absence of 
functional atrA at days 3 and 4, it was substantially higher (64 fold) at day 2 (L645 vs 
M145). If reproducible this result would indicate that atrA regulation of actI-ORF1 
expression is more complex than activation of actII-ORF4. More specifically, atrA may 
repress the expression of a least some act biosynthetic genes earlier in growth. It may 
also repress the expression of SCO4119, which is adjacent and co-localised throughout 
evolution. The level of SCO4119 expression was 6.3, 2.0 and 1.4 fold higher at days 2, 3 
and 4, respectively in L645 (cf. M145). Given the absence of a good match to the AtrA 
PWM within the promoter region of SCO4118/9 and the absence of a strong 
interaction between AtrA and this region, at least in vitro, these results suggested that 
SCO4119 is either repressed indirectly by AtrA or directly by another form of AtrA, 
perhaps a conformer, that has different binding specificity. The expression of accA2, 
SCO4922, ackA, SCO5529, and SCO6027 (and SCO6026, the gene downstream of 
SCO6027) all increased with growth. However, the expression of these genes did not 
appear to be affected substantially (>2 fold) by atrA disruption.  
Gene Name Strain 
Transcriptional Abundance 
48 hrs 72 hrs 96 hrs 
actII-ORF4 (SCO5085) 
M145 2.88 132.51 714.79 
L645 0.69 11.29 153.50 
actI-ORF1 (SCO5087) 
M145 2.61 174.64 713.92 
L645 165.71 61.25 113.50 
SCO4119 
M145 0.80 3.34 9.83 
L645 5.08 6.98 13.41 
accA2 (SCO4921) 
M145 1.60 5.84 11.98 
L645 0.76 4.06 9.44 
SCO4922 
M145 0.01 0.03 0.05 
L645 0.01 0.02 0.08 
ackA (SCO5424) 
M145 2.45 6.40 9.12 
L645 4.02 7.83 11.46 
leuA (SCO5529) 
M145 10.03 15.72 15.28 
L645 10.29 13.81 22.18 
SCO6027 M145 0.39 1.52 1.43 
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L645 0.59 0.67 1.68 
SCO6026 
M145 1.8 5.94 7.57 
L645 1.81 6.26 10.65 
ssgA (SCO3926) 
M145 5.20 14.33 18.65 
L645 9.26 54.01 29.49 
ssgB (SCO1541) 
M145 0.21 2.79 6.00 
L645 17.43 14.33 18.99 
ssgC (SCO7289) 
M145 0.09 0.87 3.18 
L645 0.32 5.39 9.79 
ssgD (SCO6722) 
M145 16.25 41.52 176.93 
L645 5.11 30.91 203.25 
ssgE (SCO3158) 
M145 1.21 4.07 14.89 
L645 10.92 22.22 34.49 
ssgF (SCO7175) 
M145 0.16 1.29 2.41 
L645 0.45 0.57 2.25 
ssgG (SCO2924) 
M145 0.07 0.45 0.97 
L645 0.23 0.75 1.38 
ssgR (SCO3925) 
M145 0.15 0.47 0.91 
L645 0.24 0.98 1.40 
rpsL (SCO4735) 
M145 99.92 99.09 97.81 
L645 99.78 99.07 98.22 
 
Table 4.1: Expression levels of transcripts in M145 and L645 strains at various time 
points. Transcriptional abundance for each gene was calculated as mentioned earlier. 
The calculation of differences in abundance using the equation 2ΔCT assumes that the 
abundance of the PCR products during the exponential phase does indeed double with 
every cycle under the conditions used. To check that this is indeed the case, we diluted 
serially a PCR product containing the region amplified by the primer pair used to 
analyse rpsL, i.e. the binding sites for the primer pair (SCO4735p3 and SCO4735p4) 
used for analyse rpsL were nested within a larger fragment that had itself been 
produced by PCR. The dilutions were then analysed by qPCR and the Threshold Cycle 
(CT) determined for each dilution and plotted versus the log of the DNA quantities 
(Figure 4.8). This produced a straight line with almost no scatter (R^2=0.999). From the 
gradient of the slope (- 3.29), the efficiency was calculated to be 1.0, which equates to 
100%. 
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Figure 4.8: A Standard curve from rpsL PCR product. Panel A shows kinetic 
amplification of rpsL region, which generated from rpsL gene using SCO4735p1 and 
SCO4735p2 primers. Reactions were done in Corbett Rotor-Gene 6000 system using 
SensiMix™ SYBR No-ROX kit. The red, blue, green, brown, orange and grey solid lines 
correspond to reactions to which 2, 0.50, 0.12, 0.03, 0.78 x 10-2 and 0.20 x 10-2 ng 
template were used, respectively. The cyan solid line is a “non-template control” 
(NTC). Panel B shows standard curve that obtained from plotting threshold cycle vs 4-
fold serial dilution of known concentration of rpsL DNA fragments. PCR efficiency was 
1.0%, which calculated using the following equation; efficiency = 10(-1/slope) -1.  
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4.2.3 Actinorhodin Extraction and its effect on AtrA mobility 
4.2.3.1 TLC purification of actinorhodin 
The finding by Bin Hong and colleagues (Peking Union Medical College, China) that the 
DNA-binding activity of AtrA-gl could be inhibited by actinorhodin as well as a 
biosynthetic intermediate of lidamycin (see Section 4.1) prompted study of the 
regulation of S. coelicolor AtrA by small molecule(s). As an obvious candidate was 
actinorhodin, small molecules were extracted from an overproducing strain, L646, 
which constitutively expresses actII-ORF4 (Towle, 2007). Mycelia were grown on the 
surface of TSA plates for 6 days, a point at which the production of blue pigment was 
conspicuous. The mycelia and agar were mashed to a pulp in water before ethyl 
acetate was added to extract actinorhodin along with other polar organic compounds. 
The ethyl acetate layer was then concentrated, dried, weighed and the crude extract 
resuspended in a small volume methanol. For details of the above, see Section 2.17.1. 
Prior to further purification, the crude extract was analysed for activity that inhibits the 
binding of AtrA-c and AtrA-gl binding to Site 2 of the actII-ORF4 promoter (Figure 4.9 
panel A and B). Approximately 50% of the binding activities of both proteins were 
inhibited when crude extract was added to a final concentration between 1 and 2 ng/ 
µL (see lanes 4 and 5, respectively). The addition of methanol (the solvent) had no 
effect on the DNA-binding activity of AtrA (Figure 4.9, panel C).  
 
Figure 4.9: The effect of crude chemical extract from L646 on AtrA-c and AtrA-gl 
binding activities. Panel A illustrates effect of various concentration of crude extract 
on binding of AtrA-c to actII-ORF4 region 2. Lane 1 to 9 contains crude extract at 
following concentration; 0 ng, 0 ng, 10 ng, 20 ng, 40 ng, 80 ng, 160 ng, 320 ng and 640 
ng. Reaction mixture in each lane contains 5 nM of substrate (actII-ORF4 region 2), 2 
µg salmon sperm DNA and 150 nM of AtrA-c except lane 1. Labels in panels B and C 
are as panel A except that the AtrA-c was replaced with AtrA-gl in panel B and crude 
extract replaced with the solvent in panel C. Conditions are as Figure 4.3. 
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Having identified an inhibitory activity in the crude extract, actinorhodin was further 
purified by thin-layer chromatography using a toluene: glacial acetic acid (4:1, v/v) 
mobile phase. Two distinct red pigmented bands were readily visible (Figure 4.10, see 
right inset). The top red band, which had an Rf of 0.6, was removed from TLC plate, 
extracted with EtOAc, dried, weighted and then stored at 4°C. LC-Mass spectrometry 
analysis revealed that the majority of the purified material had an m/z value of 618.6 
(Figure 4.10). However, the molar mass of actinorhodin (C32H26O14) is 634.54 g mol−1. 
The short fall of 15.9 g mol-1 probably corresponds to a single oxygen atom and 
suggests incomplete tailoring of the backbone. Addition of the C32H26O13 derivative of 
actinorhodin to DNA-binding assays had no discernible effect on the activity of AtrA at 
the highest concentration of 32 ng/ µL (1 mM) (Figure 4.10, see left inset).  
 
Figure 4.10: Mass spectrometry analysis of actinorhodin extracted from M145 stain. 
The inset on the top left hand illustrates the position of actinorhodin band that been 
removed from TLC plate (indicated by blue box). Under our experimental conditions, 
LC-MS displays a product with retention time of 2.12 min and 618.4 (m/z), which is 
believed belonging to ACT. The inset on the right hand side shows crude extraction 
interaction with AtrA-c. Conditions are as Figure 4.3 and labels are as Figure 4.9, panel 
A. 
To determine whether bona fide actinorhodin (and perhaps some of its derivatives) 
was the source of the activity that inhibits AtrA, the crude extract of M1146, a strain 
that lacks the entire gene cluster for actinorhodin plus those of undecylprodigiosin, the 
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calcium-dependent antibiotic and the “cryptic” polyketide (Gomez-Escribano & Bibb, 
2011). This approach was preferred to assaying the two pigmented bands observed for 
the extract of L646 by TLC. The analysis was expanded to include two additional 
controls, the binding of E. coli TetR to the promoter region of tetA (Meier et al., 1988), 
which encodes the efflux pump that confers tetracycline resistance (Hillen & Berens, 
1994), and the binding of ActR to the promoter region of actA (Caballero et al., 1991), 
which encodes the efflux pump for actinorhodin (Fernandez-Moreno et al., 1991). The 
ActR/ActA repressor/efflux pump pair is encoded within the act biosynthetic cluster 
(Tahlan et al., 2007). Intermediates in the actinorhodin biosynthetic pathway bind 
ActR, thereby relieving inhibiting is DNA-binding activity and in turn “inducing” 
expression of actA. The addition of crude extract from M1146 was able to inhibit the 
DNA-binding activity of AtrA-c, but not TetR nor ActR, at the highest concentration 
used (32 ng/ µL) (Figure 4.11, panels A, B and C). This result indicated that S. coelicolor 
produces a compound that specifically inhibits AtrA and is not encoded by the act 
cluster (nor indeed the red, cda and cpk clusters). The addition of tetracycline inhibited 
the DNA-binding activity of TetR, but not AtrA nor ActR (Figure 4. 11, panels D, E and 
F). The IC50 for TetR was 250 nM of tetracycline (in the presence of Mg2+). This value is 
1 ± 0.2 X 108 M-1 compared with published data (Kamionka et al., 2004). 
 
Figure 4.11: The effect of crude chemical extract from M1146 and tetracycline on 
TetR family regulator binding activities. 150 nM of TetR family regulator protein was 
used in each reaction with 5 nM of their specific substrate and 2 µg salmon sperm DNA 
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in 20 µL 1 x TGED reaction buffer. Panels A, B and C represent M1146 crude extract 
activity. Lanes 1 and 10 serve as negative controls (without protein), lane 2 contains 
water and lane 3 contains solvent (methanol). Lanes 4 to 9 contain the crude extract as 
follows; 20 ng, 40 ng, 80 ng, 160 ng, 320 ng and 640 ng, respectively. Panels D, E and F 
represent tetracycline activity. Lanes 1, 2 and 10 remain same as above. Lanes 3 to 9 
contain 31.25 nM, 62.5 nM, 125 nM, 250 nM, 0.5 µM, 1 µM and 2 µM of tetracycline 
with 5 mM Mg2+, respectively. Conditions are as Figure 4.3. 
4.2.3.2 HPLC fractionation of actinorhodin 
Encouraged by the finding that M1146 produces a compound that inhibits AtrA, a 
crude extract was further fractionated by preparative reverse-phase chromatography 
using a C18 column and a methanol. This fractionation made use of a crude extract 
from strain L646, which constitutively expresses S. coelicolor atrA (Towle, 2007). Four 
distinct peaks were identified and collected along with the flow through (Figure 4.12, 
panel A). The material in each fraction was concentrated, dried, weighed and then 
dissolved in methanol to a concentration of 9.5 µg µL-1. Each fraction was then added 
to each of the three binding reactions at concentrations ranging from 1 to 32 ng µL-1 
(Figure 4.13, panels A to F, respectively). In addition to the fractions described above, 
crude extract from L646 as well as M511 were assayed (lanes 4 and 10, respectively). 
At the lowest concentration of 1 ng µL-1 (panel A), an activity was detected in the crude 
extract of L646 (lane 4) that could inhibit the DNA-binding of TetR and to a lesser 
extend AtrA, but not ActR (panels B to F). The inhibition conferred by the crude extract 
of L646 is not necessarily associated with a single compound. Similar results were 
obtained for the crude extract of M511 (lane 10) in as much as inhibition of TetR was 
detected before AtrA and ActR at a concentration of 4 ng µL-1 (panel C). At 
concentrations of 16 ng µL-1 and above, the crude extract also inhibited AtrA and ActR 
(panels E and F). The inhibitory activity(ies) in the crude extract of M511 is lower than 
that of L646. At concentration of 2 ng µL-1 (panel B), an activity(ies) was detected in 
the fractions corresponding to peak 3, peak 4 and the flow through (lanes 7, 8 and 9 
respectively) that inhibited the activity of TetR. Activity in fractions corresponding to 
peak 4 and the flow through (lanes 8 and 9, respectively) also inhibited to some extent 
the activity of AtrA and to a lesser extent ActR (panel B). At a concentration of 8 ng µL-1 
94 
 
 
 
and above (panels D, E and F), the activity(ies) in peak 3, peak 4 and the flow through 
(lanes 7, 8 and 9 respectively) completely inhibited TetR, AtrA and ActR.  
 
 
 
Figure 4.12: Fractionation of crude extract from L646 strain. Panel A represents a 
total ion chromatogram (TIC) for crude extract fractionations. Numbers from 1 to 20 
on top of each peak are refer to retention time in each fraction, which indicated by F 
as follow; 0.97, 1.186, 1.521, 2.637, 3.203, 3.451, 6.371, 6.524, 6.707, 6.840, 7.011, 
7.1, 7,304, 7.435, 7.508, 7.785, 7.924, 8.145, 8.421, 8.76, respectively. Y axis displays 
the sum of intensities of all ions observed at any point in time. Fractions are collected, 
when at least one peak detector detects a peak. Panel B represents extracted ion 
chromatogram (EIC) at 635 m/z. Y axis displays the intensity of 635 m/z at any point in 
time. Number 1, 2 and 3 refer to 0.962, 8.704 and 8.979 min, respectively. Fraction 4 
that started from 7.6814 to 9.0739 min has been labelled to show the peak 
composition. Region around m/z 634.2:635.5 at 8.701 retention time revealed a peak 
at 634.5 m/z which is likely to be ACT (indicated by red box). 
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Figure 4.13: Interaction of crude extract HPLC fractions, L646 and M511 crude extract 
with TetR family regulator binding activities. Each reaction in panels A to F contain 20 
ng, 40 ng, 80 ng, 160 ng, 320 ng and 640 ng of relative fraction, respectively. 20 µL 
reaction was composed of 150 nM of specific TetR-family protein was used in 
individual reactions, which labelled at the top of each gel image, with 5 nM of their 
specific substrate and 2 µg salmon sperm DNA, all made in 1 x TGED buffer. Lane 1 
serves as negative control (does not contain any protein), lane 2 serves as positive 
control (containing water), and lane 3 contains solvent (methanol). Lanes 4 to 10 
contain crude extract from L646 strain, fraction 1, fraction 2, fraction 3, fraction 4, flow 
through and crude extract from M511 strain, respectively. Conditions are as Figure 4.3. 
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4.3 Discussion 
It is shown within this chapter that AtrA binds specifically to sequences in the 
upstream region of ssgR, which the PREDetector algorithm (Hiard et al., 2007) revealed 
was likely to contain an AtrA-responsive element (GGAACCACCGGTTCC; −289 to −275 
relative to the predicted start of ssgR). The inverted repeats in this example are perfect 
with 5 out of 6 matches to the original consensus GGAATG/C for the repeats (Uguru et 
al., 2005). The translational start codon of ssgR is incorrect in current annotation of the 
genome (Kim et al., 2015) and is likely the TTG triplet 123 nt farther upstream (start at 
chromosomal position 4318125). Proteomics experiments have unequivocally shown 
that the SsgR protein is at least 19 aa longer than previously predicted (Van Wezel, 
pers. comm.). In addition to identifying AtrA binding to the promoter region of ssgR 
(Figure 4.3, panel H), disruption of atrA was shown to reduce transcription of ssgR and 
ssgA in vivo (Figure 4.7). Taken together with the DACA data, our data indicate that 
AtrA activates the transcription of ssgR, the gene product which is in turn required for 
the transcriptional activation of ssgA, the best-studied SALP, which has a crucial role 
on septation and the morphology aerial hyphae (Traag & van Wezel, 2008).  
Initially it was thought that ssgR and consequently ssgA would be under the regulation 
of the whi (white) genes are unable to complete the developmental process to form 
mature chains of spores; however, as part of a report that included the above findings 
(Kim et al., 2015), it was found that this is not the case. The likely explanation is that 
SsgA is not only needed for sporulation-specific cell division, but during germination 
and tip growth and branching of the vegetative hyphae when the whi genes are not yet 
expressed (Noens et al., 2007). However, as originally reported, activation of ssgR by 
atrA is not essential under at least some conditions for the production of aerial hyphae 
and spores. However, others have found that morphological development appears to 
be impeded (van Wezel, pers. comm.). AtrA can probably be best described as a 
moderator of ssgR expression, functioning much like the c-AMP receptor protein of E. 
coli to enhance, rather than determine, the expression of genes within its regulon. 
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It was also shown within this chapter that AtrA binds specifically to a sequence in the 
186 bp upstream region of SCO5529/leuA2 with an affinity (Kd´ value of ~ 150 nM; 
Figure 4.3, panel F) similar to that for Site 2 in the actII-ORF4 promoter region. The 
predicted binding site for AtrA in the promoter region of SCO5529/leuA2 
(CCGGAATGACCGGTTCCAC) is located −34 to −52 relative to the predicted start. The 
inverted repeats in this example perfectly matches the original consensus for the 
repeats (Uguru et al., 2005). Binding of AtrA was also detected in the 165-bp upstream 
region of SCO6027 (-251 to -87 relative to the start of the gene), but the affinity was 
lower (Kd´ value of 1.25 µM; Figure 4.3, panel G). This was not unexpected as the 
sequence in the promoter region of SCO6027 is not as good of a match as that of leuA2 
to the PWM of AtrA. The binding of AtrA to the promoter of genes encoding enzymes 
that directly utilise and produce acetyl-CoA, respectively, suggest that it has a direct 
role in coordinating the utilisation of acetyl-CoA for primary and secondary 
metabolism. The reach of AtrA regulon may also extend to SCO4922/aacA2, which 
encodes a subunit of acyl-CoA carboxylase complex, if as predicted actII-ORF4 binds 
the promoter region of SCO4922/aacA2. The potential points at which AtrA regulates 
acetyl-CoA metabolism are shown in Figure 4.14. Analysis of the expression of 
SCO6027 and leuA2 by RT-qPCR did not reveal any more than 1.5-fold differences 
between M145 and L645 (Table 4.1). Thus, while the expression of these genes does 
not appear to be highly dependent on AtrA under at least the growth conditions of the 
analysis, this is not evidence that AtrA does not have a physiologically important role in 
acetyl-CoA metabolism. What does appear to be clear is that not all genes with 
promoters bound by AtrA are regulated in the same way as actII-ORF4. This is not 
surprising given that the activities of most promoters, at least in E. coli, are governed 
by multiple transcription factors (Kao et al., 2004). One of the next steps would be to 
insert promoters bound by AtrA (with and without the predicted site disrupted) in 
front of reporter genes as a transcriptional fusion and assay their activity under a 
variety of conditions. Conditions in which normal promoter activity is found to be 
dependent on AtrA would be selected for further study by ChIP-seq, for example. 
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One of the most exciting findings stemming from this study is evidence that a small 
molecule(s) regulates AtrA. A preparation of solvent extracted material from strain 
M1146 was found to inhibit the DNA-binding activity of AtrA, but not that of two 
controls: E. coli TetR (Ahn et al., 2007) or S. coelicolor ActR (Figure 4.13). Both controls 
were also members of the TetR family (Cuthbertson & Nodwell, 2013). The extent to 
which the inhibitor was specific for AtrA is as yet unclear as inhibition of the DNA-
binding activity of AtrA was only detected at highest concentration of crude extract 
used in the analysis. Nevertheless, the source of the inhibition is not actinorhodin nor 
undecylprodigiosin, the calcium-dependent antibiotic and the “cryptic” polyketide as 
the clusters for these secondary metabolites are deleted in M1146 (Gomez-Escribano 
& Bibb, 2011). This finding meets with initial expectations as, while AtrA is found 
within all streptomycetes, at least to our knowledge, these clusters are not. Further 
fractionation of a solvent-extracted material from L646 was conducted, this revealed 
what appears to be a second inhibitor; one that is more potent against TetR than 
either AtrA or ActR (Figure 4.13). These results are in agreement with the findings 
reported by Yim et al. (2007) that some antibiotics act as signal molecules to modulate 
gene transcription related to SMs production and physiological function. 
One of the next steps would be to fractionate solvent extracted material from M1146 
and M114 with the aim of confirming and identifying the inhibitor with specificity for 
AtrA. This would be approached using reverse-phase chromatography in combination 
with mass spectrometry as was used to identify a derivative of actinorhodin (Figure 
4.12). The identification of a small molecule inhibitor of AtrA would provide insight 
into the physiology that regulates secondary metabolism and morphological 
development and may allow as simple means of altering the profiles of secondary 
metabolites produced by streptomycetes, perhaps even stimulating the production of 
metabolites that would otherwise remain cryptic. It would also provide a powerful tool 
to dissect further the role of AtrA in S. coelicolor. With hindsight priority should have 
been given to the analysis of the effects of inhibitors on S. globisporus AtrA. An open 
question is whether or not all orthologues of S. coelicolor AtrA are sensitive to the 
same small molecule(s). As indicated in the Introduction to this chapter, collaborators 
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have shown that the activity of S. globisporus AtrA is regulated by actinorhodin as well 
as a biosynthetic intermediate of lidamycin (C-1027). Binding of the latter, which is 
produced by S. globisporus, provides negative feedback. Moreover, as the feedback 
occurs at the level of AtrA and not a cluster-situated regulator it is highly that it 
provide a mechanism for coordinating the production of lidamycin with that of other 
secondary metabolites. As AtrA is evolutionarily conserved, negative feedback of the 
type described here may be widespread within the streptomycetes.  
 
Figure 4.14: Possible link to acetyl-CoA metabolism. The position of the 
corresponding enzymes within the pathways linking to acetyl-CoA are shown here. An 
alignment of the predicted sites to the consensus sequences is shown in the inset.  
100 
 
 
 
Chapter 5 
5 Epitope tagging of AtrA 
5.1 Introduction 
As part of the previous chapter it was shown that AtrA binds in vitro as predicted by a 
position weighted matrix to the promoter regions of genes associated with 
morphological development and primary metabolism. The latter connection is of 
particular interest to the natural product community as an understanding of the co-
regulation of primary and secondary metabolism may inform strategies for increasing 
or even activating the expression of silent / cryptic biosynthetic pathways harboured 
by actinomycetes. However, the in vivo evidence for the regulation of acetyl-CoA 
metabolism by AtrA on its own was tenuous rather than convincing. The disruption of 
atrA in S. coelicolor did not produce obvious changes in the expression of genes with 
promoters bound in vitro by AtrA. While it was argued that not all promoters bound by 
AtrA need be as dependent on atrA as actII-ORF4 in vivo, it was clear that evidence for 
the predicted interactions occurring in vivo was required. Indeed, prior to the initiation 
of this thesis, an attempt was made to map sites of AtrA binding in vivo using 
polyclonal antibodies that have been generated with aid of Freund’s adjuvant raised 
against AtrA as part of the ChIP-chip approach (Davis et al., 2011), whereby 
microarrays (or chips) were used to identify DNA regions purified by chromatin 
immunoprecipitation. Unfortunately, these antibodies cross-reacted considerably with 
proteins in the extract of L465, the atrA-disrupted strain. In hindsight, this cross-
reactivity is unsurprising since Freund’s adjuvant contains crushed mycobacterial cells; 
its use will therefore generate polyclonal antibodies capable of binding mycobacterial 
proteins, many of which are similar to those found in other actinobacteria (Scherr & 
Nguyen, 2009). It was presumed that the cross-reacting proteins were some of the 
many other members of the TetR family present in S. coelicolor (Cuthbertson & 
Nodwell, 2013, Ahn et al., 2012). While in theory it should have been possible to 
subtract this “background” to identify sites of AtrA binding in M145, the accuracy of 
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any subtraction would have been critically dependent on precisely matching the 
physiology of M145 and L645. Therefore, it was decided to explore here the tagging of 
AtrA with the 3 X FLAG™ tag (Einhauer & Jungbauer, 2001), an epitope that can be 
recognised by highly specific antibodies available commercially. The FLAG-tag is 
reported to have the advantage that it was designed to be hydrophilic, which in turn 
reduces its capacity to denature or interfere with the activity of a protein to which it is 
attached. Monoclonal antibodies were then raised against the designed tag. In the first 
iteration of epitope tagging, the tag was derived by identifying a peptide recognised by 
a monoclonal antibody raised against a larger protein (Hopp et al., 1988). In this 
chapter the successful tagging of AtrA from S. coelicolor is reported. 
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5.2 Results 
5.2.1 The ability of AtrA with the 3 x FLAG tag™ to complement disruption of atrA 
in the chromosome 
5.2.1.1 Construction and description of plasmid 
Although the 3 x FLAG tag™ is relatively unimposing, it is well established that 
transcription factors interact physically with each other and RNA polymerases (Dyson 
et al., 2004). To safeguard against adverse effects of the 3 x FLAG tag™ we generated 
C-terminal and N-terminal 3 x FLAG tageed variants of AtrA expressed from the native 
atrA promoter (Figure 5.1, panel A). The latter was produced by the laboratory of Colin 
Smith (Surrey) in collaboration with the McDowall group. The coding sequence of the 3 
x FLAG tag™ was codon optimised for streptomycetes (for details, see Materials and 
Methods, Section 2.16.1). To provide a baseline control, an untagged version of atrA 
was also produced. All versions of the recombinant genes incorporated the promoter 
region of atrA. In the case of the N-terminally tagged version generated at Surrey, the 
region upstream of atrA extended to position -426 (relative to the start codon), while 
for the others it only extended to position -332. The constructs designed in Leeds were 
shortened to facilitate their synthesis by Invitrogen. The 49-bp region immediately 
downstream of atrA was also included with the C-terminally tagged gene to allow the 
option of replacing the 3 x FLAG tag™ using SLiCE, a cell extract-based DNA cloning 
method (Zhang et al., 2012). This option was never utilised, however, BamHI and EcoRI 
sites at the 5′and 3′ends of the atrA genes designed at Leeds were also included to 
facilitate cloning. EcoRV cutting sites were added in the front of BamHI and EcoRI sites 
at the 5′and 3′ends of the atrA genes designed at Surrey to allow the option of blunt 
cloning. 
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All three version of atrA were cloned into the BamHI and EcoRI of vector pAU3-45 
(Bignell et al., 2005), a derivative of pSET152 (Bierman et al., 1992) that confers 
resistance to thiostrepton. The pSET152 vector could not be used to set up a 
complementation assay as it shares the apramycin resistance gene with the cassette 
used to disrupt the chromosomal atrA gene (Uguru et al., 2005), i.e. L645 is already 
resistant to apramycin (Uguru et al., 2005). The constructs with N and C tagged and 
untagged atrA were designated pAU-3xatrA, -atrA3x and -atrA. Putative plasmid clones 
were verified by BamHI and EcoRI restriction digest (Figure 5.1, panel B) and the 
integrity of cloned inserts was verified by sequencing (Figure S2, S3 and S4). All three 
of these construct and the empty pAU3-45 vector were separately introduced into 
L645 by interspecies conjugation, as described previously (Gust et al., 2003). 
 
Figure 5.1: Schematic representation and enzymatic analysis of constructs based on 
pAU3-45. (A) The position of the 3 x FLAG tag™ is labelled “3x” and depicted by a box 
filled red, while the promoter region and coding regions are depicted by boxes filled 
blue and gold, respectively. The boxes filled turquoise and tan indicates the position of 
the 94 bp of upstream sequence present only in pAU-3xatrA, and the 49 bp of 
downstream sequence present only in pAU-atrA3x, respectively. The numbers in 
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parenthesis indicated the length of corresponding BamHI and EcoRI fragments (for 
further details, see Section 2.16.1). (B) Products of digestion with BamHI and EcoRI. 
Lanes 1 to 3 correspond to pAU-atrA3x, -atrA and -3xatrA, respectively. Lane M 
corresponds to 1kb DNA ladder (New England Biolabs). Numbering on the left indicate 
the sizes of representative markers. 
5.2.1.2 Analysis of transconjugants and chromosomal integration 
Spores and mycelia from the colonies of multiple putative transconjugants of L645 
were streaked individually onto the surface of SFM plates containing thiostrepton to 
eliminate any false positives. In our hands thiostrepton is not as selective as apramycin 
when using S. coelicolor. Transconjugants confirmed as thiostrepton resistant were 
then isolated and analysed by PCR to confirm their integration at the expected site and 
their identity. Integration at the expected site was confirmed using a forward primer 
that targets a region upstream of the ΦC31 attB site and a reverse primer that targets 
a region downstream of the ΦC31 attP site in the pAU3-45 plasmid. Using this primer 
pair (Figure 2, panel A), the expected amplicon (1,635 bp) was produced for each of 
the four transconjugants (lanes 7 to 10), but not the parental strain L645 nor M145 
(lanes 6 to 1). The presence of the original atrA disruption was confirmed using a 
forward primer that binds a site downstream of chromosomal atrA, but outside the 
fragment inserted into pAU3-45, and a reverse primer than binds within the apramycin 
cassette. Using this pair (panel B), an amplicon (800 bp) was produced for all four of 
the transconjugants (lanes 7 to 10) and L645 (lane 6), but not M145 (lane 1). 
The status of the 3′ ends of the recombinant atrA genes delivered by pAU3-45 was 
confirmed using a forward primer that binds with the 3′end of the coding region of 
atrA and a reverse primer that binds within the pSET152 backbone of the delivery 
plasmid (panel C). Amplicons were produced for transconjugants containing pAU-
atrA3x, -atrA and -3xatrA (lanes 8 to 10), but not pAU3-45 (lane 7) nor L645 (lane 6) 
and M145 (lane 1). Moreover, the amplicon corresponding to pAU-atrA3x (lane 8) 
migrated more slowly confirming the presence of the 3 x FLAG tag™ at the 3′ end of 
atrA (304 vs 186 bp). The difference is size reflects the presence of downstream 
sequences of atrA as well as the 3 x FLAG tag™ in pAU-atrA3x. Similarly, the status of 
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the 5′ends of the recombinant atrA genes delivered by pAU3-45 was confirmed using a 
forward primer than binds with the promoter region of atrA and a reverse primer that 
binds within the coding region of atrA at a site disrupted in L645 (panel D). Amplicons 
were produced for transconjugants containing pAU-atrA3x, -atrA and -3xatrA (lanes 8 
to 10), but not pAU3-45 (lane 7) nor L645 (lane 6) and M145 (lane 1). Moreover, the 
amplicon corresponding to pAU-3xatrA (lane 10) migrated more slowly confirming the 
presence of the 3 x FLAG tag™ at the 5′end of atrA (274 vs 205 bp). 
 
Figure 5.2: Confirmation of integrated plasmids construct into L645 by PCR and gel 
electrophoresis. (A), (B), (C) and (D) assay integration of pAU3-45-based constructs at 
the attB site, the presence of atrA disrupted by the apramycin cassette, and the status 
of the 3′and 5′ends of the recombinant atrA genes, respectively. Lane 1 corresponds to 
M145, while lane 6 corresponds to L645. Lanes 7 to 10 correspond to transconjugants 
(L645) containing pAU3-45, pAU-atrA3x, pAU-atrA and pAU-3xatrA, respectively. Lanes 
2 to 5 correspond to transconjugants (M145) containing pAU3-45, pAU-atrA3x, pAU-
atrA and pAU-3xatrA, respectively. Lane M corresponds to the 1kb DNA ladder (New 
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England Biolabs). Numbering on the left indicate the sizes of representative markers. 
The primers used to generate the results shown in (A), (B), (C) and (D) were attB-F and 
attP-R, atrA56Dn-R and Apra-F, atrAF3 and pSET-R2, and 3xatrA-R and 3xatrA159-F, 
respectively (for sequences, see Table S2). (A) and (B) were analysed using 1% [w/v] 
agarose gels, while (C) and (D) were analysed using 2% [w/v] gels. 
5.2.1.3 Analysis of the phenotypes of the transconjugants 
The phenotypes of the transconjugants were compared against L645 and M145 when 
grown as circular patches (12-15 mm diameter) on R5 plates. Representative results 
are shown following incubation at 30 oC for 2, 3, 4 and 5 days (Figure 5.3). As reported 
initially (Uguru et al., 2005), disruption of atrA blocks production of blue-pigmented 
actinorhodin (cf. L645 and M145). Moreover, the production of actinorhodin was 
restored by introducing untagged or N-terminally tagged atrA. The presence of 3 x 
FLAG tag™ at the C terminus of AtrA appears to interfere with the function of atrA. The 
presence of untagged or N-terminally tagged atrA also seemed to restore the 
production of aerial hyphae which were first obvious around the edge of patches as a 
white ring (see 72 hours). Thus, all the indications are that the addition of a 3 x FLAG 
tag™ to the N-terminus of AtrA does not interfere with the function of AtrA in vivo. 
As part of the phenotypic analysis, we also included M145 into which pAU3-45 had 
been introduced. The reason for doing so was a report by a previous PhD student that 
the introduction of pSET152 into S. coelicolor substantially reduced, if not blocked, the 
production of actinorhodin (Jane Towle, pers. comm.). In agreement with this report, it 
was found that transconjugants of M145 containing pAU3-45 did not produce 
actinorhodin. The plasmids pAU3-atrA and pAU-3xatrA were also introduced into 
M145. Their inclusion showed that the introduction of genes encoding untagged or N-
terminally tagged AtrA overcame the negative effects of pSET152 on actinorhodin 
production (Figure 5.3). The results of this analysis also suggested that pAU3-45 also 
interferes with morphological development as evidence by the bald phenotype (i.e. 
lack of white aerial hyphae) associated with patches of M145 (pAU3-45), and that the 
insertion of genes encoding untagged or N-terminally tagged AtrA can overcome this 
additional effect of pAU3-45, see M145 (pAU-atrA) and M145 (pAU-3xatrA) (Figure 
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5.3). PCR analysis confirmed the integrity of all of the M145 transconjugants (Figure 
5.2). It should be noted that as expected no amplicon was produced for any of the 
M145 transconjugants when the atrA disruption was assayed (panel B) and two 
amplicons were produced for transconjugants containing pAU-3xatrA when the 
5′status of atrA was assayed (panel D). 
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Figure 5.3: Complementation of L645 with untagged, N- and C-terminally 3 x Flag 
tagged AtrA. Labelling at the top indicates the strains. The plasmids introduced by 
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conjugation are indicated in parenthesis, where appropriate. Labelling on the left 
indicates the length of incubation prior to photographing of the patches. Images 
representative of at least five independent replicates. 
5.2.2 Identification of a “phenotype neutral” vector for the delivery of tagged genes 
The finding that the 3 x FLAG tag™ to the N-terminus of AtrA does not interfere with 
the function of AtrA in vivo was consistent with the finding that the addition of a His-
tag™ (or decahistidine-tag) to the N-terminus of AtrA does not block DNA-binding in 
vivo. At this juncture, it was learnt that our collaborators in Beijing were planning on 
using AtrA tagged at the C-terminus with 3 x FLAG tag™ to map binding sites in S. 
globisporus, and delivering the corresponding gene via pKC1139, a non-integrative 
plasmid (Figure 5.4, panel A). To test whether pKC1139, unlike pAU3-45, could deliver 
recombinant genes into M145 without interfering with actinorhodin production or 
morphological development, the pKC1139 vector was requested and introduced into 
M145 by conjugation. A pKC1139-based construct encoding AtrA from S. globisporus 
with the 3 x FLAG tag™ at the C-terminus (a gift from Bin Hong) was also introduced, 
see pKC-atrA3x-gl (Figure 5.4, panel B). The integrity of these plasmids was confirmed 
by PCR and sequencing (data not shown). The vector pSET152 was also introduced to 
confirm the original observation that this widely used, integrative vector blocks 
actinorhodin production. The integration of pSET152 at the attB site was confirmed by 
PCR analysis, as described above (data not shown). Transconjugants containing the 
pKC1139 vector and the atrA-gl-containing construct, but not those containing 
pSET152 produced actinorhodin and developed normally (Figure 5.4, panel B). 
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Figure 5.4: Schematic representation of pKC1139 and pKC-atrA3x-gl and the 
phenotype of M145 when these plasmids are resident. (A) As labelled, the plasmid 
pKC1139 contains the origin of transfer from RP4, the origin of replication from pSG5 
and the promoter and coding region of atrA from S. globisporus, which was inserted 
into pKC1139 between the NdeI and BamHI cloning sites. (B) Labelling at the top 
indicates the strains. The plasmids introduced by conjugation are indicated in 
parenthesis. Labelling on the left indicates the length of incubation prior to 
photographing of the patches. Each of the results are representative at least five 
independent repeats. 
5.2.3 AtrA tagged with 3x Flag™ tag at C-terminus activity test 
Having found that the addition of the 3x FLAG tag™ to the C-terminus of AtrA blocks 
complementation of the disruption of chromosomal atrA in S. coelicolor, the DNA-
binding activity of AtrA tagged at the C-terminus with 3 x FLAG tag™ was assayed in 
vitro. The corresponding gene was expressed from pET16b and its product purified 
(Figure S5), as described previously for atrA without a segment encoding a tag at its 3′ 
end (see Chapter 4). The DNA-binding activity of AtrA3x was then assayed using “Site 
2” of the actII-ORF4 promoter region, as described previously (see Chapter 4). This 
revealed an apparent Kd´of 78 nM (Figure 5.5) indicating that the DNA-binding activity 
of AtrA in isolation is unaffected by a 3 x FLAG tag™ on its C-terminus. 
 
Figure 5.5: S. coelicolor AtrA tagged at C-terminus electrophoretic mobility shift 
assay. Each reaction of 20 µL 1 x TGEK contains 5 nM of fluorescein labelled actII-ORF4 
site 2 region and 2 µg salmon sperm DNA (Invitrogen). Lanes 2 to 17 contain 0 nM, 0.6 
nM, 1.2 nM, 2.4 nM, 4.8 nM, 9.75 nM, 19.5 nM, 39 nM, 78 nM, 156 nM, 312.5 nM, 625 
nM, 1.25 µM, 2.5 µM, 5 µM and 0 nM of AtrA3x protein, respectively. Lane 1 and 18 
contain 150 nM of AtrA, which used as positive control. The reactions were run in a 4% 
(37.5:1) acrylamide: bis-acrylamide gel in 1 x TGED buffer for 40 min at 120V. The gel 
was imaged using Fujifilm FLA-5000 imaging analyser system. 
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5.3 Discussion 
The work described in this chapter was successful in showing that the addition of the 3 
x FLAG tag™ to the N-terminus of AtrA does not hinder its ability to functional 
substitute for untagged AtrA in S. coelicolor (Figure 5.3). Thus, it should be possible to 
proceed with a ChIP analysis of AtrA using antibodies against the FLAG epitope. In 
terms of ChIP analysis, there are two existing strain pairs that could form part of a 
study; M145 with pAU-atrA or pAU-3xatrA and L645 with pAU-atrA or pAU-3xatrA. A 
possible disadvantage of using M145 as the background for comparison is the 
expression of untagged atrA from the chromosome, which might diminish the signal 
significantly. However, an advantage is that it might be easier to match the physiology 
of strains containing pAU-atrA or pAU-3xatrA. This would be particularly important if 
other ’omic analyses were integrated with a ChIP analysis of AtrA. Repeated 
observations suggest that in L645, while actinorhodin production and morphological 
development proceed with N-terminally tagged AtrA, both these process might be 
delayed at earlier time points (Figure 5.3). 
Interestingly, the addition of the 3 x FLAG tag™ to the C-terminus of AtrA hindered its 
ability to substitute functionally for untagged AtrA in S. coelicolor (Figure 5.3). The 
basis of this difference is not known, but it would be relatively straightforward using 
polyclonal antibodies against AtrA, which have been raised by our laboratory already, 
or monoclonal antibodies against the FLAG epitope to check that C-terminally tagged 
AtrA is produced to normal levels. If so, then it would be interesting to compare DNA 
binding profiles of N- and C-terminally tagged AtrA. It might be that the C-terminal tag 
disrupts cooperative interactions with other factors that facilitate its binding to some 
sites. Electrophoretic mobility shift assays showed that DNA binding of AtrA3x was 
indistinguishable to that of untagged AtrA, thus a C-terminal 3 x FLAG tag™ does not 
abrogate binding to DNA, at least in vitro (Figure 5.5). 
Consideration should be given also to the vector used to deliver recombinant atrA 
genes. The results of this work clearly shows that the widely used, integrative vector 
pSET152 (Bierman et al., 1992), but not the non-integrative vector pKC1139 (Bierman 
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et al., 1992), blocks actinorhodin and morphological development (Figures 5.3 and 5.4, 
panel B). The finding that pSET152 causes defective or decreased antibiotic production 
is not new (Baltz, 1998) and has been described in the context of landomycin E 
production by S. globisporus (Luzhetskii et al., 2001), tylosin production by S. fradiae 
(Voeikova, 1999), and kanamycin production by S. kanamyceticus (Luzhetskii et al., 
2000). A study by (Combes et al., 2002) suggested that pSET152 can integrate at 
several position of genomic DNA of streptomycetes and cause chromosomal 
rearrangements, which may alter the production of secondary metabolites. The 
remarkable finding from this study is that expression of atrA from its own promoter, 
but within chromosomally integrated pSET152 can reverse the effects of pSET152 on S. 
coelicolor M145. Although the integrity of the chromosome of transconjugants was not 
checked as part of this study, it is unlikely that the presence of atrA within pSET152 
would prevent pSET152-induced chromosomal rearrangements. The presence of a 
gene coding C-terminal tagged AtrA was certainly unable to block the effects of 
pSET152. An alternative explanation is that pSET152 in some ways blocks expression of 
atrA at its normal chromosomal position, either directly or further back in the 
regulatory pathways, but is unable to do so when atrA is repositioned at the attB site. 
Given pSET152 is not neutral with regard to the physiology of M145, it is 
recommended that pKC1139 is considered as the vector for the delivery the genes 
encoding untagged and N-terminally AtrA for ChIP analysis. It would also be interesting 
to compare the M145 and M145 (pSET152), by transcriptomics and proteomics in an 
attempt to better understand the effect of pSET152.  
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Chapter 6 
6 Concluding remarks and future work 
Combining differential and global RNA sequencing approaches, nucleotide-resolution 
transcriptome maps detailing the positions of transcriptional start sites and the 
boundaries of transcription have been identified in S. coelicolor using the UCSC 
microbial genome browser (Schneider et al., 2006, Chan et al., 2012) (see Chapter 3). 
These maps have already allowed us to better define the nature of one class of 
promoter (Kazakov et al., 2007) (Figure 3.2, table S2); identify small RNAs (Figure 3.4, 
table S5), many of which are expected to be regulatory; and confirm that leaderless 
transcripts are widespread in S. coelicolor (Figure 3.3, table S3). They have also allowed 
us to identify which of the regulatory genes that have been previously annotated 
(Castro-Melchor et al., 2010) were expressed within our sample (Figure 3.9) and are 
thus likely to have contributed to the observed transcription. Sequences upstream of 
TSSs associated with the translational machinery have been analysed and revealed two 
conserved hexanucleotide regions (Figure 3.10, panel A and figure S1), which are 
similar to the consensuses sequences reported previously for ‘vegetative’ promoters of 
streptomycetes (Strohl, 1992) and Escherichia coli (Figure 3.10, panel B) (Harley & 
Reynolds, 1987, Lisser & Margalit, 1993). These sequences can be used as a guide to 
predict the location of other vegetative promoters. 
It should be noted that several of the RNAs annotated here as 5’ regions of mRNA 
were previously listed as small RNAs (Vockenhuber et al., 2011). The detection by us of 
longer transcription units may reflect an increase in the sensitivity of transcript 
detection using FRT RNA-seq or possibly the attenuation of transcription of the 
corresponding genes in the mycelial sample studied previously (Figure 3.7, panel C). 
Attenuation is a mechanism by which transcription from a promoter can be terminated 
in a regulated manner before reaching structural genes (Henkin & Yanofsky, 2002). The 
best studied attenuation system is the tryptophan operon of E. coli (Merino et al., 
2008). By comparing our approach with information from hundreds of transcriptome 
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studies, most of which to date have used microarray, allowed for the identification of 
genes with expression patterns that match closely those of regulators either directly or 
inversely, suggesting positive or negative regulation, respectively (Castro-Melchor et 
al., 2010).  
It will be interesting to analyse the network modules, groups of genes that appear to 
be co-regulated (Castro-Melchor et al., 2010), and identify those that contain a 
regulator that is expressed in our sample. This would be followed by the analysis of the 
sequences in the vicinity of the TSSs of proposed target genes for conserved sequences 
that might represent a shared cis-regulatory element (i.e. the binding sites of 
transcription factor(s)). The latter can be done using MEME (Bailey et al., 2009). It 
would also be interesting to determine whether binding sites predicted with 
knowledge of TSSs differs from those predicted by simply scanning a fixed distance 
upstream of the predicted start codons of target genes (Castro-Melchor et al., 2010). 
The binding of transcription factors to predicted cis-elements could be investigated 
experimentally. Analysis of individual regulators that link to either morphological 
development or secondary metabolism (van Wezel & McDowall, 2011) has already 
revealed new layers of transcriptional complexity (see Figure 3.8). The goal in the end 
would be to develop automated, computer-based ‘piplines’ that produce maps of TSSs 
and TUs from raw RNAseq data because it is extremely labour intensive to assign these 
features manually.  
Another aspect of my work was the study of the AtrA regulon and its impact on 
metabolism and morphological development (Chapter 4). EMSA (Figure 4.3, panel H) 
combined with transcript analysis (Figure 4.7) showed that ssgR transcription is 
directly activated by the developmental regulator AtrA, which also activates 
actinorhodin biosynthesis. This provides a novel and direct link between development 
and antibiotic production and also highlights the first developmental target for AtrA 
itself. Furthermore, our results (Figure 4.3, panel G) suggest that AtrA plays an 
important role in regulating precursor supply via the SCO5529/ leuA2 gene, which 
encodes enzymes that directly utilise acetyl-CoA for primary and secondary 
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metabolism (for more details see Section 4.3). In addition to the identification of AtrA 
binding in the promoter regions of ssgR and leuA2 (Figure 4.3, panels H and G, 
respectively), disruption of atrA was shown to reduce transcription of ssgR and its 
target ssgA, the best-studied SALP in vivo (Figure 4.7). However, analysis of the 
expression of leuA2 showed lower differences between wild type (M145) and atrA 
knockout (L645) strains (Table 4.1). One of the next steps would be to construct 
reporter plasmids for each of the predicted AtrA binding sites by cloning the DNA-
fragment containing the sequence of interest into pMU1* (Craney et al., 2007) in an 
orientation such that lux expression would be driven by the inserted promoter. The 
activity could then be measured (bioluminescence) in the host organism under a 
variety of conditions. 
The remarkable result that we obtained from studying small molecules was the ability 
of crude extract from M1146 (Figure 4.11, panel A), in which four metabolite gene 
clusters have been deleted (Gomez-Escribano & Bibb, 2011), to inhibit DNA-binding 
activity of AtrA at high concentration (32 ng/µL). However as yet, the small molecule(s) 
inhibition specificity for AtrA is unclear. The next step would be to fractionate a crude 
extract from the M1146 strain and screen the fractions against AtrA to identify the 
fraction containing the inhibition activity. The most active fraction could be analysed 
using analytical LC-MS to obtain a high quality molecular weight that can be used to 
acquire a formula. Finally, to determine the physical and chemical properties of the 
small molecule, NMR could be used. 
The goal for the final results chapter was to gain a wider and better knowledge about 
the regulon of AtrA by performing ChIP-sequencing. The approach we undertook was 
successful. A 3 x FLAG tag™ was added to the N-terminus of AtrA, which does not 
hinder its ability to functionally substitute for untagged AtrA in S. coelicolor (L645 
strain, Figure 5.3). Limited time prevented me from completing the experiment. In the 
future, it would be of interest to immunoprecipitate AtrA/DNA complexes from L645 
(with pAU-3xatrA) cells that have been treated with formaldehyde by using ChIP-grade 
antibodies against the FLAG epitope (anti-Flag), which are available commercially. 
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Finally, it would be interesting to conduct ribosome profiling for the wild type (M145) 
and atrA knockout (L645) strains. This approach would give us a wider knowledge 
about the transcriptome and proteome. Ribosome profiling targets only mRNA 
sequences protected by the ribosome unlike RNA-seq, which sequences all of the 
mRNA in a given sample. The advantages of this technique includes the determination 
of actively translated mRNAs at a particular moment, provides the precise position of 
the ribosome on the mRNA, estimates the speed of translating ribosomes and 
quantitative measurement of gene expression (Ingolia et al., 2012, Ingolia, 2014). 
Briefly, this could be preceded by nuclease digestion of the mRNA bound by ribosomes 
and followed by ribosome footprints, reverse transcription and deep sequencing of 
mRNA fragments that are protected by the ribosome (Ingolia et al., 2009).  
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7 Supplementary figures and tables 
Score Gene ID Function Position Cis-element 
17.27 SCO6059 hypothetical protein SC9B1.06 -74 gcggaatctcccgttccgt 
15.56 SCO0775 conserved hypothetical protein 400 acggaacgggagattcccg 
15.16 SCO1657c; 
SCO1658, gylR 
putative methionine synthase, glycerol 
operon regulatory protein 
-205 
ccggaacgtcccactccgg 
14.93 SCO5285; lon ATP-dependent protease 2395 gcggagcgtgaggttccgg 
14.48 SCO4109 putative oxidoreductase -39 ccggaatcccccgctccgg 
14.18 SCO5529, leuA2 putative 2-isopropylmalate synthase -52 gtggaaccggtcattccgg 
13.95 SCO2507, zurM putative metal transport ABC transporter 850 gcggagtgcaagattccgg 
13.89 SCO0509, glk2 glycerol kinase 2 (ATP:glycerol 3-
phosphotransferase) (EC 2.7.1.30) 
-17 
gcggaatgtgagcttccat 
13.89 SCO5987c; 
SCO5988 
conserved hypothetical proteins 
-223 
gtggaacccctcattccga 
13.84 SCO4029 hypothetical protein 672 ccggaatgtcaaactccgg 
13.53 SCO2907, nagE2 putative PTS transmembrane component -90 gcggaatcacgggttcctt 
13.17 SCO6054c putative transmembrane transport protein 17 cgggaacctccggttccgg 
13.14 SCO3526 conserved hypothetical protein 1063 acggaacggatccttccgc 
13.11 SCO3217, cdaR transcriptional regulator of calcium-
dependent antibiotic 
734 
acggaatgcggtattccat 
13.06 SCO1251 putative integral membrane protein 159 acggaacctgaccttccag 
12.85 SCO1839c putative transcriptional regulator -143 acggaacccctgattccag 
12.66 SCO1842c conserved hypothetical protein SCI8.27c 70 ccggagcgcgccattccgg 
12.41 SCO6429 hypothetical protein 128 acggaatcagcggttccat 
12.4 SCO2273 FecCD-family membrane transport protein 240 gtggaacgtgcggttcccc 
12.27 SCO5461 putative secreted protein -37 ccggaatgcgtcgctccgc 
12.2 SCO5085, actII-
ORF4 
act cluster (and  possibly aacA2) activator 
protein 
43 
gcgggatgtgtaattccgc 
12.13 SCO0098c putative transposase -43 ccggaaggctccgttccgc 
12.13 SCO0566c; 
SCO0567 
putative membrane protein, insertion 
element transposase 
-308 
gcggaacggagccttccgg 
12.13 SCO3467 transposase -42 gcggaacggagccttccgg 
12.13 SCO3538c; 
SCO3539 
hypothetical protein, putative transposase 
-445 
gcggaacggagccttccgg 
12.13 SCO6910c insertion element transposase -43 ccggaaggctccgttccgc 
11.94 SCO1623 conserved hypothetical protein SCI41.06 703 ctggagcgcgagattcccc 
11.86 SCO6956 putative oxidoreductase 1290 ctggaacctcgcgttctgg 
11.54 SCO5084, actII-3 Act membrane protein 2084 caggaatgccagattctat 
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11.52 SCO2869 putative regulatory protein 298 caggaatcggttattccac 
11.47 SCO2007 hypothetical protein 456 ccggaatcccggactccct 
11.35 SCO6840c, 
SCO6841  
hypothetical protein SC3D9.08c, conserved 
hypothetical protein SC3D9.09 
-247 
gcggaatgggagatttccc 
11.32 SCO1226c putative bifunctional protein -169 ccggaatcaacggctccgc 
11.13 SCO3867c, 
SCO3868 
putative ferredoxin, hypothetical protein 
SCH18.05 
-158 
cggcaatcccacattccgc 
11.06 SCO1403 putative membrane protein 94 ccggatcgcgacattccgg 
10.99 SCO6039c putative flavoprotein oxidoreductase 918 gcggaatgtgccgctcctg 
10.97 SCO3925, ssgR  putative transcriptional regulator -291 caggaaccaccggttccct 
10.97 SCO5445c conserved hypothetical protein 14 cgggaaccgctggttccgg 
10.96 SCO4462 putative integral membrane protein 1157 ccggaacccgcggttcccg 
10.94 SCO6103c putative acetyltransferase -27 agggaatcatccgctccgc 
10.92 SCO3968c putative integral membrane protein -103 acggaagatcacattctgt 
10.91 SCO2917,  conserved hypothetical protein 1297 ggggaacccgtcattccga 
10.87 SCO4113c conserved hypothetical protein 698 ccggaacgggacgatccgc 
10.8 SCO7139 putative aldehyde dehydrogenase 486 gtggaacttcccgctccag 
10.63 SCO3472c putative transposase remnant 113 ctggaacggttcactccgg 
10.6 SCO6027c; 
SCO6028c 
acetyl-coA acetyltransferase (thiolase), 
putative ribonuclease 
-194 
ccggaatccgccgctcctg 
10.55 SCO1706c putative aldehyde dehydrogenase 434 gtggagcgggtagttccag 
10.55 SCO2948c; 
SCO2949, murA 
conserved hypothetical protein, UDP-N-
acetylglucosamine transferase (MurA) 
-228 
acggaacgcgagattcatg 
10.55 SCO5666 putative aldehyde dehydrogenase 498 gtggaactacccgctccag 
10.52 SCO2116 putative secreted protein 193 gaggagttcgacgttccgc 
10.5 SCO6780 putative secreted protein 711 gtggaaggtcccgttcccg 
10.38 SCO0646 putative TetR-family transcriptional 
regulator 
10 
ccggaaccccccgccccgc 
10.38 SCO3920c, cysA; 
SCO3921c 
putative cystathionine/methionine gamma-
synthase/lyase, low molecular weight 
protein-tyrosine-phosphatase 
-6 
gcggaatcgctcatgccgc 
10.33 SCO5875c putative potassium uptake protein 258 gcggaacgccgtactccgt 
10.32 SCO4828 betaine aldehyde dehydrogenase 483 ctggaactacccgctcctt 
10.31 SCO1840c putative ABC transporter ATP binding 
protein. 
1518 
gcagaatgatccgttccgg 
10.3 SCO5479 oligopeptide ABC transporter ATP-binding 
protein 
871 
caggaacgcctcatcccgg 
10.26 SCO1862c putative integral membrane protein -57 acggaagccacgattccgg 
10.26 SCO4775 serine/threonine protein kinase 992 gcggagcgctgcgttccgt 
10.24 SCO3189 putative membrane protein -238 ggggaacgccacgttccgg 
120 
 
 
 
10.24 SCO4350c putative integrase 524 ccggaacgagacgtcccgc 
10.21 SCO1434 putative CbxX/CfqX family protein 1674 ggggaacgggcggttcctg 
10.2 SCO6840c; 
SCO6841 
hypothetical protein SC3D9.08c, conserved 
hypothetical protein SC3D9.09 
-188 
ttggaacgaaaaattccgt 
10.17 SCO6226c hypothetical protein SC2H4.08c 1030 gcggaacgcggcagtccgg 
10.15 SCO0197c conserved hypothetical protein 5 gcggaatccgtcgttgcgg 
10.13 SCO0372c putative secreted protein 2306 gcggaacgtcacgtcctgg 
10.13 SCO5352 putative arginyl tRNA synthetase 681 ggggaatcccctgttccgc 
10.13 SCO6841 conserved hypothetical protein SC3D9.09 4 gaggaatcgcggattcccg 
10.12 SCO5091 cyclase 363 gccgaacgtgaccttccgc 
10.11 SCO3330c putative acetoin utilization protein 903 ccggaatcaccgtctccgg 
10.09 SCO1555c putative methyltransferase 1169 caggaacgcaacgctccgc 
10.05 SCO4283c putative sugar kinase 733 gcggagtcgcccgctccgg 
10.02 SCO5260c (the 
other atrA); 
SCO5261 
secreted protein, putative malate 
oxidoreductase -268 
cgggaatctgcccttccgg 
10.02 SCO6407 putative gamma-glutamyltranspeptidase 
(putative secreted protein) 
18 
acggaatctgacggtcctg 
 
Table S1: PREDetector output 19-mer matrix aptamers. PWM scores express the 
strength of the identified motifs. Sites that have been experimentally verified are in 
bold.  
 
Primer Name Binding site Sequence ( 5’3’) 
Product 
Size (bp) 
Template Tm 
Used for EMSA (Reverse primers “p2” were labelled at 5’ end with fluorescent (FAM)) 
actII-4p1 
actII-ORF4 
TCTCGATGTCGGCCGGTGGATGTGG 
395 
S. 
coelicolor 
55°C 
actII-4p2 FAM-TCGTGCCGCCTGAGGAGCAGCAGC 
actII-4(s2)p1 TTGGGACGTGTCCATGTAATCACC 
101 
actII-4p2 FAM-TCGTGCCGCCTGAGGAGCAGCAGC 
actIp1 
actI-ORF1 
AAGAACGAGATCCGGCGCGTC 
419 
actIp2 FAM-ACCCCTCCTTACCGAGCCTGCGGGC 
vdhp1 vdh 
(SCO4089) 
CGATCACCGAGGACACC 
386 
vdhp2 FAM-GGAGTGGAGGGCGATCACGGCCTT 
SCO4119p1 
SCO4119 
CTACACACCGTGGGAAAGAA 
180 
SCO4119p2 FAM-AGCCGCGGGAACCAACGTCG 
SCO4921p1 
SCO4921 
GCCCTTACAGAGACCTTGAC 
195 57°C 
SCO4921p2 FAM-AGGCTCCCTCCTTGAAAC 
SCO5424p1 
SCO5424 
AGCAGCTCGCCGACATC 
197 
60°C 
SCO5424p2 FAM-CGCGTCGTACTGGATCG 
SCO5529p1 
SCO5529 
CGCGCGCAGACCTCTC 
186 
SCO5529p2 FAM-CGAAGACGTGGAACGAAT 
SCO6027p1 
SCO6027 
GCAGGTGGAGCAGGTG 
165 57°C 
SCO6027p2 FAM-ACGTAGCTGCCCAGTCC 
ssgRp1 SCO3925 GTGAGAGCCGTGGGACAC 225 58°C 
121 
 
 
 
ssgRp2 FAM-AGCGAATGCGGTGTCAG 
ssgBp1 
SCO1541 
ACGGCCAAACACTACCG 
122 
ssgBp2 FAM-CGGTGCCGTTGTAAACC 
actAp1 actA 
(SCO5083) 
CGTGCTCCTCATCGTATGG 
102 
actAp2 FAM-CGGGTCCTCGACTATTGG 
tetAp1 
tetA 
CATTAATTCCTAATTTTTG 
84 
XL1-Blue 
MRF’ 
45°C 
tetAp2 FAM-CATTTCACTTTTCTCTATC 
Used for gene amplification (restriction sites are underlined) 
atrAF2 
atrA 
AAGCTTGGGCTGCAGGT 
1270 pAU-
atrA3x 
plasmid 
65°C 
atrAEcoRI- R2 GGACTGAATTCTCACACCGGCCGCGACC 
NdeIatrA-F 
atrA3x 
AAAACATATGCATGTTCAGGATTCT 
981 61°C 
atrABamHI-R ACGAAGGATCCTCACTTGTCGTCGTCGT 
Used for for generation of riboprobe templates (The T7 promoter sequence is bold) 
SRP-F 
SRP RNA 
CCGAAAAAATAATCGCCAAC 
95 
S. 
coelicolor 
55°C 
SRP-Rt7 
ATCCTAATACGACTCACTATA 
GGGACGCACCCGCCAGAG 
tmRNA-F 
tmRNA 
CCGAAAAAATAATCGCCAAC 
301 
tmRNA-Rt7 
ATCCTAATACGACTCACTATA 
GGGAATCAGGGCTTCTCCGTGT 
LDS2-F 
scr3871 (Xu 
et al., 2012) 
ACACCAACAAGGCTGGACA 
169 57°C 
LDS2-Rt7 
ATCCTAATACGACTCACTATA 
GGGGTGGGGCTAACAGGATGTGA 
LDS3-F scr2822 
(Touzain et 
al., 2008)  
ATCACGGGGGCCAACT 
114 
55°C 
LDS3-Rt7 
ATCCTAATACGACTCACTATA 
GGGGCCTTGCACCTGCATTTC 
LDS6-F scr2100 
(Touzain et 
al., 2008) 
GGCGGGAGCGAGACAC 
106 
LDS6-Rt7 
ATCCTAATACGACTCACTATA 
GGGTCTCCTGCTCCCCCGTA 
Used for QPCR 
SCO3926p1 
ssgA 
GACCGCACCGACAAGCTG 
105 
cDNA 
from RT 
60°C 
SCO3926p2 GCTCTGTTCCTCCGCCAG 
SCO1541p1 
ssgB 
GTCGTGTGCATCGCTCT 
129 55°C 
SCO1541p2 ATCGAAGTGCCGGTGTT 
SCO7289p1 
ssgC 
CCCACACGAACACCACCG 
85 
60°C 
SCO7289p2 GGCATGTGGGACGAGCTG 
SCO6722p1 
ssgD 
GGGAGAAGGTCCAGCAGA 
100 
SCO6722p2 GCCACCCTGCACTACGAC 
SCO3158p1 
ssgE 
AGTTCGCGGGAGAAGGT 
121 
SCO3158p2 GAGCGATACCCGTCGTG 
SCO7175p1 
ssgF 
AACGCACACGGTGACATA 
139 55°C 
SCO7175p2 CGAACAGCTTGGAGAGGA 
SCO2924p1 
ssgG 
CTTCTGGTGGAGGGCGTCTTC 
99 60°C 
SCO2924p2 GCTCAGCGCGACGAGTAC 
SCO3925p1 
ssgR 
GCTGTTCTTCCTCGGTGA 
136 55°C 
SCO3925p2 CCGGTACGTGGCGTAGTA 
SCO4119p3 
SCO4119 
CTGCAACGGAATCTCAAGG 
93 
60°C 
SCO4119p4 GAGGAACGGCTGATAGGTC 
SCO5529p3 
SCO5529 
CATCGCACGGCACCTGGA 
118 
SCO5529p4 GTGCTTGAAGTCGATCTCCTG 
SCO4118p1 
atrA 
GCACGTGCTCCAGATTGC 
98 
SCO4118p2 CGGCGGTGCGATGAGTA 
SCO5085p1 actII-ORF4 TACTTCGCCCTGATCGAC 139 
122 
 
 
 
SCO5085p2 CTCGCCAGAGATCCAGTC 
SCO5087p1 
actI-ORF1 
CAACGCGTACCACATGAC 
118 
SCO5087p2 GTGCGCGTTGATGTAGTC 
SCO4735p3 
rpsL 
GGCAAGTGGAAGGTCAAC 
111 
55/ 
60°C SCO4735p4 GTCGTAGCGGTTGTCCAG 
SCO5424p3 
ackA 
GAAGGACTCGTGATGGGTAC 
118 55°C 
SCO5424p4 CGCTCCTCTTGTTGAGAAG 
SCO4921p3 
accA2 
AGGCGATGAAGATGGAACAG 
119 60°C 
SCO4921p4 TCAGTCCTTGATCTCGCAGA 
SCO4922p1 
SCO4922 
GCGCTGAACTGGTTCCT 
85 55°C 
SCO4922p2 AGGACACGGACATCACG 
SCO6026p1 
SCO6026 
GCCAAGAAGCTGAAGAAGAC 
105 
 60°C 
SCO6026p2 GTCGATGACGTTCTGGATCT 
SCO6027p3 
SCO6027 
GTTCCTGGAGCACTACGG 
137 
SCO6027p4 GCTGCTCCTCGAACTGAC 
SCO4735p1 
rpsL 
AGCTACACCACCGAGTCC 
429 
S. 
coelicolor 
55°C 
SCO4735p2 CTTCAGACCGGCCTTCTT 
Used for confirmation of integrated plasmids construct into S. coelicolor 
attB-F 
attB site in 
S. coelicolor 
CGGTGCGGGTGCCAGGGC 
1635 
Transconj
ugants 
65°C 
attP-R 
attP site in 
pSET152 
TTCGGCGGCTTCAAGTTCGG 
Apra-F 
Apramycin 
gene 
TGGGCCACTTGGACTGAT 
800 60°C 
atrA56Dn-R 
downstream 
atrA 
CCGCGGTAATAACGCTCA 
Apra-F Apramycin 
gene 
TGGGCCACTTGGACTGAT 
519 bp 
58°C 
Apra-R CCGACTGGACCTTCCTTCTG 
atrAF3 atrA ACGTGCTGCTGGTCATAG 
304/ 186 
pSET-R2 pSET152 TGTTGTGTGGAATTGTGAGC 
3xatrA159-F 
upstream 
atrA 
AACGTGCCCCTTCTGAAT 
274/ 205 
3xatrA-R atrA CGGACGACCAATGAGAAT 
Used for Sequencing confirmation 
Bec-F 
atrA 
AGCGCAATCTGGAGCAC 
137 bp atrA 55°C 
Bec-R GTCCTTGCTCGGAAAGC 
gl-atrA-F 
atrA-gl 
GACCGAGCAGGCGCGTA 
189 bp atrA-gl 61°C 
gl-atrA-R GTCTCGTCCACCGATTCC 
 
Table S2: Names, binding sites, sequences, sizes, templates and annealing 
temperatures of primers used in this thesis. All primers were designed using primer3 
web-based tool. 
 
Table S3: Transcription start sites identified for S. coelicolor. The corresponding 
values where above the upper envelope boundary (see Figure 4.1). The first column 
shows the TSS id, which named based on their direction forward (FWD) or reverse 
(RVS), followed by the TSS class (I, II or III) and first nucleotide of the TSS. Second 
column represent TSS direction. Fourth and fifth columns represent nucleotide 
positions within 8 nt of each other were classified as belonging to the same TSS. (*) 
123 
 
 
 
refers to data extracted from (Cipriano et al., 2013). (**) refers to data extracted from 
(Vockenhuber et al., 2011). See Excel file on attached CD. 
Table S4: Leaderless mRNAs identified for S. coelicolor. See Excel file on attached CD. 
Table S5: Identifiable 3′ processing associated with tRNAs in S. coelicolor. See Excel 
file on attached CD. 
Table S6: Comparison with prior RNA-seq analysis of S. coelicolor. (*) indicates 
expression verified by northern blotting (Vockenhuber et al., 2011). See Excel file on 
attached CD. 
Table S7: List of annotated and small RNAs in S. coelicolor. Labelling in parentheses 
indicates whether the sRNA is upstream (u) or downstream (d) of the nearest protein-
coding gene and whether on the same (+) or opposite (-) strand. The prefix 'scr' is used 
for discrete RNAs of unknown function, 'as' is reserved for those that are antisense to 
genes, and 'rs' is served for riboswitches that appear to be active. (*) sRNA probed by 
northern blotting. (**) indicates sRNA detected by northern blotting. See Excel file on 
attached CD. 
Table S8: Examples of S. coelicolor genes whose annotation merits review. See Excel 
file on attached CD. 
Figure S1: Alignment of upstream of TSSs associated with genes of the translational 
machinery. Gaps have been introduced 6 nt upstream of the ‘-10 boxes’ (TAnnnT) to 
maximise alignment to a second conserved hexanucleotide sequence (GnTTTG), which 
labelled as ‘-35 box’. TSS loci are presented as bold alongside each sequence. 
Underlined sequences were identified using MEME (Bailey et al., 2009), while 
highlighting indicates nucleotide matches to the consensus sequences. See word file 
on attached CD. 
Figure S2: Sequence of recombinant 3xatrA (pAU-3xatrA). The ruler above uppercase 
nucleotide sequences, which are referred to the original DNA sequences, indicates 
position of a particular base pair in the constructed plasmid. Lowercase nucleotide 
sequences indicate sequenced DNA fragment, which aligned with the original 
sequences (uppercase). pAU-3xatrA construct was sequenced by Beckman Coulter 
Genomics using primers Bec-R and Bec-F (in violent). Start codon is indicated in pink, 
Lacz-α in plum, BamHI and EcoRI sites in yellow (for further details, see Section 2.16.1). 
Labels are as Figure 5.1. See word file on attached CD. 
124 
 
 
 
Figure S3: Sequence of recombinant atrA3x (pAU-atrA3x). Labelling are as Figure S2. 
See word file on attached CD. 
Figure S4: Sequence of atrA in pAU-atrA (pAU-atrA). Labelling are as Figure S2. See 
word file on attached CD. 
Figure S5: Purification of AtrA3x from E. coli by IMAC. Panel A shows the HPLC profile 
for the elution step of the purification. The absorbance measure at 260 nm (blue) and 
280 nm (red) are plotted against elution volume (mL). The green line shows the 
gradient of imidazole from 145 mM to 1 M (0 to 100%, respectively). The flow rate was 
1 mL/min. Panel B shows SDS-PAGE analysis of fractions from different steps in the 
purification. Lane 1 contains cell lysate from BL21 (DE3) cells prior to IPTG induction, 
lane 2 contains IPTG inducted BL21 (DE3) cell lysates, lane 3 contains ultracentrifuge 
supernatant, lane 4 column flow through, lane 5 before dialysis, lane 6 after dialysis, 
lane 7 contains 3.2 µg of S. coelicolor AtrA. Lanes labelled M contain PageRuler 
Unstained Protein Ladder (Fermentas). Numbering on the left of this panel indicates 
the sizes of the markers (kDa). Lane 7 contained 3.2 µg of purified S. coelicolor AtrA. 
See word file on attached CD. 
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